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SUMMARY
STUDIES ON THE COMPARATIVE VIROLOGY OF PESTIVIRUSES
This study reports the in vivo and in vitro comparison of 
two pestivirus isolates, one of swine (87/6) and another of 
sheep origin (137/4). Both showed similar growth 
characteristics in vitro, and other features in common with 
most border disease virus (BDV) strains. It was hypothesized 
that, rather than being a strain of hog cholera virus 
(HCV), the swine isolate might be a "BDV-like virus" 
infecting pigs. Both viruses were inoculated into pregnant 
swine and sheep in order to: a) determine whether or not the 
swine isolate would infect the offspring in utero and b) to 
ascertain the congenital transmissibility of BDV to swine.
Both viruses were able to cause transplacental infections in 
the two species. A variety of combinations of virus and 
antibody status were recorded in the fetuses, including some 
which revealed the concomitant presence of virus and 
antibody, suggesting the presence of circulating immune 
complexes. Pathological findings were compatible with 
previous reports of border disease in sheep.
It was concluded that the swine isolate could not be 
distinguished from the BDV isolate 137/4 on the basis of 
their cell culture growth characteristics and ability to in-
duce transplacental infections in both sheep and swine, or 
by the serological responses of infected animals. These 
findings provided evidence that the isolate 87/6 is a virus 
more closely related to BDV than to HCV, despite its origin 
from swine.
Next, a fraction of the pestivirus genome coding for 86% of 
the core gene was prepared from both isolates using reverse 
transcription polymerase chain reaction. Amplified fragments 
were subsequently cloned, sequenced and compared with other 
pestivirus genomes. This provided further support for the 
hypothesis of the BDV-like nature of the swine isolate. It 
is suggested that the virus may have crossed the species 
barrier in nature. The present study shows that
transplacental infections in swine with BDV-like viruses can 
occur.
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CHAPTER 1 . LITERATURE REVIEW
1.1, Taxonomy:
At present, hog cholera virus (HCV) (synonym: classical 
swine fever virus), bovine viral diarrhoea virus (BVDV)
(synonym: mucosal disease virus) and border disease virus 
(BDV) are members of the Pestivirus genus of the family 
Togaviridae. The other three genera within the family are 
Alphavirus, Rubivirus and Arterivirus.
The genus Pestivirus can be defined as enveloped RNA 
viruses, 50—60 nm in diameter, which multiply in the
cytoplasm and accumulate in cytoplasmic vesicles.
Molecular weights (MWs) of structural proteins most 
generally reported are 55-57 kilodaltons (kDa), 44-46 kDa
and 34-36 kDa. The viruses have a buoyant density around 
1.13 g/ml in CsCl. They are serologically interrelated, 
but unrelated to other members of the Togaviridae. In 
comparison to the alphaviruses, no invertebrate host has, 
to date, been identified for pestiviruses. Vertebrates 
affected are bovine, swine, ovine and caprine. Vertical 
transmission is common (Westaway and others, 1985). The
type species of the genus is BVDV strain "Oregon C24V" 
(Gillespie and others, 1960).
To date, pestiviruses have been only partially
1
characterized, mainly due to difficulties in growth, 
purification and assay of these viruses. Recent work
indicates that the genomic organization of BVDV is
very similar to that of the flavivirus genus of the family
Flaviviridae (Collett and others, 1988c). The taxonomic
position is, therefore, currently under review. The 
comparative aspects of pestiviruses and viruses of other 
groups are discussed below (see section 1 .8 ).
The viruses are responsible for hog cholera (HC) in swine 
(HCV), bovine viral diarrhoea (BVD) and mucosal disease (MD) 
in cattle (BVDV) and border disease (BD) or "hairy shaker" 
in lambs. Although the preferential hosts for each of the 
presently recognized pestiviruses are well known (swine 
for HCV, bovine for BVDV, ovine and caprine for BDV), the 
natural host range may include a wider variety of 
Artiodactylae. Evidence exists for pestivirus infections 
in a variety of wild ruminants (Nettleton, 1990) . It has 
also been suggested that pestiviruses might infect 
human beings (Giangaspero and others, 1988; Yolken and 
others, 1989; Wilks and others, 1989; Potts and others, 
1987), however more evidence is required to allow any 
conclusions to be drawn regarding human infections. 
Throughout this thesis, the term pestiviruses will refer to 
the three recognised members of the group (HCV, BVDV and 
BDV), unless otherwise stated.
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1.2. The genome of pestiviruses:
The nucleic acid of pestiviruses is single stranded RNA of 
positive polarity (Horzinek, 1976), with a sedimentation 
coefficient of 37-45S (Horzinek, 1976; Enzmann and Rehberg, 
1977). Both HCV and BVDV RNAs have been shown to be in­
fectious (Zeegers and Horzinek, 1977; Frenzel and Meyer, 
1980). The RNA of BVDV has been shown to have a high degree 
of secondary structure (Purchio and others, 1983). Also, 
unlike the Alphavirus and Rubivirus genera of Togaviridae, 
no sub-genomic RNA species has so far been identified in 
pestivirus infected cells (Westaway and others, 1985).
Evidence for the presence of complementary ("minus") RNA 
moieties has recently been presented (Schroeder and 
Balassu-Chan, 1990). Whether these RNA moieties represent 
fragments of sub-genomic RNA or full length minus strands, 
remains to be determined. The role of such minus moieties 
in virus multiplication also remains undetermined. It has 
been suggested that, as with flaviviruses, the complementary 
strand might be necessary for the transcription and ac­
cumulation of positive sense ("plus") RNA necessary for 
translation and virion assembly (Schroeder and Balassu-Chan, 
1990). Such a mechanism of multiplication would add to the 
similarities found between pestiviruses and flaviviruses 
(see below section 1 .6 .).
The MW of pestivirus RNA is about 4 x 1 0 * *  daltons (Enzmann 
and Rehberg, 1977; Collett and others, 1988a). Pestivirus
genomes so far sequenced are about 12 kilobases (kb) in 
length (Renard and others, 1985; Collett and others, 1988a; 
Meyers and others, 1989; Moormann and others, 1990).
The base composition of the two BVDV strains sequenced was 
found to be nearly identical. The composition of the NADL 
strain is A 31 .7%, G 25.7%, U 22.2% and C 20.4% (Collett 
and others, 1988a). The sequence of the NADL strain was 
found to be 12,573 nucleotides in length, with one single 
open reading frame (ORF) starting at positions 386-388 (from 
the 5 1 end of the genome) and extending up to nucleotide 
12,349. It was determined to have a coding capacity for 3988 
amino acids or 449 kDa of protein.
For HCV, the nucleotide sequence of the strains Alfort 
(Meyers and others, 1989) and Brescia (Moormann and others, 
1990) have been published. The sequence of the Alfort 
strain of HCV is 12,284 nucleotides in length, with one 
large ORF of 11 ,694 nucleotides starting at position 5' - 
364 to 366 and extending up to nucleotide 12,058. This 
corresponded to 3898 potentially coding codons, with a 
coding capacity for 435 kDa of protein (Meyers and others,
1989). The sequence of the Brescia strain of HCV was 12,283 
nucleotides long (Moorman and others, 1990). Its single ORF 
started at position 5'- 361 to 363 and extended up to the 
TGA stop codon at position 12,055 to 12,057. The single 
ORF was shown to have a coding capacity for 439 kDa of pro­
4
tein (Moorman and others, 1990).
An accurate analysis of the termini of the RNA of 
pestiviruses has not yet been reported. The results obtained 
so far indicate that the viral genome lacks a significant 
polyadenylated tail (Purchio and others, 1983; Renard and 
others, 1985; Potgieter and Brock, 1987). On the other 
hand, the 5 1 end of the pestivirus genomes so far sequenced 
have sequences have no "cap" structures (Collett and others, 
1989; Moorman and others, 1990; Meyers and others, 1989).
Renard and colleagues (1985) described for the BVDV strain 
Osloss the presence of two large potential protein-coding 
regions, whereas Collett and others (1988a) found only 
one ORF. As commented above, the two published sequences of 
HCV strains also indicate the presence of only one ORF 
(Moormann and Hulst, 1988; Meyers and others, 1989). Later, 
the presence of two ORFs in the Osloss strain was recognized 
as equivocal (Renard, quoted in Moorman and others, 1990).
1.3. Comparison of amino acid sequences:
The HCV strains Brescia and Alfort have an overall amino 
acid homology of 93% (Moorman and others, 1990). The Alfort 
strain has a homology of about 85% in amino acids in 
relation to the NADL BVDV strain (Meyers and others, 1989), 
whereas the Brescia strain has about 70% overall amino acid
5
homology with both BVDV strains sequenced (Moorman and oth­
ers, 1990). The level of homology is not evenly distributed 
throughout the genome, the highest variation being found at 
the region of the putative glycoproteins (Collett and 
others, 1989; Moorman and others, 1990). On the other hand, 
the most conserved regions were those coding for a protein 
of 80 kDa (see proteins of pestiviruses below).
1.4. The proteins of pestiviruses:
There is still uncertainty regarding which proteins of 
pestiviruses are actually components of the virion or 
non-structural polypeptides. Pestivirus RNA is translated 
into a large precursor polypeptide, which is probably split 
into viral structural and non-structural proteins during and 
after translation (Purchio and others, 1984; Akkina, 1983;
Moormann and others, 1990). In Table 1.1 a summary of the 
published data on pestivirus proteins is presented.
HCV:
Three structural polypeptides with MW 55 kDa, 46 kDa and 36 
kDa were described for HCV, of which the first two were 
glycosylated (Enzmann and Rehberg, 1977; Enzmann and 
Hartner, 1977). The glycosylated protein of 46 kDa (gp46) 
was the main protein found in cell culture supernatants, 
probably as a result of the loss of the fragile spikes seen 
in the HCV envelope (Enzmann, 1988).
6
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The nonstructural proteins of HCV appear to be similar to 
those of other pestiviruses. The most conserved protein of 
pestiviruses is a protein of MW 80 kDa (p80 ), derived from 
p125, and supposed to be the common cross-reactive antigen 
of pestiviruses (Matthaeus, 1980; Collett and others, 1989).
BVDV:
In the first report on BVDV polypeptides, three proteins 
were identified, respectively gp57, gp44 and p34
(Matthaeus, 1979). These were believed to represent 
structural components of the virus, in analogy with previous 
findings for HCV. After that, a much wider variation has 
been reported in the protein composition of BVDV. The 
polypeptide gp53 is the major protein involved in neu­
tralization (Dubovi and others, 1987; Donis and others, 
1988; Bolin and others, 1988; Magar and others, 1988a), and 
is therefore likely to be a structural component of the 
virus. The other structural components of BVDV are 
uncertain, since the method used by most authors for the
determination of virus proteins (i.e. radio- 
immunoprecipitation) does not discriminate between
structural and non-structural components. The number of pro­
teins identified in infected cells ranges from 3 to 12,
with considerable variability in MWs (Table 1.1.). Com­
parisons between strains of BVDV revealed a marked variation 
between protein MWs of different isolates. The most strik­
ing observation was the presence of the 80 kDa polypeptide
only in strains of the cytopathic (CP), and not of the 
non-cytopathic (NCP) biotype (Donis and Dubovi, 1987c, d; 
Pocock and others, 1987; Magar and others, 1988b).
BDV:
There is little information on the protein composition of 
BDV. Akkina (1983) observed that BDV polypeptides of 115 kDa 
60 kDa could be precipitated from infected cells by BVDV 
anti serum. The 115 kDa polypeptide appeared to be very 
similar to the BVDV pi 15. Nettleton (1985) described a 
peptide of 80 kDa which was detected in BDV infected cells, 
probably analogous to the pBO found in radio- 
immunoprecipitates of BVDV— and HCV—infected cells 
(Matthaeus, 1980; Collett and others, 1988b). More recently, 
it has been shown that polypeptides of apparent MW 80 kDa 
and 130 kDa were precipitated from cells infected with with 
a cloned CP strain of BDV (strain Moredun), whereas a single 
polypeptide of 120 kDa was precipitated from cells infected 
with the NCP variant of the same virus (Dutia and others, 
1990). Therefore, a similar association between 
cytopathogenicity and protein processing appears to apply 
for both BVDV and BDV.
1.5. Genomic organization of pestiviruses:
Collett and others (1988b) produced a series of chimaeric 
BVDV proteins as fusion peptides in Escherichia coli , which
were then inoculated into mice or rabbits in order to obtain 
a panel of monospecific antisera. The antisera were then 
allowed to react with radiolabelled infected cell lysates. 
Using this method, they putatively assigned the 
corresponding regions of the genome to the polypeptides 
encoded (Fig. 1.1). Thus, from the 5' end of the genome on­
wards, the first was p20, to which no corresponding 
peptides were found in infected cells. Next was pi 16 which 
spanned the entire region of the genome coding for the pu­
tative glycoproteins and was precursor to both gp62 and 
gp53. Further post-translational processing of gp62 origi­
nated gp48 and gp25. After that, there is a region with a 
coding capacity of 30 kDa, to which no polypeptides were as­
signed. The next polypeptide, p125, was found to be the 
precursor to p54 and p80. This is particularly interesting 
since pBO is the polypeptide absent from radio- 
immunoprecipitates of NCP BVDV strains (Pocock and others, 
1987; Donis and Dubovi, 1987a, b ) . Further along the genome 
(towards the 3' end) was located p133, precursor to p58 and 
p7 5 . The pi 33 region was considered to be the region 
responsible for the viral RNA polymerase. In addition, 
there were two segments with a potential coding capacity 
for two polypeptides of 30 kDa and 38 kDa respectively, at 
the boundary regions between gp53/p125 and p125/p133, whose 
products were not identified (Fig. 1.1.). This model of or­
ganization has recently been reviewed, and the results of 
such findings are in press (Collett and others, 1991).
10
Fig. 1.1. a) Schematic representation of the potential 
protein-coding (S' to 3 1 ) regions of BVDV strain NADL. The 
rectangle represents the whole genome with one single ORF 
(thick bars). The numbers above the rectangle refer to the 
approximate amino acid position. Lines below the rectangle 
represent the putative BVDV NADL proteins in its positions 
relative to the potential coding region on the genome. Numbers 
close to the lines refer to the respective MWs of proteins (p)
or glycoproteins (gp). Broken lines refer to the regions to
which no polypeptides had so far been assigned, with MWs
30 kDa ( 30K?) and 38 kDa ( 38K? ) . b) Relative position of HCV 
glycoproteins in respect to the NADL genome (Stark and others, 
1990) . Other HCV proteins (not shown) are presumptively 
similar to those of NADL (Meyers and others, 1989; Moormann
and others, 1990).
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Moormann and others (1990) proposed a model for HCV genome 
organization at the 5 1 end of the genome, the region 
expected to code for the structural proteins of the virus. 
Based on the analysis of the sequence of the Brescia strain, 
they predicted a genomic organization similar to that 
proposed for BVDV (Collett and others, 1988b) . The first 
protein, p30, was equivalent to the p20 of BVDV, and was 
supposed to represent the as yet unidentified capsid protein 
of HCV. Next, a glycosylated protein, gp42, was predicted, 
analogous to gp48 of BVDV. A small glycoprotein, gp31, was 
to follow, equivalent to BVDV p25. Adjacent to that region 
would be the putative glycoprotein of approximately 53 kDa, 
the major glycoprotein of HCV strains, equivalent to BVDV 
gp53. The non-structural proteins would be encoded by the 
remaining region of the genome towards the 3 end, in 
analogy with BVDV (Moormann and others, 1990). Stark and 
others (1990) also examined the glycoprotein region of HCV. 
They found four glycoproteins whose putative order in the 
genome was 5 ' - gp44/gp48-gp33-gp55-31, which is similar to 
the previous models proposed (Collett and others, 1988b;
Moorman and others, 1990). The proposed genomic
organization of the putative HCV glycoproteins is compared 
with the equivalent region of BVDV NADL in Fig. 1.1.
The BVDV strains Osloss and NADL were shown to possess 
insertions at the region coding for the (putative) 
non-structural protein of 125 kDa. The insertion in the
13
Osloss genome has a nucleotide sequence homologous to the 
protein ubiquitin, one of the normal cell constituents and 
found widespread throughout the zoological scale. A 
different insertion, although at approximately the same 
region, was also found in BVDV NADL (Moormann and others,
1990). Such insertions might have been incorporated into the 
virus genome through recombination (Meyers and others, 
1989b). Based on the absence of such insertions in the two 
published HCV sequences (both clearly NCP, see below), it 
has been speculated that their presence may be related to 
the differences between CP and NCP strains of BVDV found in 
animals suffering from MD (Meyers and others, 1990). No
sound evidence, however, has to date been presented to 
support such a hypothesis (Moormann and others, 1990).
1.6. Comparison with viruses of other groups:
It has been suggested that pestiviruses be reclassified as 
members of the family Flaviviridae (Renard and others, 1985; 
Collett and others, 1988c). In analogy to flaviviruses, BVDV 
RNA lacked a 3 1 poly-A tract, and no subgenomic RNA has been 
detected in infected cells (Purchio and others, 1983; Renard 
and others, 1985). Furthermore, the genomic organization
appears to be very similar to that described for 
f laviviruses. From the 5 1 end of the genome, the region 
coding for the core protein and the matrix protein of 
flaviviruses seems analogous to the p20-30 of
14
pestiviruses. Next is the region encoding the putatively 
structural glycoproteins in both pestiviruses and
flaviviruses. Further along the genome is the region 
responsible for the non-structural proteins of flaviviruses 
which may have their counterparts in p125 and p133 of 
pestiviruses (Meyers and others, 1989; Moormann and others,
1990; Stark and others, 1990). The reclassification has
been criticised based on the lack of homology between se~ 
guences (Meyers and others, 1989; Moormann and others, 
1990). In addition, another argument used to suggest the
inclusion of pestiviruses in the Flaviviridae relies on the 
similarity of segments of pi 33 with a number of viral RNA 
polymerases, in particular the motif Gly-Asp-Asp, found only 
once in the two BVDV strains sequenced (Collett and others, 
1988c). Such a motif, however, was found repeated in 
distinct locations on HCV strains, more precisely on amino 
acid positions 2,227-2,229 in Alfort and Brescia, and again 
encoded by residues 784-786 in the Brescia strain (Moormann 
and others, 1990). Therefore, the presence of that amino 
acid sequence in different regions and its presence more 
than once in HCV strains seems to oppose such an argument.
Similarity in the predicted protein sequence was also found 
between the NS3 protein of flaviviruses, the plant 
potyvirus Cl coat protein (Lain and others, 1989) and the 
p80 region of pi 25 in HCV and BVDV, suggesting that p80 
might represent a protein with helicase activity (Moormann
15
and others, 1990). In addition, a trypsin-like serine 
protease domain has been identified in both flavivirus NS3 
and p80 (Bazan and Fletterick, 1989). The nucleotide 
sequences in the equivalent pBO regions on the other 
pestivirus strains (e.g. BVDV Osloss, HCV Alfort and 
Brescia) were nearly completely conserved (Moormann and 
others, 1990). These findings were suggestive that pBO might 
be a bifunctional protein, with helicase and protease 
activity (Moormann and others, 1990).
More recently, it was shown that hepatitis C virus (or 
non-A, non-B hepatitis) shares significant protein sequence 
similarity with the non-structural protein NS3 of 
flaviviruses. Even greater similarity was found with the 
equivalent region (p125) in pestiviruses (Miller and 
Purcell, 1990). In addition, protein sequence similarity 
with some plant virus supergroups was also found. Based on 
these similarities, it was suggested that there may be an 
evolutionary link between the the group of viruses 
encompassing pestiviruses, flaviviruses and plant viruses, 
where hepatitis C virus would be an example of such a link 
(Miller and Purcell, 1990).
1.7, Antigenic relationships:
Pestiviruses have been shown to cross-react in laboratory 
tests. However, no cross-reactivity has been reported with
16
other members of the Togaviridae (Westaway and others, 
1985). HCV was first seen to cross-react serologically with 
BVDV on an agar-gel precipitation test (Derbyshire, 1960). 
This relationship was confirmed thereafter (Dinter, 1963; 
Mengeling and others, 1963a; Snowdon and French, 1968; 
Corthier and others, 1974; Liess and others, 1977). The 
serological relationship between BVDV and BDV was discovered 
later (Acland and others, 1972; Hamilton and Timoney, 1972). 
Cross-reactivity between the three pestiviruses was also 
observed in neutralization tests (Osburn and others, 1973). 
There were, however, considerable differences between the 
levels of cross-reactivity among strains (Corthier and 
others, 1974; Hafez and others, 1976; Liess and others, 
1977). The nature of this neutralizing cross-reactivity is 
still unclear (Moennig and Liess, 1990).
1.8. Viral multiplication:
Adsorption of pestiviruses to the cells has been reported to 
be slow and dependent on the cell system used (Horzinek, 
1981; Enzmann, 1988). Complete adsorption of BVDV in calf 
testis cells was only attained after 100 minutes (Moennig,
1971). Addition of DEAE-Dextran allowed an increase in speed 
of adsorption and infectivity. Spleen cells allowed adsorp­
tion 13 times quicker than kidney cells (Schiff and others,
1973).
17
The first HCV antigens were detected at 4-7 hours 
post-infection, with an exponential growth up to 15 hours 
(Enzmann; 1988). The first detectable viral RNA was found 
at 6 to 8 hours post-infection, but its synthesis was highly 
dependent on the multiplicity of infection (Horzinek, 1981). 
In studies with BVDV, the first detectable viral products 
were found at about eight hours post-infection, followed by 
exponential phases of up to twelve hours (Nuttall, 1980).
A hypothesis for HCV maturation has been proposed in which 
it would be achieved by budding through the vesicles of the 
Golgi apparatus and from there transported to the outside of 
the cell (Scherrer and others, 1970). It did not exclude, 
however, the possibility of budding directly at the outer 
cell membrane (Scherrer and others, 1970).
Cytopathic effect:
So far, only two strains of HCV induced cytopathic effects 
when cultured i n  v i t r o (Laude, 1987). These strains are 
presently not used in most laboratories for studies on HCV 
and are mentioned here for historical reasons. All other 
HCV strains are NCP. Amongst pestiviruses of ruminants, 
non-cytopathic strains are most common, and are capable of 
inducing persistent infections i n  vivo (Roeder and Drew,
1984). Strains of BVDV that are CP in  v i t r o , are found in 
episodes of MD in cattle (Brownlie and others, 1984). In 
sheep, CP BDV strains can rarely be isolated from animals
18
affected with a "mucosal disease-like syndrome" (Barlow, 
1983; Gardiner and others, 1983).
1.9. Pathogenesis :
1.9.1. Postnatal infections:
HCV:
HCV is responsible for swine fever or HC, the most 
economically important disease caused by members of 
the pestivirus group. Strain variation may account 
for differences in pathogenic effects of pestiviruses 
(Van Oirschot, 1988; Terpstra, 1985; Harkness and Roeder,
1988). For HCV, in particular, a classification of strains 
based on their virulence for swine is generally accepted, 
with the term "virulence" being used to define the 
capacity of a strain to induce disease of more or less 
severity. Highly virulent strains tend to produce acute or 
peracute disease, while strains of moderate virulence 
usually induce subacute or chronic disease in younger 
animals. Low-virulence strains tend to cause little or no 
clinical disease, although they may still be pathogenic 
for fetuses. Finally, the avirulent strains are
non—pathogenic even for fetuses (Van Oirschot, 1980) . A 
brief summary of the different forms of HCV infections and 
their main features is presented in Table 1.2.
19
The peracute form of HC is characterized by death of the 
infected animals within two to five days post-infection, 
without showing any clinical signs except for a rise in 
temperature. This can be observed when the infection occurs 
in a non-immune population (Dunne, 1975). The classical 
acute form can lead to mortality rates approaching 100%. 
Initial signs are generally observed after two to seven 
days of exposure and consist of fever, anorexia
and depression. Conjunctivitis, nasal discharge and
digestive system disturbances may also be observed. The 
most characteristic features of acute infections are the 
severe generalized vasculitis and depletion of lymphocytes. 
Generalized petechiation, infarction of the spleen 
and signs of encephalitis are common. Death occurs 
usually up to 20 days after infection. An example of HC in 
its classical acute form has been recently described in 
Great Britain, where the disease affected a totally 
susceptible population (Williams and Mathews, 1988). A 
subacute form of HC has also been described, where 
infected animals develop less severe clinical signs than 
in the acute form, and die within 30 days (Dunne, 
1975). The chronic form of HCV infection is characterized 
by a prolonged period of disease which can be extended for 
30 or more days (Van Oirschot, 1980; Mengeling and 
Cheville,1968; Mengeling and Packer, 1969). In contrast, the 
late onset form of the disease is associated with prenatal 
infections in peristently infected piglets, and will be
20
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referred to later (Van Oirschot and Terpstra, 1977).
Pestiviruses of ruminants:
BVDV is clinically associated with two diseases: BVD, a
relatively mild, acute disease in immunocompetent cattle 
(Olafson and others, 1946) and MD, a usually lethal 
manifestation in persistently infected cattle (Ramsey and 
Chivers, 1953; Roeder and Drew, 1984). The pathogenesis of 
BVDV infections in cattle is represented schematically in 
Fig. 1.2. The majority of postnatal infections of cattle 
with BVDV are subclinical (Malmquist, 1968). Clinically 
noticeable acute BVD infections are usually observed in 
cattle between 6 months and two years of age (Baker, 1987). 
The clinical signs that can be observed are fever, 
leucopenia, depression, nasal discharge, cough, erosions of 
mucosal surfaces, laminitis and diarrhoea (Pritchard, 1963). 
Postnatally acquired BVDV has been shown to cause 
immunosuppression and may potentiate the effects of other 
infections (see section 1.7). More recently, BVDV has 
increasingly been incriminated in North America as the 
aetiological agent of a disease observed mainly in veal 
calves, characterised by severe thrombocytopenia and 
haemorrhages (Rebhun and others, 1989; Corapi and 
others,1989, 1990). So far, no similar manifestation of
BVDV infections in postnatally infected animals have 
been described outside the United States of America.
22
Fig. 1.2. Schematic representation of the pathogenesis of BVDV 
infections in cattle (adapted from Harkness, 1987). Signs 
"+ve" and "-ve" refer to presence or absence of detectable 
virus (V) or neutralizing antibodies (Ab). "Sheep" and "Deer" 
illustrate other species that may act as possible sources of 
virus contamination for cattle. "Synergisms" represent other 
possible concurrent infections that may contribute to the 
clinical picture.
23
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Infections with BDV in sheep in the postnatal period are 
mostly sub-clinical (Nettleton, 1990). A mild febrile 
response and a transient neutropenia may occur (Shaw 
and others, 1967; Vantsis and others, 1979). However, in 
France, a BDV-like virus was isolated from a clinically 
severe syndrome characterized by leucopenia, enteritis and 
high mortality (Chappuis and others, 1984, 1986). Therefore, 
as the other members of the group, BDV may also be 
implicated in episodes of acute clinical disease.
1.9.2. Prenatal infections :
Most of the pathogenesis of pestiviruses, particularly the 
pestiviruses of ruminants, is associated with prenatal 
infections (Gillespie and others, 1967; Barlow, 1983). 
All three recognised pestiviruses may cause pathology in 
the fetuses, or may cross the placenta without producing 
any lesions (Casaro and others, 1971; French and others, 
1974; Van Oirschot, 1983). This section reviews what is 
known about the pathological findings with the gestational 
period, from conception to birth. In Fig. 1.3. a diagram 
of the likely outcome of fetal infections with pestiviruses 
is presented.
Transmission of BVDV and BDV to the fetus via semen can 
occur, but is probably a rare event (Gardiner and Barlow, 
1981 ; Meyling and Jensen, 1988; Paton and others, 1990).
25
Fig. 1.3. Schematic representation of of the likely outcome of 
pestivirus infections in different periods of gestation. 
Rectangles represent the gestational periods of swine, ovine and 
bovine. Numbers refer to days of gestation. Hatched areas 
refer to approximate period of emergence of
immunocompetence. The signs " + " and " - " refer respectively to 
presence or absence of detectable infectious virus or 
neutralizing antibodies. (adapted from Harkness, 1987 and 
Nettleton, 1990).
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This is in agreement with the protective action of the 
zona pellucida on the embryo against infection by most 
viruses, including pestiviruses (Evermann and others, 
1981 ; Singh and others, 1982; French and others, 1974; 
Dulac and Singh, 1988; Gillespie and others, 1990) . Other 
authors, however, showed that BVDV may interfere with 
fertilization in artificially inseminated cows, in cows 
served by persistently infected bulls or semen, or yet 
by intrauterine infusion of the virus (Archbald and 
Zemjanis, 1977; McClurkin and others, 1979; Whitmore and 
others, 1981 ; Grahn and others, 1984; Barlow and others,
1986; Meyling and Jensen, 1988). BVDV was also reported 
to persist in the ovaries of infected calves, in the
absence of a persistent viraemia (Ssentongo and others, 
1980).
Following implantation in the uterus, infection most 
probably leads to fetal death and resorption of embryonic 
tissues (Dunne and Clark, 1968; Archbald and Zemjanis, 1977; 
Grahn and others, 1984; Whitmore and others, 1981; Manktelow 
and others, 1969).
If the fetus is big enough to avoid regression of the corpus 
luteum (Kendrick, 1971), or if there are more fetuses in 
gestation, the soft tissues may be autolysed, but the
inability to reabsorb the bones may give rise to a 
mummified or macerated fetus. Mummification is a common
28
finding in infections with the three major pestiviruses 
(Van Oirschot, 1983). Despite the presence of mummified fe­
tuses, provided that there are more animals in gestation, it 
is very likely that the pregnancy will continue to term or 
be aborted later.
Abortion is more frequently associated with pestivirus 
infections in cattle and sheep than in swine. In the latter, 
abortion is usually related to infection early in 
gestation (Van Oirschot, 1983), while in cattle, it is
usually observed following infections between 50 to 100 
days of gestation (Kahrs, 1968; Casaro and others, 1971; 
Kendrick, 1971 ; Done and others, 1980; Duffell and Harkness, 
1985). In sheep, abortion has been observed in in­
fections up to mid-pregnancy (Barlow and Gardiner, 
1969). The placentitis observed in infected sheep (Barlow,
1972) may also lead to early deaths or abortions (Barlow, 
1983). The induction of abortion may be related to a 
precociously enhanced fetal adrenocortical activity (Osburn 
and others, 1972).
Malformations may be seen if infection occurs at a time 
when organ differentiation is taking place (Baker and 
Sheffy, 1960; Johnson and others, 1974; Van Oirschot, 1979a; 
Barlow, 1983). A number of different malformations or
degenerations of already formed organs have been reported 
after congenital infections with pestiviruses. Central
29
nervous system (CNS) pathology is a common target for 
malformations or degenerative lesions in pestivirus 
infections. Signs of CNS involvement include the "con­
genital tremor" observed in HC, associated with cerebellar 
hypoplasia (Harding and others, 1964, 1966; Done and
Harding, 1966; Vannier and others, 1981). On the other 
hand, the classical tremor or "hairy shaker" observed in BD 
affected lambs is related to the hypomyelination
particularly of the spinal cord (Anderson and others, 
1987). Tremor can also be seen in cattle, but is not a 
typical feature of BVDV infection (Done and others, 1980). 
Other lesions in the CNS can be found to different degrees, 
varying from decreased brain weight to severe cavitating 
lesions (Terlecki and others, 1973; Scott and others, 1973;
Brown and others, 1973; Done and others, 1980). In addition, 
defects of skin or its appendages, such as the "hairyness" 
of BD affected lambs (Derbyshire and Barlow, 1976), 
alopecia in piglets (Carbrey and others, 1976) and alopecia 
and dermatitis in calves (Casaro and others, 1971) can be 
observed. Lesions in the eyes, thymus, lungs, bones and 
articulations have also been reported (Ward, 1971; 
Casaro and others, 1971; Scott and others, 1973; Terlecki 
and others, 1973; Brown and others, 1974, 1975; Richardson, 
1977; Roeder, 1974; Van Oirschot, 1980).
Stillbirths can also occur, usually after infection during 
the second half of gestation. In one experiment with HCV, a
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high incidence of stillbirth and mummification was observed 
in litters of sows infected between 30 and 100 days of
gestation (Cowart and Morehouse, 1967). The greatest number 
of stillborns was obtained from sows infected between days 
70 and 90. Stillbirth is more frequently seen in HCV
infections than in BVDV or BDV infections (Van Oirschot, 
1983).
Intra-uterine growth retardation (IUGR) is also a frequent 
sequel to pestivirus infections (Terpstra, 1985; Richardson, 
1977; Ohmann, 1982; Done and others, 1980), and can occur at 
any gestational age (Duffell and Harkness, 1985). Growth 
arrest lines (GALs) in the bones of affected fetuses may
be observed in infections with the ruminant pestiviruses
(Terlecki and others, 1973; Done and others, 1980).
1.9.3. Persistent infections:
HCV strains of low to moderate virulence and NCP strains of 
pestiviruses of ruminants are capable of causing persistent 
infections (Van Oirschot, 1983; Nettleton, 1987; Brownlie 
and others, 1989). If the conceptus is infected before the 
development of fetal immune competence, a persistently 
infected animal may be born that will probably harbour the 
virus throughout life. Virus antigens would, in theory, be 
recognised as "self11, thus leading to immunological 
tolerance (Brownlie, 1990). The host would become
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specifically immunotolerant to the infecting strain (Baker 
and Sheffy, 1960; Van Oirschot, 1979a; Frey and others, 
1980; Plateau and others, 1980; Liess and others, 1984; 
McClurkin and others, 1984). This phenomenon probably 
represents the most important factor in the maintenance of 
pestiviruses in nature, since it allows infectious virus to 
be continuously shed into the environment (Coria and 
McClurkin, 1978; Van Oirschot, 1979a; Terpstra, 1981). 
HCV-persistently infected swine tend to die early in 
postnatal life (Van Oirschot, 1988), while cattle and 
sheep persistently infected with pestiviruses of ruminants 
can survive for years without clinical signs of disease and 
give birth to persistently infected offspring (Westbury and 
others, 1979; McClurkin and others, 1979). These
persistently infected "families" have great epidemiological 
significance in the maintenance and spread of infection in 
herds (Littlejohns and Walker, 1985). Affected animals 
often bear clinical signs or lesions. They usually have no 
specific neutralizing antibodies in their sera, and virus 
can be recovered from their tissues without difficulty (Done 
and others, 1980). Persistence has often been reported as 
"neither absolute nor permanent", due to low or fluctuating 
levels of neutralizing antibodies found in some
persistently infected animals (Van Oirschot, 1983; Brown and 
others, 1973; Scott and others, 1973; Roeder and others, 
1987; Edwards and others, 1991), or the ability to produce 
neutralizing antibodies to other antigenically distinct
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pestivirus strains (Steck and others, 1980; Bolin and 
others, 1985a; Brownlie and others, 1987a, b; Shimizu and 
others, 1989; Bolin, 1988).
Chronic forms of disease in persistently infected animals: 
Chronic forms of disease associated with congenitally 
acquired pestivirus infections have been described. The 
late onset disease in HCV is related to intrauterine 
infections of piglets with strains of low virulence. The 
affected animals show progressive depression, anorexia, 
conjunctivitis, dermatitis and locomotion disturbances (Van 
Oirschot, 1988; Cheville and Mengeling, 1969). The disease 
can be prolonged for as much as eleven months. Viraemia and 
absence of detectable immune responses are observed 
throughout (Van Oirschot and Terpstra, 1977; Van Oirschot, 
1977, 1988). In BVDV infections, the chronic form of BVD is 
characterised by anorexia, long episodes of intractable 
diarrhoea, rhinitis, conjunctivitis and dermatitis. 
Progressive cachexia may last for several months (McClurkin 
and others, 1985). Both CP and NCP forms of BVDV can be 
isolated from affected animals. The pathogenesis of such 
BVDV chronic infections is not well established. A mechanism 
based on partial homology of the persistently infecting 
strain, and a superinfecting NCP strain has been proposed 
(Brownlie and others, 1987b) . In some cases it may be 
associated with an incomplete form of specific 
immunotolérance (Edwards and others, 1991).
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Mucosal Disease:
MD is a clinical entity that corresponds to the development 
of a usually fatal illness (Malmquist, 1968) in cattle born 
with a persistent BVDV infection (Boeder and Drew, 1984; 
Liess and others, 1974). The pathogenesis of the disease has 
been related to the presence of two forms of BVDV, 
distinguishable by their in vitro characteristics. The CP 
biotype is able to cause cytopathogenicity in cultured 
bovine cells (usually CTs, BTs or MDBKs; see Chapter 3), 
whereas the NCP viruses cannot. Persistence has been 
reported to be induced only by NCP strains (Brownlie and 
others, 1984). In MD affected calves, both NCP and CP 
biotypes of virus can be isolated (Brownlie and others, 
1984; Bolin and others, 1985c; Barber and others, 1985; 
McClurkin and others, 1985). Both CP and NCP viruses iso­
lated from MD cases induce in infected cells an almost 
identical protein profile when analysed by poly-acrylamide 
gel electrophoresis (PAGE), differing only in the absence of 
a protein of 80 kDa in the NCP strains (Pocock and others,
1987). Experimentally, MD has been induced by superinfection 
with the homologous CP biotype in calves persistently 
infected with the NCP virus ( ; Bolin and others, 1985a; 
Clarke and others, 1987). Other strains of similar matching 
profile may also trigger MD (Liess and others, 1983; Bolin 
and others, 1985a; Moennig and others, 1990). The origin of 
the the CP virus in natural cases of MDis still unknown, 
but due to its close similarity with the NCP virus, it is
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Fig. 1.4. Current hypothesis on the pathogenesis of Mucosal 
disease (Brownlie, 1990).
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more likely that it originates from within the infected 
herd, rather than from external sources (Brownlie and 
others, 1987; Corapi and others, 1988). Therefore the 
possibility of an external source for triggering MD in 
persistently infected animals cannot be discarded. 
Vaccination has also been associated with triggering of MD 
outbreaks (Peter and others, 1967; Bolin and others, 1987a), 
as has the introduction of persistently infected animals to 
a herd (Barber and others, 1985). Such outbreaks of disease 
imply on the transmission of the relevant CP biotype between 
persistently infected cattle. Outbreaks of MD might 
originate in an index case, followed by the development of 
MD in other persistently infected animals (Harkness and 
Boeder, 1988). MD appears to have its counterpart in sheep 
(called "mucosal disease-like syndrome"), where recovered 
"hairy shaker" lambs develop a clinical state similar to MD 
after superinfection with a CP BDV strain. However, such a 
syndrome has only rarely been reported (Barlow and others, 
1975; Gardiner and others, 1983; Nettleton, 1985). In HCV 
infections, on the other hand, no such counterpart has been 
found. In Fig. 1.4. an illustration of the current 
hypotheses on the pathogenesis of MD are presented.
1.9.4. Virus distribution and tropism in tissues:
In acute HCV infections, the virus was present in the 
tonsils from 3 hours to at least seven days after
exposure. Replication in this primary target organ was 
detected between 7 and 48 hours post-infection. It 
reaches the adjacent lymph nodes (mandibular,
retropharyngeal, parotid and cervical lymph nodes) via the 
lymphatic system. From about 24 hours post-infection, the 
virus enters the blood and spreads to other organs. Virus 
excretion was observed in urine and faeces from 6 to 7 days 
post-infection (Ressang, 1973). Recovered animals have a 
clearly detectable immune response to the virus (Matthaeus 
and Korn, 1966).
For pestiviruses of ruminants, the mechanism of virus 
distribution has not been clearly established (Brownlie, 
1990). In acutely infected animals, infection probably 
occurs through the oronasal route (Brownlie, 1990). After an 
incubation period of five to seven days, a transient 
viraemia could be detected which might last up to 15 days 
after infection (Duffell and Harkness, 1985; Brownlie and 
others, 1987a). During this period, spread of the virus 
and subsequent infection of the fetus in pregnant animals 
may occur (Brownlie and others, 1987a; Liess and 
Moennig, 1990). Distribution of virus in immuno- 
logically mature animals is limited by the development 
of antibodies and elimination of the virus (Harkness and 
Boeder, 1988).
Pestiviruses have a great affinity for cells of the
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reticuloendothelial, lymphoid and epithelial tissues 
(Ressang, 1973; Van der Molen and Van Oirschot, 1981 ; Van 
Oirschot, 1983; Bezek and others, 1988; Ohmann and others, 
1982). In blood, BVDV infects T and B lymphocytes, 
monocytes and "null cells" (Bolin and others, 1987b; 
Ohmann and others ; 1987; Ellis and others, 1988). In
contrast, piglets persistently infected with HCV had B 
cell areas in lymphoid tissues, kidneys and adrenal glands 
more severely affected (as evidenced by lymphocyte 
depletion and destruction) than T cell areas (Van der Molen 
and Van Oirschot, 1981). Some strains of BVDV may heavily 
infect thrombocytes and eventually lead to severe platelet 
destruction (Corapi and others, 1990). In BD affected lambs, 
a poorly developed thymus, lymph nodes and scarcity of 
lymphocytes in the spleen have been described (Richardson, 
1982).
1.10. Immune responses in pestivirus infections:
1.10.1. Immune response in postnatally infected animals :
Host reactions in postnatally acquired pestivirus infections 
appear to follow the traditional pattern of development of 
an immune response and subsequent recovery with elimination 
of the agent (Harkness and Roeder, 1988). Animals that 
recover from HCV infections have a clearly detectable immune 
response (Matthaeus and Korn, 1966). BVDV has been shown to
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exert immunosuppressive effects during the course of acute 
infections in normal postnatally infected cattle. The res­
piratory disease sometimes observed in BVDV infections 
could be the result not only of the virus infection itself, 
but also of the association with bacteria or other viruses 
(Reggiardo, 1981). BVDV was found to interfere with 
clearance of bacteria from blood (Roth and Kaeberle, 1983; 
Reggiardo and Kaeberle, 1981). In contrast, it did not 
disturb clearance rates or immune response to bacterial 
antigens (Lopez and others, 1982; Shope, 1964, cited in 
Steck and others, 1980). The virus was found to promote 
dissemination of infectious bovine rhinotracheitis virus 
(IBRV) from the respiratory tract of calves (Potgieter and 
others, 1984). However, vaccination of cattle with IBRV 
vaccine two days after BVDV inoculation did not interfere 
with protection to subsequent challenge, although IBRV 
shedding was significantly increased (Edwards and others, 
1986; Yates, 1984). Immunosuppressive effects might be 
related to the liberation of prostaglandins from infected 
cells (Markham and Ramnaraine, 1985). Other mechanisms pro­
posed were reduced interferon production, suppression of 
plasma cell development and reduced immunoglobulin 
synthesis (Atluru and others, 1979). Atluru and others
(1990) proposed that the immunosuppression (as evidenced by 
a suppressed mitogenic activity of phytohaemagglutinin­
stimulated peripheral blood mononuclear cells) was not due 
to cell destruction, but probably to an inhibition of en-
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zymes that regulate proliferation of those cells. A 
transient leucopenia may also be related to the development 
of immunosuppression (Ellis and others, 1988). It is pos­
sible that the divergence in the results of experiments on 
BVDV-induced immunosuppression is related to strain 
variation (Castrucci and others, 1990).
1.10.2. Immune response in prenatally infected animals:
Congenital infections at the onset of immune competence:
In piglets, antibodies to HCV have not usually been 
detected in infections of sows before day 90 of gestation 
(Van Oirschot, 1979b; Frey and others, 1980; Plateau and 
others, 1980). Nevertheless, piglets from sows infected at 
65-67 days had increased levels of immunoglobulins, with
very little or no neutralizing activity (Von Benten and 
others, 1980). Persistently infected piglets apparently had 
depressed IgG synthesis and enhanced IgM production
(Hermanns, 1978, cited in Von Benten and others, 1980). In
calves, fetal immune responses have been found as early as 
93 days of gestation, more often between 100 to 150 days 
(Ward and others, 1969; Kendrick, 1971 ; Casaro and others,
1971 ; Braun and others, 1973; Roeder and Drew, 1984, Liess 
and others, 1983). In lambs, at about 60 to 80 days of
gestation, the fetuses start to develop immune competence
(Zakarian and others, 1975; Terpstra, 1981). Increased 
levels of antibodies of no or low specificity have also been
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reported in fetuses infected with ruminant pestiviruses 
(Braun and others, 1973; Brown and others, 1979; Osburn and 
others, 1973).
Persistent infections and immunotolérance:
Viruses that are able to cause persistent infections do not 
normally induce cytopathology (Mims and White, 1984). 
Lysis of fetal cells could result in death or malforma­
tions, diminishing the chances of survival for the host. The 
need for such "lack of cytopathogenicity" is exemplified by 
BVDV, where only NCP virus has been found to induce per­
sistent infections, although able to cross the maternofetal 
barrier (Done and others, 1980; Roeder and Drew, 1984; Coria 
and McClurkin, 1978). A second factor essential for the 
establishment of persistence is that there must be a 
mechanism for bypassing the host's immune mechanisms (Mims 
and White, 1984). This immunological tolerance could be 
accomplished by infections before the advent of im­
munocompétence (Van Oirschot, 1979a; Duffell and Harkness,
1985), or by interfering with regulatory mechanisms, as 
shown by an increased suppressor cell activity in per­
sistently infected cattle (Larsson and others, 1986; 
Larsson, 1988; Larsson and others, 1986). Increased numbers 
of CD8+ (cytotoxic- suppressor) T-lymphocytes were found in 
sheep persistently infected with BDV (Woldehiwet and Sharma, 
1990). Reduced number of MHC class I antigens have also been 
found in persistently infected sheep (Burrells and others,
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1989), which may hamper recognition or presentation of 
viral antigen on infected cells (Zinkernagel and Doherty,
1974). Defective antigen presentation has also been pos­
tulated as a possible cause of tolerance to BVDV (Ohmann and 
others, 1987). HCV may reduce its presentation to the im­
mune system by minimal or absent expression of viral an­
tigens on the cell surface (Van Oirschot, 1980), a common 
strategy used by other viruses to avoid immune surveillance 
(Mims and White, 1984). Another possibility is the im­
pairment of defence mechanisms by the infection of cells in­
volved in the generation of the immune response (Mims and 
White, 1984). Reduced numbers of T-cell marker bearing 
cells (as shown by a depressed mitogenic reactivity to 
phytohaemagglutinin) have been reported in persistently 
infected animals on a number of occasions (Johnson and 
Muscoplat, 1973; Roeder, 1984; Ohmann and others, 1987; 
Sawyer and others, 1986; Woldehiwet and Sharma, 1990). On 
the other hand, increased numbers of B cells have been 
frequently reported (Ohmann and others, 1987; Burrells and
others, 1989; Woldehiwet and Sharma, 1990). These findings 
are indicative of a virus-associated imbalance on cells of 
the immune system.
The immune defect involved in pestivirus-related 
immunotolérance is apparently very specific and strain-re­
lated. Neutralizing antibodies to strains antigenically dif­
ferent from that involved in persistence are often found
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(Steck and others, 1980; Bolin and others, 1985a; Brownlie 
and others, 1987a; Howard and others, 1987a; Bolin, 1988; 
Shimizu and others, 1989). Cattle with clinical MD vacci­
nated with the BVDV strain C24V developed neutralizing 
antibodies to the vaccinal virus, but nevertheless died from 
MD caused by a BVDV field strain to which no neutralizing 
antibodies were detected (Steck and others, 1980).
1,10,3. Involvement of immune responses in pathogenesis:
The interplay between antigen and antibody may be involved 
in the induction of lesions in pestivirus-congenitally 
infected animals. Dysplastic lesions in BVDV infected 
calves were found usually in infections between 94 to 150 
days of pregnancy (Ward and others, 1969; Scott and others, 
1973; Brown and others, 1973, 1974, 1975; Ohmann, 1982).
These calves had eliminated virus by the time of birth and 
the immune response was suspected to have contributed for 
the more severe lesions (Roeder and others, 1986). In BD af­
fected lambs, a similar picture can also be drawn from the 
so called "alternative pathology", where the most severe le­
sions were found in lambs with BDV—specific neutralizing 
antibodies (Gardiner and others, 1983; Barlow, 1983). It 
appears that the emerging immune response might enhance the 
pathogenetic effects of the infections (Harkness and Roeder,
1988). Once the fetus is capable of mounting a more mature, 
clearly detectable antibody response to the antigen (e.g. by
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the last third of gestation), the probability of fetal 
damage decreases and the more likely outcome of infections 
in this period is the development of antibodies and elimina­
tion of the virus (Nettleton, 1985; Harkness and Roeder, 
1988; Brownlie, 1990).
1.10.4. Effect of maternal antibodies in persistence:
Animals born with persistent infections have no or very 
little neutralizing antibodies in their sera (Van Oirschot,
1983). Colostrum was not capable of eliminating the virus
causing persistent infection, although passive antibodies 
appeared to have interfered with virus isolation from blood 
(Van Oirschot and Terpstra, 1977; Terpstra, 1981; Liess and 
others, 1984). Persistence may reduce the half-life of ma­
ternal antibodies in the host (Van Oirschot, 1979b), 
possibly by the formation of virus-antibody complexes 
(Harkness and Roeder, 1988).
1.11. Cross-infections with pestiviruses:
In the present study, the term "cross-infection" is defined
as an infection with a virus or viral strain in a species
different from that where the virus was originally isolated.
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1.11.1. Postnatal cross-infections:
BVDV in swine:
In early experiments, the inability to distinguish clearly 
between BVDV and BDV led authors to consider all probable 
cross-infections in pigs as being caused by BVDV. In this 
section reports are reviewed in which pestivirus infections 
in swine were attributed to "BVDV-like" viruses, although in 
most of them the distinction between BVDV and BDV had not 
been attempted. The criteria used for classification of the 
viruses as "BVDV" relied essentially on the (bovine) origin 
of the isolates used for experimental infections, or on 
properties similar to those of known BVDV strains. 
Therefore, the term "BVDV-like" will be used here to 
highlight this uncertainty. BVDV-like viruses have been 
sporadically isolated from pigs infected naturally 
(Fernelius and others, 1973; Carbrey and others, 1976), 
although it was not clear whether the infections resulted 
from post- or prenatal infections. Most postnatal infections 
of pigs with BVDV showed very little or no clinical signs 
(Phillip and Darbyshire, 1972; Stewart and others, 1971, 
1980; Castrucci, 1977; Sheffy and others, 1962). One
BVDV-like pig isolate was able to reproduce BVDV in calves, 
whereas further passage in pigs did not cause reduction of 
virulence for cattle. Virus shedding in mucus and faeces was 
also detected (Fernelius and others, 1973). The
neutralizing antibody responses in such infections were
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usually more intense against the infecting strain, although 
exceptions were found (Snowdon and French, 1968, 1976;
Carbrey and others, 1976; Liess and others, 1977). Levels of 
cross-neutralizing antibodies induced to other BVDV and HCV 
strains were variable, as was protection against challenge 
with HCV (Snowdon and French, 1968; Stewart and others,
1971). More recently, the well established BVDV strain NADL 
was inoculated into pregnant sows which developed neutral­
izing antibodies to the virus but showed no clinical signs 
of disease (Leforban and others, 1990b).
BDV in swine:
The only two reports on experimental BDV infections in swine 
come from infections with pestiviruses isolated from sheep, 
one from a pool of tissues from BD-infected lambs (Wrathall 
and others, 1978) and another using the Aveyron strain of 
BDV (Leforban and others, 1990b). BDV-infected sows showed 
no clinical signs of disease, although they seroconverted 
with the production of BDV neutralizing antibodies and some 
cross-neutralizing antibodies to BVDV and to the HCV strain
Baker A (Wrathall and others, 1978; Leforban and others,
1990b). In addition, development of neutralizing antibodies 
in pigs experimentally kept in contact with BDV-persistently 
infected lambs have also been reported (Terpstra, 1981; 
Leforban and others, 1990b). Moreover, some episodes of 
disease associated with BDV in swine were inadvertently 
caused by the administration of HCV vaccines contaminated
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with BDV. These will be covered below (section 1.11.2).
Evidence for antibodies to pestivirus of ruminants in swine 
A number of reports have been published on detection of 
antibodies to BVDV in pig populations. The percentages of 
pigs reacting with neutralizing antibodies to BVDV varied 
from 1.5% to 37.7% (Lamont, 1977; Snowdon and French, 1976;
Lenihan and Collery, 1977; Terpstra and Wensvoort, 1988;
Jensen, 1985). In Britain, a more recent search for 
antibodies (1983) involved a sample of 2,325 sera from 147 
herds widely distributed throughout England. Thirty eight 
sera (1.6%) had neutralizing antibodies to BVDV, represent­
ing approximately ten per cent of herds (S. Edwards, 
personal communication).
Postnatal cross-infections in ruminants:
HCV in ruminants:
There are no reports on natural postnatal transmission of 
HCV to ruminants. Experimentally, HCV has been inoculated 
into goats (Jacotot, 1939; Sasahara and others, 1964;
Shimizu and Kumagai, 1989), calves and sheep (Zichis,
1939). Dahle and colleagues (1987) inoculated four calves 
with the Alfort strain of HCV. All developed neutralizing 
antibodies to higher levels against HCV than BVDV, whereas 
virus was recovered from one calf on days 5 and 7 post 
inoculation.
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BVDV and BDV in ruminants :
Both BVDV and BDV can cross-infect sheep or cattle 
respectively in the postnatal period without noticeable 
clinical signs (Parsonson and others, 1979; Snowdon and 
French, 1976; Ward, 1971 ; Gibbons and others, 1974).
However, the main concern regarding infections with viruses 
of ruminants in the postnatal period is the possibility of 
transplacental passage of the viruses to fetuses in the 
pregnant animal and this will be reviewed below.
1.11.2. Congenital Cross-infections :
Congenital infections with BVDV in swine:
Stewart and colleagues (1971) reported the detection of BVDV 
antibodies in colostrum-deprived hysterectomy-derived 
piglets. Later, the isolation of a BVDV virus from a sow and 
piglets was reported (Fernelius and others, 1973). No 
evidence of pathological signs of the infection were seen in 
piglets, although the virus was still virulent for calves. 
More recently, a natural infection of pigs with a BVDV 
strain led to the appearance of signs resembling those of 
HCV infections. At about two to four weeks after birth, pig­
lets developed anaemia, wasting, rough hair coat, 
polyarthritis, conjunctivitis and diarrhoea. Perinatal death 
was also observed. The lesions most often found were 
chronic gastroenteritis and multiple haemorrhages in lymph 
nodes, epicardium and kidneys (Terpstra and Wensvoort,
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1988). The virus was confirmed as BVDV using a panel of 
monoclonal antibodies (Mabs) (Wensvoort and others, 1986). 
The authors concluded that most, if not all the infections 
in that study, were congenitally acquired. Infection of pigs 
with such naturally occurring BVDV strains was probably a 
rare event, since in ten years only thirteen cases were 
detected in Netherlands. Experimental infections with BVDV 
in pregnant swine have often resulted in failure to achieve 
fetal infection (Leforban and others, 1990b; S. Edwards, 
personal communication), suggesting that there may be 
variation in the ability of different strains to replicate 
in porcine tissues.
Congenital infections with BDV in swine:
Wrathall and colleagues (1978) inoculated pregnant sows at 
day 34 of gestation with a suspension of tissues from BDV 
infected lambs. One piglet out of nineteen was born with 
cerebellar hypoplasia and malformation. Another nine piglets 
presented a reduction in cerebellum weight, without any 
other signs of pathology. Leforban and others (1990b) 
observed that the majority of piglets born persistently 
infected with BDV showed no noticeable clinical signs, 
although they tended to die shortly after birth. 
Haemorrhagic lesions, palpebral oedema and diarrhoea were 
observed in some infected piglets. Other episodes in which 
infections of pigs were attributed to BDV rather than BVDV 
were incidents related to the use of BDV-contaminated
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vaccines, arising from the use of lamb cells for virus 
growth. A vaccine against Aujesky's disease produced in BDV 
infected cells induced the birth of infected piglets which 
after ten to fifteen days developed palpebral oedema, 
locomotive disturbance and emaciation. High mortality of 
piglets and increased return to service were also noticed 
(Vannier and Carnero, 1985). Another incident involving 
contaminated vaccines was reported more recently (Wensvoort 
and Terpstra, 1988), many litters having dead and mummified 
fetuses. Often, piglets born alive showed alopecia, ascites 
and tremors. Other signs were diarrhoea, petechiae in the 
skin, vascular congestion and growth retardation. At 
post-mortem examinations the affected piglets showed oedema, 
multiple petechiae and haemorrhagic lymph nodes. Some 
piglets also presented button ulcers in the colon. The 
origin of the cell used for vaccine production (fetal lamb 
kidney cells) plus the patttern of reactivity of Mabs with 
the isolate led to the conclusion that the contaminant was 
likely to be a strain of BDV (Wensvoort and Terpstra, 1988).
Congenital cross-infections in ruminants:
Cross-infections in ruminants with HCV:
No congenital cross-infections with HC in sheep and cattle 
have been registered so far (Harkness and Roeder, 1988). In 
goats, however, experimental congenital transmission of HCV 
has recently been reported (Shimizu and Kumagai, 1989).
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Pregnant dams were infected between 64 to 84 days of 
gestation. They developed a mild transient viraemia with 
subsequent development of neutralizing antibodies. Of eleven 
fetuses, one stillborn, one mummified and three oedematous 
kids were born. The remaining six were born normal, with 
pre-colostral neutralizing antibodies in their sera. Other 
fetuses were examined between 5 to 61 days post-inoculation 
and 11 out of 13 were positive for virus isolation. Although 
no persistently infected kids were obtained in the 
experiment, the possibility of transplacental infections in 
goats with HCV was demonstrated.
Cross-infections in ruminants with BVDV or BDV:
As commented above, the distinction between pestiviruses of 
ruminants is not clearcut. Nevertheless, there are a number 
of reports on prenatal cross-infections of cattle and sheep 
with pestiviruses isolated from either species. The viruses 
were able to cross the placenta and induce fetopathogenicity 
regardless of the species of origin of the virus (Parsonson 
and others, 1979; Snowdon and others, 1975; Ward, 1971; 
Gibbons and others, 1974). Goats can also transmit BDV to 
the offspring in utero (Loken and others, 1982; Huck, 1973; 
Barlow and others, 1975).
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1.11.3. Infection of other species with pestiviruses:
HCV infections:
Although there are no reports of natural infection of 
species other than swine with HCV, the virus has been 
propagated in peccaries, deer (Loan and Storm, 1968) and 
rabbits (Baker, 1946). Passage in rabbits gained impor­
tance due to the interest in producing live attenuated 
vaccines (Baker, 1946; Koprowski and others, 1946; 
Anonimous, 1978). Vaccines developed with strains that have 
undergone passages in rabbits, the so called "lapinized" or 
the "Chinese" ("C") strains and its derivatives, have 
demonstrated their effectiveness throughout the world 
(Biront and Leunen, 1988).
Infections with pestiviruses of ruminants:
Rabbits were the only laboratory animals susceptible to BVDV 
(Baker and others, 1954; Fernelius and others, 1969). 
Attempts to propagate the virus in other species have been 
unsuccessful (Olafson and Rickard, 1947; Baker and others, 
1954; Taylor and others, 1963). Nevertheless, antibodies to 
BVDV/BDV have been found in a variety of wild ruminants 
(Nettleton, 1990). In some occasions, pestiviruses have been 
isolated from wild animals (S. Edwards, personal com­
munication). It remains undetermined whether or not these 
isolates represent distict pestiviruses, although at least 
one cervine isolate displayed a distinctive pattern of
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monoclonal antibody reactivity (Edwards and others, 1988). 
It is also not known whether the serological responses 
observed in wild animals are due to infections with the 
recognised members of the pestivirus group or to infections 
with currently unclassified or unidentified viruses.
1.12. Monoclonal antibodies and pestiviruses:
As comented in section 1.11., polyclonal pestivirus antisera 
can sometimes neutralize the three major members of the 
pestivirus group in neutralization tests. However, the 
pattern of cross-reactivity of polyclonal antisera may show 
substantial variability (Snowdon and French, 1968; Stewart 
and others, 1971), not only in neutralization tests but also 
in other laboratory assays (see section 1.13. below). The 
development of Mabs to pestiviruses offered the potential 
for the diferentiation between the viruses of the group 
based on their antigenicity profile, without the 
disadvantage of the variability displayed by polyclonal 
antisera in laboratory tests. Moreover, they might also 
become useful in studies such as the characterization of 
viral structural and non-structural components.
A variety of Mabs have been produced against pestiviruses, 
many of which have not yet been fully characterised with 
respect to their binding affinities (Cay and others, 1990). 
Nevertheless, some of the relationships between Mab
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specificity and role of targeted protein can be
extrapolated from the results of neutralization and 
immunoprécipitation studies already available. Thus, Mabs 
allowed the definition of gp53 as the protein involved in 
neutralization (Wensvoort and others, 1989, Donis and 
others, 1988; Bolin and others, 1988; Magar and others, 
1988a, b; Weiland and others, 1989). At least three distinct 
domains were identified on gp53 of both HCV and BVDV, 
capable of mediating neutralization (Wensvoort, 1989; 
Greiser-Wilke and others, 1990; Baton and others, 1991).
More recently, another Mab, directed to gp48, was also 
demonstrated to elicit neutralization, albeit with limited 
activity in comparison to those directed to gp53 (Xue and 
others, 1990). Mabs to other viral or virus-associated 
proteins have not shown neutralizing activity. Panreactive 
Mabs (that is, reactive to all pestiviruses) have been 
observed to recognize epitopes on the proteins pi 25 and p80 
found in infected cells (Moennig and others, 1987; Dutia and 
others, 1990; Baton and others, 1991).
Mabs to epitopes on other proteins are less frequently 
obtained, and are probably directed to more discrete 
antigens in cells or virions. Mabs to these less conserved 
epitopes (Juntti and others, 1987; Wensvoort and others, 
1989; Baton and others, 1991) may become of use in the 
study of functional or structural details of specific 
strains or isolates. For instance, Mabs to gp42 of HCV
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allowed the discrimination between vaccinal and virulent 
virus strains (Wensvoort and others, 1989).
Panels of Mabs of different specificities have been used to 
group strains and isolates of pestiviruses (Wensvoort and 
others, 1986; Moennig and others, 1987; Edwards and others, 
1988; McHugh and others, 1988; Edwards and Sands, 1990;
Cay and others, 1990). Distinction between HCV and 
pestiviruses of ruminants was readily accomplished, whereas 
the differentiation between BVDV and BDV was less clearcut 
(Cay and others, 1990). Sheep isolates and strains of BDV 
could be distinguished from the majority of cattle isolates 
on the basis of "lack of reactivity" with Mabs to BVDV 
(Edwards and others, 1990). To date only one paper has 
reported the preparation of Mabs against BDV, and these 
workers found that none of the Mabs were capable of 
distinguishing between BVDV and BDV (Dutia and others,
1990). The difficulties in distinguishing pestiviruses of 
ruminants with Mabs may be complicated by cross-infections 
with BVDV or BDV in cattle or sheep, as suggested by recent 
evidence (Paton and others, 1991).
1.13. Diagnosis of pestivirus infections :
Although pestiviruses can be identified with relative ease 
in most laboratories, so far there is no widely adopted 
diagnostic method capable of making a differential diagnosis
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of pestivirus infections without laborious additional tests. 
This has led to the use of a widely adopted adopted 
criterion for classification of pestiviruses based on the 
species from which virus isolation was first achieved 
(Harkness and Roeder, 1988). This problem, which may appear 
merely academic for the identification of HCV in an episode 
of acute HC, becomes of considerable importance when strains 
of HCV of low to moderate virulence are to be distinguished 
from pestiviruses of ruminant origin. Moreover, this 
difficulty in the differential diagnosis of pestiviruses may 
cause serious economic losses in HCV-free countries, in case 
of cross-infections in swine with viruses of ruminant origin 
(ADAS, 1988). In fact, most of the work in the present 
thesis is directed towards the demonstration of the 
"BDV-like" nature of one swine isolate with such 
characteristics.
Regarding pestiviruses of ruminants, as commented above the 
distinction between pestiviruses of cattle and sheep origin 
has, to date, not been clearly established (Edwards and 
others, 1988; Nettleton, 1990; Paton and others, 1991).
1.13.1. Virus isolation:
One of the major problems frequently found in the diagnosis 
of pestivirus infections is contamination introduced by 
pestivirus-infected cells or serum, or the presence of
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antibodies in serum (Fernelius and others, 1971; King and 
Harkness, 1975; Nettleton, 1985). Therefore, attempts to 
carry out laboratory work with pestivirus require that 
appropriate measures be taken (e.g. screening for the
presence of pestiviruses and/or specific antibodies in 
batches of serum and cell cultures).
HCV:
Diagnosis of HCV has, in the past, relied essentially on in­
oculation of susceptible animals, and this is still the most 
sensitive method for virus identification (Carbrey, 1988). 
Such practice is not generally used due to its cost, length 
of time and risks of transmission (Dunne, 1970; Carbrey,
1988). A number of other tests used in the early days of 
laboratory diagnosis have been outdated by more sensitive 
techniques. Among those early diagnostic methods, the agar 
gel precipitation test led to the discovery of the
cross-reactivity between HCV and BVDV (Derbyshire, 1960).
Also, complement fixation tests were often employed (Millian 
and Englehard, 1961; Gutekunst and Malmquist 1964; Boulanger 
and others, 1965; Eskildsen, 1977), as well as the 
"interference" tests, such as the "END" ("enhancement of 
Newcastle disease"), based on the exaltation of the CPE of 
Newcastle disease virus in HCV infected cultures (Kumagai 
and others, 1958).
The direct fluorescent antibody test (DFAT) was a great
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breakthrough in HCV diagnosis, as it could be employed in 
both tissues sections (Solorzano, 1962 cited in Dunne, 1975; 
Carbrey, 1965) or impression smears (Aiken and others, 
1964). Virus isolation in cell culture followed by 
immunofluorescence was also developed (Mengeling and 
others, 1963b; Carbrey, 1965), and this method together with 
DFAT are currently recommended for HC diagnosis (FAO, WHO & 
OIE, 1989). To date, DFAT is the single most widely employed 
test used in the diagnosis of HCV infection throughout the 
world. More recently, the immunoperoxidase technique was 
adapted for HCV and is largely used at present for
detection of antigen in cell cultures infected in vitro 
(Saunders, 1977; Jensen, 1981).
In countries where vaccination is used, the distinction
between vaccinal virus and field virus strains may pose a 
problem for the diagnostic laboratory. Virus from lapinized 
strains may be observed in tonsillar tissues of pigs be­
tween 9 and 14 days after vaccination (Dunne, 1975; 
Terpstra, 1978). Recently, an ELISA test was developed based 
on a Mab that recognizes the gp42 of HCV, and was able to
distinguish vaccinal strains from virulent ones (Wensvoort
and others, 1989). Such a test may become extremely useful 
not only for diagnostic purposes, but also for vaccine 
production and control.
Pestiviruses of ruminants:
Diagnosis of BVDV followed similar steps to HCV. Interfer-
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ence tests were adapted for BVDV identification (Inaba and 
others, 1963; Gillespie and others, 1962; Itoh and others, 
1983; Maisonnave and Rossi, 1982; Hadjisaavas and others,
1975). Equally, the DFAT was also applied to BVDV detection 
(Mengeling and others, 1963a; Fernelius, 1964; Frey and 
Liess, 1971). Immunoperoxidase techniques were also 
developed both for BVDV and BDV (Terpstra, 1978; Ohmann and 
others, 1981 ; Ward and Kaeberle, 1984; Chu and others, 
1987). More recently, an ELISA test has been described for 
the identification of BDV antigen in persistently infected 
sheep (Fenton and others, 1990). Techniques similar to this 
latter development are expected to become widely used 
diagnostic tools (Edwards, 1990).
1.13.2. Serology:
HCV:
The agar gel immunodiffusion test, and complement fixation 
tests were also used for serological diagnosis (Millian and 
Englehard, 1961; Gutekunst and Malmquist 1964; Boulanger and 
others, 1965; Eskildsen, 1977). Neutralization tests are the 
most sensitive and specific for the detection of antibodies 
to HCV (Liess, 1988). The interference tests were used for 
measurement of neutralizing antibodies to pestiviruses 
(Inaba and others, 1963; Kubin, 1964). The neutralization 
test based on virus detection by DFAT was adapted for HCV 
(Mengeling and others, 1963b; Torlone and others, 1968;
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Mengeling, 1970; Terpstra and Tielen, 1976; Van Oirschot, 
1977). Peroxidase-linked assays were later applied in the 
detection of antibodies (Saunders, 1977; Jensen, 1981) and a 
number of variations followed (Straver and others, 1987; 
Afshar and others, 1989; Hyera and others, 1987; Have,
1984). ELISA tests have also been recently developed for 
use in serology of HCV infections (Wensvoort and others, 
1986, 1988; Hess and others, 1988; Yu and others, 1988).
Pestiviruses of ruminants:
Virtually all the tests employed for HCV serology were also 
to detect antibodies to BVDV and BDV (Gutekunst and 
Malmquist 1964; Terpstra, 1978; Harkness and others, 1978). 
As in HCV, the virus neutralization test (VNT) (Carbrey and 
others, 1971) is the reference test for antibodies to BVDV 
(Edwards, 1990). The use of a CP virus allowed direct
reading of the test (Malmquist, 1968; Rossi and Kiesel, 
1971). Plaque reduction assays could also be employed 
(Kniazeff and Pritchard, 1961 ; Straver, 1971; Corthier and 
Aynaud, 1973; Nettleton, 1985). However, results of 
neutralization tests can vary according to the strain used 
(Edwards, 1990) . This is presumably due to the high amino 
acid variability of gp53 the major protein involved in 
neutralization (Donis and others, 1988; Bolin and others, 
1988, Magar and others, 1988a).
More recently, a variety of ELISA systems have been
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described using either polyclonal or monoclonal antibodies 
for pestivirus serology (Chu and others, 1985; Howard and 
others, 1985; Juntti and others, 1987; Westenbrink and 
others, 1986; Fenton and others, 1990; Edwards, 1990). They 
appear to correlate well with neutralization tests (Chu and 
others, 1985; Howard and others, 1985). Since ELISA tech­
niques do not rely only on the biological function of 
neutralization, they are assumed to be less affected by 
strain differences than virus neutralization tests 
(Radostits and Littlejohns, 1988).
Differential serology:
Serological responses to the distinct pestiviruses are 
difficult to distinguish, due to the already mentioned 
problems of cross-reactivity. Whereas the distinction 
between serological responses to HCV and pestiviruses of 
ruminants may be achieved in most cases, the differentiation 
between antibodies induced to BDV and BDV infections might 
be more complex. The presence of a dominant pattern of Mab 
reactivity in the majority of BVDV isolates from cattle, 
distinct from that shown by most BDV isolates (e.g. of sheep 
origin) suggest that there may be actual differences between 
BVDV-like and BDV-like viruses (Baton and others, 1991). 
This opens the possibility for the development of a 
differential serological test. Differentiation between 
serological responses to pestiviruses has so far been 
attempted in the majority of cases by the use of comparative
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serology for neutralizing antibodies (Snowdon and French, 
1968; Stewart and others, 1977; Liess and others, 1977; 
Nettleton, 1987). Results of neutralization tests have been 
used with the purpose of classifying pestivirus strains 
according to their antigenic relatedness (Corthier and 
others, 1974; Kamijo and others; 1977; Wensvoort and others,
1989). This method requires a number of laborious and time 
consuming neutralization tests to be performed.
Recently, a blocking ELISA was described, that allowed the 
distinction betweeen serological responses to the three 
pestiviruses based on differential levels of 
cross-reactivity (Leforban and others, 1990a). The future, 
however, appears to point towards Mab-based tests that 
can discriminate between serological responses to different 
pestiviruses (Hess and others, 1988; Wensvoort and others,
1986, 1988).
1.14. Epizootiology:
1.14.1. Geographical Distribution:
HCV is of enormous economic importance in countries where 
pig farming is a major enterprise. Apart from the potential 
losses due to the occurrence of outbreaks, the costs of 
controlling the disease are high. In addition, restrictions 
to exports of other agricultural products are often imposed
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to countries with enzootic HC. In countries where the 
disease is not enzootic, eradication or maintenance of the 
"HCV-free" status often involves considerable costs. HCV has 
been reported throughout the world, particularly in Western 
Europe, South America and the Far East, although a number of 
countries have been able to eradicate the disease (Liess, 
1981). Even more widespread is BVDV, probably due to the 
fact that it only causes clinical disease under special 
conditions. BDV has been reported in a number of countries 
in Europe, in the United States and Australia (Terpstra,
1985), but its geographical distribution is probably much 
wider than reported.
1.14.2. Transmission:
A number of wild species have been shown to possess anti­
bodies to pestiviruses (Nettleton, 1990). However, the role 
of non-domesticated animals as reservoirs is unknown. The 
main reservoirs of HCV, BVDV and BDV for domestic animals 
are apparently their own respective target species (Liess, 
1981; Harkness and Boeder, 1988).
HCV can be transmitted through two main mechanisms (Liess, 
1981): i) direct or indirect contact with an infected animal 
or secretions; ii) vertical transmission. Infection of sows 
during pregnancy may lead to the central event in virus 
perpetuation for pestiviruses, that is, the birth of
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persistently infected animals that harbour the virus and 
cause the infection of healthy penmates. Chronically 
infected animals (Cheville and others, 1970) may also carry 
the virus for a considerable time before death and 
contribute to the dissemination of the infection.
Establishment of indirect contact can be carried out in a 
number of ways, including feeding with contaminated pork 
products. Very often an epizootics of HC can be related to 
feeding of uncooked swill and garbage (Liess, 1981). Trans­
mission can also arise by improper handling of animals, such 
as usage of common needles and surgical instruments for cas­
tration. In Germany, handling was incriminated as the cause 
of 40% of the outbreaks in a four year period 
(Wachendorfer and others, 1978). Other possibilities are the 
use of unsafe vaccines (Tillery, 1968) and, although of less 
significance, transmission by arthropod vectors (Tidwell 
and others, 1972).
For pestiviruses of ruminants, transmission through semen 
may occur although probably uncommon (Meyling and Jensen, 
1988; Gardiner and Barlow, 1981). Contaminated semen may 
spread the infection horizontally (Coria and McClurkin, 
1978; Meyling and Jensen, 1988; Baton and others, 1990) and 
cows may become seropositive and show reduced fertility 
rates (McClurkin and others, 1979; Grahn and others, 1984).
The main mechanism of transmission of pestiviruses of
65
ruminants is probably direct and/or indirect contact 
(Pritchard, 1963; Nettleton, 1987). BVDV infections in 
post-natal life allow virus shedding for up to ten days 
after infection (Brownlie and others, 1987a). The mainte­
nance of the virus in the herd for a long period is ensured 
by persistently infected animals, born from animals 
infected during gestation. BVDV-persistently infected 
cattle may represent as much as 3% of herds (Nettleton and 
others, 1986). Within herds, up to 89% of the animals have 
been found seropositive (Bolin and others, 1985c). 
Persistently infected sheep have been incriminated as the 
cause of BD outbreaks (Vantsis and others, 1979; Nettleton, 
1987). The dangers involved in handling BVDV or BDV 
infected animals are the same as those described for HCV. 
Special mention should be made of the danger from 
pestivirus-contaminated vaccines (Lohr and others, 1983;
Vannier and Carnero, 1985; Wensvoort and Terpstra, 1988).
1.15. Control:
Despite many common aspects, a distinction can be made be­
tween control measures applicable to HCV and those 
applicable to ruminant pestiviruses, largely because of the 
widespread distribution of BVDV and BDV associated with a 
relatively low incidence of clinically recognisable disease. 
International recognition of such a distinction led to the 
grouping of HCV within the diseases that have potential for
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very serious and rapid spread, with serious repercussions 
in international trade of livestock and related products. 
BVDV, on the other hand, is classified as a disease with 
important economic influence at individual production level, 
whereas BDV is not even listed in the communicable diseases 
of sheep and goats (Anonymous, 1989).
Eradication of HC should be envisaged, and has been shown to 
be cost-effective (Ellis and others, 1977). Diagnostic sup­
port from the laboratory is fundamental for an eradication 
programme, since subclinical forms must be detected. 
Detection of persistently infected animals is obviously 
necessary in order to achieve eradication.
Vaccination is widely used as a means of control of the 
disease in countries where HC is enzootic. Vaccination with 
inactivated vaccines, such as the crystal-violet vaccine 
and the practice of vaccination with simultaneous 
administration of HCV anti serum have been replaced by the 
use of modified live-attenuated vaccines such as those 
developed with the "chinese" ("C") strain or its 
derivatives, attenuated by serial passages in rabbits and 
eventually adapted to cell cultures (Biront and Leunen, 
1988, Tamoglia and others, 1985) . Vaccines prepared in
rabbits with the so called "lapinised" strains are still in 
use in some countries. Although both "C" and lapinised 
strains have undergone a number of passages in rabbits,
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those that have totally lost virulence for pigs at any age 
are considered "C" or "C"-derived strains, whereas lapinised 
strains may still have residual pathogenicity for young pig­
lets and pregnant sows (Biront and Leunen, 1988). Two other 
strains, Thiverval (Launais and others, 1972) and GPE- 
(Shimizu, 1980) were developed by cloning and multiplication 
at lower temperatures in cell culture and are also in 
widespread use.
For pestiviruses of ruminants, control must aim towards 
prevention of prenatal infection (Harkness, 1987; Nettleton, 
1987). Measures applicable to both diseases are virtually 
the same. One example is the identification and culling of 
persistently infected animals, what may lead to a situation 
where the herd or flock is disease-free. However, this 
might prove expensive not only due to costs for the 
implementation of the policy but also for the maintenance of 
such status. Moreover, the identification of persistently 
infected cattle may be complicated by the presence of pas­
sively acquired antibodies. In addition, persistently 
infected animals might become seropositive to other un­
related strains (Steck and others, 1980; Bolin and others, 
1985b; Shimizu and others, 1989). Strict control measures 
would be obligatory in relation to the entrance of animals 
in the farm, since the population at risk would increase 
(Duffell and Harkness, 1985).
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In Artificial Insemination centres, the risks of 
transmission of BVDV via semen are probably low since 
persistently infected animals are unlikely to make suitable 
donors (McClurkin and others, 1979; Barlow and others, 1986; 
Meyling and Jensen, 1988; Baton and others, 1989). 
Nevertheless, elimination of persistently infected animals 
should be pursued in order to ensure that no virus-shedding 
animals are kept as stud bulls (Boeder and Harkness, 1986).
Another possible control measure is to attempt to induce 
immunity in the herd by "controlled exposure" to 
persistently infected animals, aiming at immunization of the 
stock, specially heifers before reproductive age (Duffell 
and Harkness, 1985).
As for HCV, vaccination appears to be a sensible approach to 
prevention of disease. A number of drawbacks, however, have 
been identified. Modified live virus BVDV vaccines may have 
detrimental effects on the immune system (Roth and Kaeberle, 
1983) and may have the potential to act synergistically with 
other microorganisms, thus being more harmful than 
beneficial (Bolin, 1985a). Vaccination of pregnant animals 
may cause fetal pathology similar to that induced by field 
virus strains (Kahrs, 1968; Liess and others, 1984). Also, 
vaccination of a persistently infected animal may induce MD 
(Peter and others, 1967). Even more problematic to control 
would be the possible development of a serological response
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to the vaccinal virus, therefore making identification of 
the persistently infected animal more difficult.
Although most vaccines against BVD contain attenuated live 
virus, inactivated vaccines have been prepared and appear 
to confer adequate immunity (McClurkin and Coria, 1980; 
Harkness and others, 1987). Vaccines with live attenuated 
virus may trigger MD in cattle, although at least in one 
case an inactivated vaccine was suspected of triggering MD 
(Bolin and others, 1987a). Inactivated vaccines are also 
expensive to produce. The addition of different virus 
strains has been proposed in an attempt to widen the 
spectrum of antigenic stimulation of the vaccine (Neaton, 
1986; Harkness and others, 1987). However, such procedures 
have not been fully evaluated, apart from bringing an extra 
component to the costs of the vaccine.
Recombinant vaccines:
A vaccinia virus-recombinant vaccine containing a segment of 
1149 nucleotides corresponding to a portion of the genome 
coding for the virus-induced glycoproteins of the Singer 
strain of BVDV was recently patented (Dale and others, 
1987). The authors claim that the vaccine can be used for 
protection against HCV and BVDV. Further testing will be 
required in vaccination trials, however, in order to ascer­
tain its efficacy. Nevertheless, the area of recombinant 
vaccines appears to have a promising future regarding
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pestivirus-induced diseases, since it may be possible to de­
velop an antigen capable of minimizing the risks associated 
with vaccination, particularly in cattle (Bolin and others, 
1985a, b ) .
1.16. Conclusion:
Current knowledge on pestiviruses still presents many un­
resolved problems. Among the different aspects that remain 
as a challenge to researchers, there is a need for a 
greater understanding of the pathogenesis of pestivirus in­
fections. The role of interspecies transmission, 
particularly transplacental cross-infections, which may be 
involved in the generation of the genetic diversity of the 
group, still does not have its significance fully evaluated 
in the natural environment. Cross-infections are also of 
great concern in the differential diagnosis of pestivirus 
infections, mainly due to the tremendous economic im­
plications of HC. However, there is also a need for a proper 
characterization and differentiation between pestiviruses 
of cattle and sheep. The pathogenesis of MD is another 
fascinating subject, with the role of NCP and CP "pairs11 not 
yet fully clarified, especially the question of the origin 
of the CP biotype in the persistently infected animal.
Furthering of our understanding of pestiviruses requires 
detailed knowledge of molecular aspects and its application
71
to their biology, by allowing the development of more 
refined diagnostic tools, the construction of safer and
cheaper vaccines and hopefully helping to unveil some of 
the unsolved questions of the pathogenesis.
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1.17. Aims of this thesis:
Most of the work in this thesis is concerned with the 
comparison between a pestivirus isolated from swine (87/6) 
and a BDV isolated isolated from sheep (137/4). The virus 
isolated from swine was shown to possess an antigenic 
composition similar to many strains of BDV, suggesting that 
it might also be of sheep origin, and thus potentially an 
example of natural cross-infections with BDV in swine. The 
existing difficulties in the differentiation between HCV and 
other pestiviruses that might cause cross-infections in 
swine led to the comparative studies here described. These 
were performed by investigating both the in vitro host cell 
range of the viruses and their pathogenic effects in 
pregnant sows and ewes and their offspring. Finally, a 
comparison was made between segments of the nucleotide 
sequences of their genomes. It is hoped that the present 
study will contribute to the understanding of the biology of 
pestiviruses, in particular those aspects related to 
cross-infections with BVD-like viruses in swine.
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CHAPTER 2. GENERAL MATERIALS AND METHODS
2.1. Cell cultures:
Passage and maintenance:
All cells and sera used for cell growth and maintenance were 
screened for the absence of contaminating pestiviruses by 
direct immunofluorescence using pestivirus specific 
conjugates and/or by virus isolation in cell culture and 
subsequent immunofluorescence.
Cells of continuous lines:
Porcine kidney (PK15) and Madin-Darby Bovine Kidney (MDBK) 
continuous cell lines were grown in MEM-FCS and split at a 
ratio of 1:4 (PK15) or 1:3 (MDBK) twice weekly.
Cells of semi-continuous lines:
Sheep choroid plexus (SCP) and bovine turbinates (BT) cells 
were grown in MEM-FCS and split at a ratio 1 :2 once 
weekly.
Primary cell cultures :
Primary cultures were prepared by trypsinization of the ap­
propriate organ as described (Paul, 1970) except that the 
growth medium was MEM-FCS. Cells were subsequently passaged 
in culture usually with a split ratio of 1:2 every two to 
three days.
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Splitting of cells:
Splitting of cells was carried out as follows: the medium
was removed from the cell cultures. Monolayers were then 
washed three times with 5ml of pre-warmed (37°C) ATV and 
incubated at 37°C for about 10 min. After that the cells 
were ressuspended in about 10ml of MEM-FCS and dispersed by 
vigorous pipetting. Additional MEM-FCS was added as ap­
propriate and the suspension seeded onto flasks. PK15 cells 
were used at an approximate passage number between 250 and 
300, MDBKs at a passage level between 200 and 250. BTs and 
SCPs were used up to passage number 40. Primary cultures 
were used between the 2n<^  and the lO^h passage level.
2.2. Viruses:
Standard strains:
All the strains and isolates used throughout this study were 
originated from the CVL stocks. The source and details of 
the known passage history of the strains and isolates more 
frequently used throughout this thesis are shown in Table
2.1. Additional strains and isolates used in cell culture 
permissivity experiments are presented in Chapter 3.
Virus multiplication and preparation of stocks:
Viruses were propagated through inoculation of preformed 
monolayers. Cells were washed with 10ml of MEM and infected 
with 0.5ml of the required virus suspension at a
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multiplicity of infection (m.o.i.) equal to 1 TCID5o/cell. 
After one hour of adsorption at 37°C the inoculum was washed 
out twice with 5ml of MEM. The monolayers were then over­
laid with an appropriate volume of fresh MEM-FCS, incubated 
for four days and frozen at -70°C. Cytopathic viruses were 
processed in the same way, except that infected cultures 
were frozen when the CPE reached about 90% of the cell sheet 
(usually 2-3 days). Frozen flasks were thawed and clarified 
by centrifugation at 1000g for 15 min. The supernatants were 
then aliquoted and stored at -70°C until required. HCV 
strains were usually grown in (PK15) cells. BVDV were grown 
in either BT or CT cells, whereas BDV strains were grown in 
BT or SCP cells, unless stated otherwise in particular ex­
periments .
Preparation of virus stocks in Cytodex 3 beads :
Alternatively, virus stocks of BVDV strain C24V were 
prepared in Cytodex 3 (Pharmacia) beads according to the 
following procedure : Approximately 1.5 grams of beads were 
pre-washed in PBS and autoclaved according to the 
manufacturer's instructions. CT cells were grown to 
confluency in 850 cm2 plastic roller bottles (Falcon), 
trypsinized and the cell suspension added onto the beads in 
an appropriate flask. Attachment was attained by letting the 
cell/beads suspension rest for 2 hours at 37°C with 2 min 
agitation periods every half hour. When nearly 100% of the 
beads were covered with cells (usually 24 hours after
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Table 2.1. Source and known passage history of standard 
pestivirus strains and isolates used in animal inoculation 
studies and serum-virus neutralization tests.
Viruses Passage 1history Source/ Reference
Swine*
Alfort 18 PK15 (1)
Baker A 22 PK15 Baker (1946) (2)
87/6 1 PK15, 2 SCP (3)
Bovine*
C24V 56 CK or CT, Gillespie and others
6 CT, 1 BT (1960) (2)
NADL 4 CK, 4 BT, Gutekunst and
3 CK, 1 CT Malmquist (1963) (2)
Ovine*
Moredun (§) 3 FLB, 3 BT, Vantsis and others
4 SCP (1976) (4)
137/4 (§) 3 BT (5)
Table 1. Footnotes
"Passage history" refers to the known passage in cell 
culture. Cells referred to as: FLB, fetal lamb brain; BT, 
bovine turbinate; SCP, sheep choroid plexus ; CK, primary 
calf kidney; CT, primary calf testis; PK15, porcine kidney. 
Numbers before cell type refer to number of passages in 
those cells.
(*) Species of origin
(@) Unknown previous passage history
(1) Kindly provided by Dr. B . Liess, Hannover.
(2) Kindly provided by Dr. E. A. Carbrey, Ames, Iowa.
(3) From diagnostic submissions at the Central Veterinary 
Laboratory (CVL), Weybridge.
(4) Kindly provided by Dr. P. Nettleton, Edinburgh, Scotland
(5) From diagnostic submissions at the regional Veterinary 
Investigation Centre, Worcester.
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seeeding), they were washed twice in PBS and infected at an 
m.o.i of approximately 5 to 10 TCID5o/cell. After adsorption 
at 37°C for 1 hour and subsequently kept in agitation at 26 
rpm (at 37°C) until cells started to dettach from the beads. 
Cell detachment was usually observed 30 to 48 hours 
post-infection. Virus yelds obtained were very often greater 
than 1 Oe-OTCIDso/ml.
Virus titrations :
Virus titrations were carried out as follows : Tenfold dilu­
tions of virus were prepared in MEM-FCS and distributed in 
50jil volumes onto 96-well flat bottomed microtitre plates 
(Nunc). Cells were trypsinized with ATV and adjusted to an 
approximate concentration of 3 x 105 cells/ml. Fifty 
microlitres of the cell suspension were then added to the 
virus dilutions. The plates incubated for four days when 
they were fixed and stained by the IPX method
(non-cytopathic viruses) or examined for the presence of 
CPE. Wells presenting positive specific staining in the IPX 
or CPE were considered positive. Fifty percent endpoint 
titres were calculated using the method of Spearman-Karber 
(Lorenz and Bogel, 1973).
2.3. Serum-virus neutralization tests (8NTs):
The method followed the procedures described for the neu­
tralizing peroxidase—linked antibody assay (NPLA) (Jensen,
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1981). Serum samples were heat inactivated at 56°C for 30 
min and stored at -20°C. Doubling dilutions of sera 
( starting at 1/10) were made in 50pl volumes, in 96-well 
flat bottomed microtitre plates. An equal volume of virus 
containing 100 TCID5o/50]il was added to the serum dilu­
tions. The mixture was incubated for 1 hour at 37°C. After 
that, 50>jl1 of a suspension of the appropriate cells (pre­
pared as described under virus titration above) were added. 
The plates were then incubated for 5 days at 37°C in a 5% 
C02 atmosphere, when they were either fixed and stained by 
the IPX method or examined for the presence of CPE on an in­
verted microscope. Titres were calculated by the method of 
Spearman-Karber (Lorenz and Bogel, 1973).
2.4. Immunoperoxidase tests (IPX):
IPX procedures followed basically the procedures described 
by Jensen (1981). Infected and uninfected cell monolayers in 
96-well microtitre plates were incubated for 1-2 days (CP 
viruses) or 4 days (NCP viruses), emptied by gentle inver­
sion and rinsed in IOOjjlI of PBS/well for 5 min. After 
removing the PBS, IOOjjlI of fixation fluid were added at 
room temperature for 10 min. The fixation fluid was then re­
moved by flicking and blotting onto several sheets of ab­
sorbent paper, which were then allowed to dry under a bench 
lamp at approximately 25°C for three hours. Plates were ei­
ther stained immediately or sealed in plastic bags and kept
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at -20°C for further processing. For staining, plates were 
rehydrated with SOpl/well of PBS-T (wash fluid) for 5 min, 
drained and SOpl of an appropriate dilution of
anti-pestivirus serum was addded to each well. The plates 
were incubated under a bench lamp at 25 °C for 15 min, 
drained and washed 3 times with SOpl of wash fluid. The 
required peroxidase-labelled anti-species conjugate 
(Dakopatts, Denmark) was then added to the wells at an 
appropriate working dilution. Plates were again incubated 
under a bench lamp for 15 min, the conjugate removed and the 
wells washed 3 times with wash fluid as above. Fifty 
microlitres of freshly prepared substrate (3-amino- 
9-ethylcarbazole, see Appendix) were added to each well and 
incubated for 10 to 15 min until colour developed. The re­
action was stopped by flicking off the substrate and adding 
SOjjlI of wash fluid per well. Reading of the plates was 
carried out with the aid of an inverted microscope. Wells 
containing cells with specific cytoplasmic staining were 
considered positive. Titres were calculated as described 
above in virus titration.
2.5. Indirect immunoperoxidase test (IIPX) for antibodies:
Sera were screened on an IIPX as described: PK15 cells were 
trypsinized and adjusted to a concentration of 3 X 105 cells 
per ml in MEM-FCS. Either 87/6 or 137/4 isolates were 
inoculated into the cell suspensions at an m.o.i. of about
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1 . Fifty microlitres of the infected cell suspensions were 
added to each well of 96 well flat bottomed microtitre 
plates and incubated for 3 days at 37 °C in a 5% C02
atmosphere. Plates with virus-infected cells were fixed and 
stored as described on IPX procedures above. Before the 
addition of serum samples, plates were rehydrated in PBS-T 
(SOpl/well) for 5 min. Test sera were diluted 1/10 and 1/20 
in IPX dilution fluid on a separate plate and transfered to 
the test plates in volumes of 50pl, two wells per dilution. 
After incubation under a bench lamp at 25°C for 15 min, the 
sera were washed and the appropriate peroxidase conjugate 
(anti-sheep or anti-pig IgG) added. Subsequent procedures 
were as described in the IPX staining method above.
2.6. Direct fluorescent antibody test (DFAT):
The DFAT was performed as follows: coverslips were
rehydrated in PBS for 10 min and covered with an appropriate
volume of fluorescein isothyocyanate (FITC)-labelled
polyclonal antibodies to pestiviruses. After incubation at 
37°C for 30 min the conjugate was removed and the coverslips 
washed twice for 10 min in PBS, after which they were 
counterstained by immersion in a 10'5/ml dilution of Evans 
Blue in PBS for 1 minute, washed briefly with distilled wa­
ter and dried at room temperature. Coverslips were then 
mounted and examined under a fluorescence microscope. The 
criteria used for interpretation of the readings was as
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follows:
? = inconclusive results 
+ = 1 0 %  or less of positive cells 
2+ = 30% or less of positive cells 
3+ = 50% or less of positive cells 
4+ = more than 50% of positive cells.
2.7. Indirect fluorescent antibody test (IIF):
The IIF test followed basically the same steps of the DFAT, 
except that anti-pestivirus polyclonal serum (produced in 
cattle) was used as first antibody, and mouse anti-cattle 
IgG conjugated to FITC (Dakopatts, Denmark) as the detector 
antibody. Controls included and virus-infected and
uninfected cell culture coverslips.
2.8. Staining of cryostat sections:
Coverslips with 5p cryostat sections of tissues of each
fetus were fixed in acetone for 10 min and either kept at
-70°C for subsequent examination or stained immediately
using the DFAT.
2.9. Samples for virus isolation:
All samples for virus isolation (including uninactivated 
sera and blood clots) were kept at —70 °C until further
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processing. Suspensions of approximately 10% to 20% foetal 
tissues (liver, spleen, mesenteric lymphnode, small intes­
tine, kidney, heart, lung, thymus, submandibular lymphnode, 
tonsils and cerebral cortex) were prepared in tryptose 
phosphate broth prepared as recommended by the manufacturer 
and supplemented with 5% of the antibiotic mixture (TPBA). 
Blood clots were also processed in the same way. Suspensions 
were prepared by grinding fragments of tissue with pestle 
and mortar, followed by centrifugation at 2000 X G for 10 
min in a refrigerated centrifuge. The clarified supernatants 
were used as inocula. Blood samples from sows and ewes were 
collected in heparin-containing evacuated tubes and 
centrifuged in Ficoll-Paque (Nycomed) according to the 
manufacturer's instructions for separation of leucocytes. 
Leucocytes and sera for were frozen once and ressuspended 
in TPBA at an approximate concentration of 10% (v/v) for in­
oculation in cell cultures.
2.10. Procedure for virus isolation:
Leighton tubes of PK15, BT or SCP cells were about 70% 
confluent were washed briefly with sterile PBS and 
inoculated with 0.2ml of the appropriate sample. 
Uninactivated serum samples were inoculated undiluted at the 
same volume. After 1 hour incubation at 37°C the inoculum was 
washed out with sterile PBS and 2ml of fresh MEM-FCS were 
added. Tubes were incubated for 4 days at 37°C. Control in­
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fected and uninfected cells were included in each batch of 
tests. Coverslips were then removed washed briefly in PBS 
and fixed in acetone for 10 min. Fixed coverslips were 
stored at -70°C until required for DFAT staining.
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CHAPTER 3. COMPARATIVE TITRATION OF PESTIVIRUSES IN CELLS OF 
DIFFERENT SPECIES ORIGIN
3.1. INTRODUCTION:
The three classified pestiviruses infect swine (hog cholera 
virus, HCV), cattle (bovine viral diarrhoea virus, BVDV), 
sheep and goats (border disease virus, BDV). On occasion, 
these viruses can bypass the species barrier and 
cross-infect different hosts. Among these cross-infections, 
the most important are those in swine where infections with 
viruses of ruminants may be attributed to HCV, with serious 
implications not only for swine health but also for inter­
national trade. Not all pestivirus strains, however, appear 
to have the capacity of bypassing the species barrier, for 
reasons that are not understood. There is some indication 
that the process may be related to the presence or absence 
of specific cell receptors (Moennig, 1989; Liess and 
Moennig, 1990). Viruses can be adapted to grow in cells of 
different origin in cell cultures "in vitro" (Fernelius 
and others, 1969), and it has been suggested that this 
capacity to multiply in cells of heterologous origin may be 
indicative of the occurrence of adaptation "in vivo" 
(Liess and Moennig, 1990).
In the present study, the growth of various pestivirus 
strains originated from swine, cattle and sheep was examined
85
in cell cultures of porcine, bovine and ovine origin, with 
the aim of determining the ability of different strains and 
isolates to infect cells originated from species other than 
their natural host.
3.2. MATERIALS AND METHODS
Cells and media:
Porcine kidney (PK15), bovine turbinate (BT) and sheep 
choroid plexus (SCP) cells were used throughout this study. 
PK15 cells were passaged twice weekly at a 1:6 split ratio. 
BT and SCP cells were passaged once weekly at a 1:3 split 
ratio. Passage and maintenance of the cells were performed 
as described in chapter 2.
Viruses:
The virus strains and isolates used and their known passage 
history are shown in table 1. These included eleven viruses 
of swine, eight of cattle and six of sheep origin. Viruses 
of ruminants had been passaged in cells of ruminant origin. 
Viruses of swine, with the exception of isolate 87/6, had 
been passaged in porcine kidney cells (PK15) lineage. Two 
isolates from wild animals which had been passaged in cells 
of cattle origin were also included, comprising a total of 
27 pestivirus strains and isolates. Viruses were passaged 
once more in cells of homologous origin (BT for cattle 
viruses, SCP for sheep viruses and PK15 for porcine
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Table 3.1. Viruses used in the comparative titrations
and known passage history.
Viruses Passage history Source/ Reference
Ovine*
Moredun (@ ) 3FLB, 3BT, 4SCP Vantsis and others (1976) (1)
R2727 2CK, 2BT Brockmann and others (1988) (2)
BDWey 9CT, 1SCP Harkness and others (1977)
2816 2CK, 1BT Roeder (1984)
137/4 (§) 3BT Worcester (3)
135661 4BT Reading (4)
Bovine*
C24V 56CK or CT, Gillespie and others(1960) (5)
6CT, 1BT
NADL 4CK, 4BT, Gutekunst and Malmquist (1963)
3CK, 1CT (5)
Al 050 3BT Edwards and others (1988)
182108 1BT ii ii ii
168053 1BT ii h ii
178021 1BT ii ii ii
162903 1BT ii ii ii
163408 1BT
n ii ii
Wild animals*
Giraffe 3CK Plowright, 1969
Roe Deer* 3BT Edwards and others (1988)
Swine*
331 11PK15 Mengeling and Cheville (1968)(
Alfort 18PK15 Dahle and others, 1987 (6)
Baker A 22PK15 Baker (1956) (5)
EVI 100 1PK15 Edwards and Sands (1990)
87/6 1PK15, 2 SCP ADAS, 1988
86/8 2PK15 Wood and others (1988)
1822 3PK15 (7)
1825 3PK15 (7)
ALD (§) 2PK15 Sato and others (1964) (8)
Osaka 1PK15 Kamijo and others (1977) (8)
Manche 2PK15 (9)
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Table 3.1. Footnotes :
"Passage history" refers to the known passage in cell 
culture. Cells referred to as: FLB, fetal lamb brain; BT, 
bovine turbinate; SCP, sheep choroid plexus ; CK, primary 
calf kidney; CT, primary calf testis; PK15, porcine kidney. 
Numbers before cell type refer to number of passages in 
those cells.
(*) Species of origin
(@) Unknown previous passage history
(**) From a park deer.
(1) Kindly provided by Dr. P. Nettleton, Edinburgh, Scotland
(2) From diagnostic submissions at the Central Veterinary 
Laboratory (CVL), Weybridge.
(3) and (4) From diagnostic submissions at the regional 
Veterinary Investigation Centres.
(5) Kindly provided by Dr. E. A. Carbrey, Ames, Iowa.
(6) Kindly provided by Dr. B. Liess, Hannover.
(7) Kindly provided by Dr. B. Cay, Brussels, Belgium
(8) Kindly provided by Dr. C. Ushimi, Ibaraki, Japan
(9) Kindly provided by Dr. Y. Leforban, Ploufragran, France
All strains were from the culture collection of the Central 
Veterinary Laboratory (CVL), Weybridge.
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viruses). Viruses of wild animals were passaged in BT cells. 
Production of virus stocks was performed following the 
standard conditions described in chapter 2. Briefly, cells 
and supernatant were frozen at -70°C, clarified by low speed 
centrifugation, aliquoted and stored at -70°C.
For comparison of infectivity of the progeny viruses after 
one multiplication in homologous and heterologous cells, 
viruses were passaged once in each of the three cell 
lines at an m.o.i equal to 0.01 and stocks prepared 
following the standard procedure described in Chapter 2.
Virus titrations:
Comparative titrations were performed simultaneously in each 
of the three cell lines in 96-well microtitre plates, using 
four wells per dilution in volumes of 50pl per well. Cells 
were added at a concentration of 3x 105 cells/ml in 50pl 
volumes. Control uninfected cells were set up in each plate 
as appropriate. The microplate were incubated at 37°C in a 
5% C02 atmosphere for four days, fixed and stained using the 
peroxidase labelled antibody assay (PLA) as described in 
Chapter 2 (Saunders, 1977). Cells with a positive PLA 
staining were considered infected. Titres were calculated 
using the method of Spearman-Karber (Lorenz and Bogel, 
1973). In order to determine the influence of one passage in 
cells of heterologous origin, a second battery of 
titrations was performed with the virus stocks produced in
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each of the three cells, and viruses were titrated as 
described above.
3.3. RESULTS
Titrations in cells of homologous origin:
The results of the virus titrations performed with virus 
stocks multiplied in homologous cells are presented in Fig.
3.1. The viruses tested usually multiplied to higher titres 
in cells of homologous origin. The results of this battery 
of titrations were used to construct a model of the
inter-relationship between cell permissivity and virus 
infectivity (Fig 3.2.). Of the eleven pestiviruses of
swine origin, six infected cells of any of the three
species. Three viruses (1822, 1825 and Osaka) infected PK15
and BT cells, whereas the two remaining strains (Manche and 
ALD) did not infect heterologous cells at all.
With the ruminant pestiviruses, all viruses tested infected 
cells of ruminant origin (BT and SCP cells). In addition, 2 
out of 8 cattle viruses and 4 out of 6 sheep viruses also 
infected PK15 cells. The viruses of wild animals were able 
to multiply in any of the three different cells tested,
although cells of the homologous species were not available 
for comparison.
PK15 cells did not show any evidence of virus infection with
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Fig. 3.1. Titration of viruses multiplied in cells of 
homologous origin. Blocks "A", "B", "C", and "D" represent
viruses originated from bovine, ovine, wild animals and 
swine origin, respectively. Viruses of wild animal origin 
were multiplied in BT cells. Titres are expressed as the 
logio of the 50% infectivity titre/50)jl1 . Abbreviations: BDV 
strain Moredun, BDM; HCV strain Baker A, BA.
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Fig. 3.2. Schematic representation of the cell susceptibility 
distribution of the pestiviruses tested. The distribution shown 
is based on the results of Fig. 3.1.
93
PK15 BT
MANCHE
OSAKA
NADIA 
A l050 \  
182108\ 
168053X 
178021  ^
162903
R2727 BDWEY
SCP
94
five of the cattle viruses. One of them (isolate 168053 ) 
showed limited ability to infect those cells as evidenced by 
some PLA stained cells at 10'1 dilution (Fig 3.1). BT cells 
were able to support replication of the largest number of 
pestiviruses (25 out of the 27 viruses tested). None of the 
viruses infected BT cells only. Five viruses of swine 
origin did not grow in SCP cells, although they were able to 
infect BTs. As with BT cells, no viruses were restricted 
to multiplication solely in SCP cells.
Titrations after one passage in heterologous cells :
The second battery of titrations was performed with the 
objective of determining whether or not one passage in cells 
of heterologous origin would alter the spectrum of cell 
susceptibility (Fig. 3.3). After one passage in PK15 cells, 
the six viruses of ruminants which had already been shown to 
infect PK15 cells in the first experiment confirmed their 
ability to infect cells of swine origin. In addition, two 
cattle isolates (A1050 and 182108) which had not been able 
to give rise to PLA-detectable multiplication in the first 
experiment infected cells at titres 101,25/50p.l and 
1 02'°/50)jl1 , respectively. Two other viruses of cattle origin 
(C24V and 163409) and one isolate of sheep origin (135661) 
were not able to infect PK15 after one passage in those 
cells, despite having infected those heterologous cells at 
titres 1 02-°/50pl in the first experiment.
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Fig. 3.3. Titration of viruses grown initially in homologous 
species cells, then passaged to homologous or heterologous 
cultures. The titrations were performed in the same cell type as 
the final passage. Blocks "A", "B", "C", and "D" represent
viruses originated from bovine, ovine, wild animals and swine 
origin, respectively. Titres are expressed as the log-j q of the 
50% infectivity titre/50>il.
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In BT cells, the results after one passage in heterologous 
cells were very similar to those of the first battery of 
titrations. However, the Osaka strain of swine origin (HCV) 
which had multiplied to considerable titre in BT cells 
(104-°/50pl) showed a very limited infectivity with the 
stock grown in those heterologous cells ( 1 0°'75/50pl) .
In SCP cells, the titrations with the heterologous stocks 
gave rise to a similar picture as above. Nearly all viruses 
which infected sheep cells in the first batch of experiments 
confirmed their infectivity for sheep cells. HCV strains 
Alfort, 331 (swine origin) and the giraffe isolate 
displayed a limited capacity of multiplication after one 
passage in ovine heterologous cells, since their titres 
were reduced by 2.5, 2.25 and 3.25 logio/50jj.l, respectively.
3.4. DISCUSSION
In the present study, the infection of cells originated from 
three different host species (porcine, bovine and ovine) was 
examined with the aim of determining their ability to 
support multiplication of pestiviruses of different host 
origin. The results obtained indicate that the majority of 
pestivirus strains and isolates examined would readily 
infect cells of porcine, bovine and ovine origin without the 
need for any special requirements such as cocultivation or 
serial blind passages (Fernelius and others, 1969). Two
98
strains of porcine origin (HCV) were more specialised in 
their cell requirements and infected only homologous cells. 
All other viruses infected cells originated from at least 
two different hosts. In a recent study with pestiviruses of 
cattle origin, it was observed that most BVDV strains and 
isolates would infect bovine and ovine cells, whereas four 
strains would only multiply in bovine cells (Liess and 
Moennig, 1990). In the present study no viruses with 
multiplication restricted to cattle cells were identified, 
although two HCV strains were restricted to porcine cells. 
Four of the six viruses of sheep origin infected PK15 
cells, whereas two (R2727 and BDWey) infected cells of 
ruminants only. Interestingly, these two strains were both 
"BVDV-like" in their monoclonal antibody pattern of re­
activity (Edwards and others, 1988).
There seems to be a range of "levels of adaptability", where 
some strains are able to infect heterologous cells more 
easily than others, as deduced from the results of the 
titrations on the three different cells. It is possible that 
this capacity in cell culture may bear some relationship to 
the ability to cause cross-infections in animals. It may be 
of significance that no congenital infection was obtained in 
pregnant sows with cattle isolate A1050, despite infected 
sows readily seroconverted to this strain (S. Edwards, 
personal communication), which here showed limited growth in 
heterologous cells in culture. On the other hand, isolates
137/4 (ovine origin) and 87/6 (swine origin) which appear to 
infect homologous and heterologous cells at similar titres 
(Figs. 3.1. and 3.2) did cause infection in the offspring 
of pregnant sows and ewes (see chapters 4 and 5).
Very little is known about the events involved in pestivirus 
attachment and penetration into the cells. A monoclonal 
antibody (Mab) directed against a bovine cell surface pro­
tein interfered specifically with the infectivity of 
cytopathic BVDV strains (Moennig and others, 1989). In­
fection with other pestivirus strains, parainfluenza 3 and 
infectious bovine rhinotracheitis virus was not impaired by 
that Mab, suggesting that a specific cell receptor might be 
involved in cell penetration. In the same study, the 
presence of a few foci of infected cells after more 
detailed examination indicated that some sort of less 
efficient receptor-independent mechanism could be involved 
in the process (Liess and Moennig, 1990). Attachment was 
shown to increase by the addition of DEAE-Dextran (Moennig, 
1971), therefore this step seems to be sensitive to 
alterations in electrical charges at virion and cell 
surfaces, which might be involved in both receptor-dependent 
and independent mechanisms of virus adsorption. In view of 
these findings, it is possible that those viruses which 
were found able to infect heterologous cells probably re­
quire some sort of receptor common to the three cell lines. 
Those which showed limited or abortive multiplication in
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heterologous cells might be relying on the participation of 
receptor-independent mechanisms for their entry into the 
cells. Irrespective of the mechanism, it seems that the 
porcine and ovine pestiviruses here tested display their in 
vitro "cross-infecting" ability more often than the viruses 
of cattle origin. This limited ability to cross-infect swine 
cells is in agreement with another study on BVDV cell 
permissivity, where only two out of 35 strains and isolates 
infected PK15 cells, although 31 viruses were able to infect 
bovine and ovine cells (Liess and Moennig, 1989). In PK15 
cells, two strains of cattle origin (C24V and 163409) and 
the sheep isolate 135661, the HCV strain Osaka in BT cells 
and strains HCV Alfort, 331 and the giraffe isolate in 
SCPs gave rise to an "abortive" type of infection, since af­
ter one passage in those heterologous cells they could not 
be detected in the PLA assay. Although the reason for this 
could not be determined, it is possible that some sort of 
defective virion production, perhaps by defective or 
anomalous incorporation of viral structural proteins, might 
have led to the inability of those strains to re-infect the 
heterologous cell system. Interestingly, the HCV strains 
Osaka and 331 were associated with the induction of a 
chronic type of illness in pigs and were cross-neutralized 
to high titres (1:512) by an antiserum against a strain of 
BVDV (Kamijo and others, 1977). Two other viruses of cattle 
origin (A1050 and 182108) in PK15 did not produce any 
PLA-detectable antigen in titrations from the stock prepared
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in homologous cells, but were shown to multiply after one 
passage in the heterologous system, although to low titres 
(Fig 4.3). The actual reason why these viruses would behave 
in an opposite way as compared to the isolates that under­
went an abortive cycle of replication in heterologous cells 
is undetermined. It is speculated that it might reflect the 
ability of those viruses to to adapt to the heterologous 
cells more easily than others.
These results, however, must be interpreted with caution 
since the constant evolutionary process of the viruses
might have led to selection of virus populations with 
special characteristics after passage in vitro. BVDV 
strains NADL and C24V from distinct laboratories and
with varying passage histories displayed different 
monoclonal antibody patterns (Cay and others, 1989). It is 
likely that passage in vitro would also alter the cell 
range permissivity of the viruses.
3.5. CONCLUSIONS
The majority of pestivirus isolates examined in this study 
were able to infect cells of porcine, bovine and ovine 
origin. Only two HCV strains were unable to infect 
non-porcine cells. All other viruses were able to infect 
cells from at least two different host species. The isolates 
87/6 and 137/4 (which were used in subsequent animal
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inoculation experiments) displayed a similar behaviour in 
the tests performed. There may be some relationship between 
the ability of pestivirus isolates to infect cells of 
different host origin in vitro and their capacity to infect 
different animal species under experimental or natural 
conditions.
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CHAPTER 4. INOCULATION OF PREGNANT SOWS WITH PESTIVIRUSES OF 
DIFFERENT HOST SPECIES ORIGIN
4.1. INTRODUCTION:
Recently in England during 1987, a pestivirus was isolated 
from pigs which was of major significance to the British 
pig industry. It caused a number of deaths in piglets with 
no previous noticeable signs of clinical disease, and was 
initially diagnosed as HCV on the basis of polyclonal DFAT 
on cryostat sections, supported by virus isolation and 
subsequent immunofluorescence staining (ADAS, 1988; S. 
Edwards, personal communication). This diagnosis led to the 
compulsory slaughter of nearly 4000 pigs either on the farm 
itself or in contact with pigs from the farm. Moreover, it 
compromised the HCV-free status of the country, with con­
sequent effects on international trade. Subsequent charac­
terization of the virus by monoclonal antibodies (Mabs) and 
by differential neutralization tests suggested that it was 
more closely related to BDV than to HCV (Edwards and Sands, 
1990). These findings were indicative of a possible case of 
natural transmission of BDV to pigs. The present studies 
were carried out in order to provide additional evidence for 
the similarities between the isolate 87/6 and BDV strains by 
examining its ability to induce transplacentally transmitted 
fetal infections in swine and its effect on the litters of 
infected pregnant sows. A sheep pestivirus with similar
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cell culture growth characteristics (isolate 137/4, see 
Chapter 3) and with a Mab pattern of reactivity common to 
most BDV strains (Edwards and others, 1988) was included in 
the experiments for comparison. The aim of this set of 
experiments was to compare the virological and serological 
findings of the two viruses in pigs and determine the 
possibility of fetal infection. Additional work involved the 
study of the clinico-pathological effects of the pestivirus 
infections on fetuses.
4.2. MATERIALS AND METHODS:
Cells and media:
Cells and media used for the multiplication of viruses were 
as described in chapter 2.
Viruses:
The pestivirus of porcine origin, 87/6, was isolated from 
Basingstoke, Hampshire, and was considered of very low 
virulence as indicated by the absence of noticeable 
clinical signs observed in the infected animals. It was 
passaged three times in PK15 cells for the production of 
virus stocks, as described in Chapter 2. The pestivirus of 
ovine origin, 137/4, was isolated at the Veterinary In­
vestigation Centre, Worcester, from an adult sheep which 
died with black scour and nasal discharge. It was passaged 
twice in BT cells at CVL for the production of working virus
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TABLE 4.1: Sows inoculated, age, inoculum and route of inoculation
j Sow No. Age Gestational age 
at inoculation
Route of 
inoculation
Inoculum |
| Group I 
| 307 1 year 46 IN 87/6 |
| 305 1 " 37 IN
1 163 1 " 34 IM
| 164 1 " 38 IM
| Group II 
| 303 1 year 49 IN 137/4 |
| 302 1 " 37 IN
| 304 1 " 41 IM
1 H I 4 " 45 IM
j Control 
1 4
uninfected 
1 year
sow
NA NA NA |
Obs.: NA = not applicable 
IN = Intranasally 
IM = Intramuscularly
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stocks (see chapter 2). Other virus strains used in the SNTs 
were the BVDV strain Oregon C24V (C24V) (Gillespie 
andothers, 1960), the BDV strain Moredun (BDM) (Vantsis and 
others, 1976) and the HCV strains Baker A (BA) (Baker, 1956) 
and Alfort (Dahle and others, 1987).
Animals and animal inoculation:
Two groups of pregnant sows of the Landrace breed were 
inoculated with either the porcine isolate 87/6 (group I) or 
the ovine isolate 137/4 (group II). The virus dose in­
oculated in animals of group I was 1 ml of a suspension 
containing 105-8 TCIDgo/ml, and in group II, 105-0 TCIDgo/ml. 
Two animals of each group were inoculated intranasally (IN) 
and two intramuscularly (IM). Body temperature was recorded 
and clinical examinations were carried out for 15 days 
post-inoculation (d.p.i.). Blood samples were taken at 0, 
5, 10, 14, 21 , 28, 42 and 56 d.p.i. The animals in each
group and inoculation details are summarised in Table 4.1. 
The sows were killed and the piglets removed by hyster­
ectomy two days before the expected date of delivery (i.e. 
112 days). The offspring were revived, placed under 
infra-red lights and left to rest for at least one hour be­
fore clinical assessment.
Clinical examinations of the offspring:
The piglets were assessed one at a time for clinical and 
behavioural signs of abnormalities while allowing them to
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move on the floor. The records were compared with those from 
the control offspring of uninoculated mothers.
Offspring sampling:
After clinical assessment, blood samples were taken through 
cardiac puncture. Piglets were designated by their mother 
number followed by the letter P (piglet) and a random 
number given at delivery. The piglets were killed with bar­
biturate, weighed and their crown-rump length (C-R length) 
measured (Richardson and others, 1976). Post-mortem examina­
tions were then carried out. Right fore and hindlimbs were 
collected and placed in PBSF for subsequent age determi­
nation and identification of growth arrest lines (GALs). 
Brain and cerebellum weights were recorded.
Serology (SNTs):
The procedures for SNTs and titre calculations were 
described in Chapter 2. Serum samples negative (i.e. titre 
<1:10) for antibodies in SNTs were examined by IIF as 
described previously (Chapter 2).
Additional serological tests:
Samples of sera from the piglets obtained in these 
experiments were examined for the presence of antibodies to 
porcine parvovirus by haemagglutination inhibition tests.
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Virological examinations:
Staining of cryostat sections and virus isolation in tissue 
culture (in PK15 cells) were performed as described in 
chapter 2.
X-ray analysis:
Radiographs were taken in a Fixatron X-ray unit (model 
14308, Hewlett Packard, U.S.A.). Hind and forelimbs of 
piglets were exposed 40 seconds at 30 kV. All exposures were 
performed with a current of 3 mA at a distance of 58 cm 
from the anode to the film (Wrathall and others, 1974). 
Measurements were taken from the mid-axial dyaphises of 
bones. Bones measured were tibia, femur, ulna, radius and 
humerus, following the procedure described by Wrathall 
(1972). Bone length was compared with standard curves for 
calculation of the relative bone age (bone length age). 
Growth arrest lines (GAL) were measured as described 
(Terlecki and others, 1973; Wrathall, 1972) and the 
approximate age of the arrest determined based on the 
standard growth curves as above.
4.3. RESULTS:
Clinico-pathological assessment:
Sows :
No signs of clinical disease were observed in either group 
of inoculated sows throughout the duration of this study.
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Fig. 4.1. Temperatures of the inoculated sows in the first 15 
days post-infection, à) Sows of group I. b) Sows of group II. 
Temperatures are registered in degrees centigrades (°C).
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TABLE 4.2: Dates of delivery, number of piglets born and
major clinical signs observed in the litters
| Sow 
| No.
Gestational
at
Delivery d
age
in
P-i.
No. of
piglets born 
alive/total
Major clinical signs j 
or lesions* |
| 307 111 65 8/8 j
| 305 
|GROUP I
112 75 10/11 Malformation (PI) | 
Hyperextension of | 
digits (P2, P3, P4, | 
P5, P7, Pli, P12) |
| 163 112 78 9 / 9 j
1 164 112 74 10/10 j
|GROUP II 303 U K * ) 62 1/6 Piglets killed by sow]
| 302 112 75 11/12 Mummified (P12) |
| 304 112 71 11/11 Perinatal death (PI) j
1 111 112 67 10/11 Mummified (PI) |
|CONTROL 4 112 NA 13/14 Mummified (PI) |
- - no noticeable signs or lesions 
NA = not applicable
Obs: (*) Farrowed one day before expected date of delivery. 
Gestational ages expressed in days.
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Fig. 4.2. Piglets of sow 305 (group I), a) Malformation on the 
left front limb and tail (PI); b) tail of the same piglet; c) 
Hyperextension of digits particularly on the pelvic limbs (P2).
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They did not have pyrexia (temperature above 40°C) during 
the first 15 d.p.i (Fig. 4.1a, b) .
Piglets of sows infected with the swine isolate 87/6 (group
I):
The number of piglets born from each sow and the major 
clinical signs observed in the offspring are shown in Table
4.2. Most piglets displayed a slight tremor and showed signs 
of ataxia (difficulty in standing, incoordination). Such 
signs, however, were also present in the control uninfected 
litter. The only clinical signs which were not seen in the 
uninfected control litter were present in the litter of sow 
305 and consisted of ahyperextension of the digits of the 
pelvic limbs, registered in seven out of the twelve 
piglets born (Table 4.2). Also absent in controls were the 
gross anatomical malformations observed in another piglet 
of sow 305 (PI), affecting the tail and the left front limb 
(Fig. 4.2). This piglet (305 Pi) was stillborn.
Piglets of sows infected with the sheep isolate 137/4 (group
II):
In this group the clinical picture observed in the offspring 
was similar to that of group I (Table 4.2). Although most 
piglets had a slight constant tremor and an apparent 
ataxia, no distinctive clinical signs that were not present 
in the uninfected control litter could be observed. One of 
the sows (303) farrowed during the night prior to the
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scheduled day of hysterectomy (111 days of gestation), and 
it was not possible to assist delivery. Six piglets were 
farrowed, five of them dead and one still alive, all showing 
signs of being attacked by the sow (e.g. crushed bones, 
lacerated limbs, fractured skulls and spine and signs of 
extensive haemorrhage through the mouth). The piglet that 
was still alive was moribund and had an abdominal hernia 
of the intestines, probably also caused by the sow. It was 
not possible to determine whether or not the piglets sucked 
before death, although their stomachs showed no evidence of 
the presence of colostrum. Sow 304 had one piglet which died 
soon after birth (Pi). Sows 302 and 111 each gave birth to 
one mummified fetus.
Control uninfected litter:
The piglets of the control uninfected litter displayed a 
pattern of behaviour largely similar to that observed in 
piglets from infected sows and consisting of tremors, 
apparent incoordination, reluctance to move, difficulty in 
standing, ataxia, walking backwards, with some presenting 
"splayleg". Moreover, the control sow also gave birth to a 
mummified fetus. Control piglets, however, did not present 
hyperextension of digits or gross anatomical malforma­
tions.
Serology:
The results of the SNTs were considered as evidence of the
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seroconversion of the animals tested. IIPX, DFAT or IIF were 
employed as a confirmatory test in most cases and are not 
referred to specifically in this section, unless otherwise 
mentioned in the text. Animals considered
"antibody-positive" were those whose sera were able to 
neutralize viral infectivity at a dilution of 1:10 or
higher. Consequently, "antibody- negative" sera refers to 
those in which no neutralizing activity was detected under 
the same conditions (i.e. titre <1:10).
Sows of group I:
The neutralizing activity detected in the sera of sows in­
fected with the pig isolate are represented in Fig. 4.3. 
Neutralizing activity to the homologous virus (titres 1:10) 
was first detected at 14 d.p.i. for sows 163 and 164 and at
21 d.p.i. for sows 307 and 305, reaching a peak at 28 to 56
d.p.i. In two sows (307, 163) titres tended to decline at 
the last sampling (day of hysterectomy). In sow 305 titres 
were kept rising, whereas in sow 164 they remained at the 
same high levels registered at 56 d.p.i. until that last 
sampling. Cross-neutralizing antibody titres were detected 
usually later and more irregularly than homologous 
responses. When present, titres were usually at least one 
log# lower than homologous titres. No definite pattern of 
cross-neutralization was evident, as the levels of
cross-reactivity varied throughout the sampling period. No 
detectable cross-neutralizing activity to the HCV strain
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Fig. 4.3. Results of serum-virus neutralization tests (SNTs) in 
sera from inoculated sows. All samples were tested with all 6 
virus strains shown. Serum dilutions (twofold) started at 1/10. 
a, b) sows of group I; c, d) sows of group II. SNT titres are ex­
pressed as the reciprocal of the serum dilution capable of 
neutralizing virus infectivity in 50% of the microtitre plate 
wells at that dilution. Last d.p.i. represented corresponds to 
the day of hysterectomy. Sera of sows 305, 163, 164 (group I), 
303 and 302 (group II) had no cross-neutralizing activity to HCV 
strain Alfort. In addition, no cross-neutralization was detected 
in sera of sows 163 (group I) and 303 (group II) against BVDV
C24V. Sows 111 and 302 showed neutralizing activity to BVDV C24V 
at low titres (1/10) only in samples collected at the day of 
hysterectomy. Sera of sows 164 (group I), 303 and 302 (group
II) were also devoid of neutralizing activity to HCV strain Baker 
A.
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Alfort was observed in three (sows 305, 163,164) out of the 
four infected sows.
Sows of group II:
The results of the SNTs in serum samples from the sows of 
this group are shown in Fig. 4.3c and d. Neutralizing anti­
bodies to the homologous strain were detected between 21 and 
28 d.p.i. Titres usually reached a peak at 42 d.p.i. or 
later and were kept at high levels until the last sampling 
at the day of hysterectomy. The overall picture was similar 
to that observed with sows of group I. Cross-neutralizing 
antibodies usually appeared delayed and at lower titres 
than the homologous response. Cross-neutralizing activity 
to the BVDV strain C24V was found in samples of sow 304 and 
in the last sample of sows 302 and 111, whereas all samples 
of sow 303 were negative for neutralizing antibodies to that 
strain. Sera from sows 303 and 302 had no cross-neutralizing 
activity to HCV strains Baker A and Alfort. No definite 
pattern could be visualized from the comparison of the 
cross-neutralizing antibody responses to the viruses tested.
Uninfected control sow:
No neutralizing antibodies were detected in samples of the 
control uninfected sow (data not shown).
Piglets of group I:
The results of the SNTs in sera of piglets from both groups
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are summarized in Table 4.3. In group I, two of the four 
litters (sows 307 and 164) had no neutralizing antibodies 
to any of the pestiviruses viruses tested. The neutralizing 
antibody profile from piglets of those sows which did have 
some neutralizing antibody-positive piglets ( 305 and 163) 
are shown in Fig. 4.4. Five piglets from the two litters 
were negative for antibodies to all pestiviruses tested. The 
majority of the sera were positive to the homologous virus 
at the highest titre levels, followed by lower levels of 
cross-neutralizing responses to the BDV strain Moredun 
(BDM) and to the ovine isolate 137/4. Levels of neu­
tralization and cross-neutralization varied within and be­
tween the two litters. Piglets from sow 163 (Fig. 4.4b)
developed overall lower neutralizing antibody titres than 
those of sow 305 (Fig. 4.4a). Cross-neutralization to other 
strains tested was very weak (Table 4.3). None of the 
piglets of these litters had cross-neutralizing antibodies 
to the HCV strain Alfort.
Piglets of group II:
All four litters of this group showed evidence of 
intrauterine infection, as judged by the presence of 
neutralizing antibodies in the sera of at least some piglets 
(Fig. 4.5). Neutralizing antibody titres showed a similar 
trend in all litters, with the homologous responses 
reaching higher levels, followed by a cross-neutralizing 
antibody response of lower (1 to 2 logio) intensity. The
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Fig. 4.4. Results of serum-virus neutralization tests (SNTs) 
using sera from piglets in group I. Tests were performed on serum 
samples collected at birth. Numbers on top of graphs refer to 
sows' numbers ; PI, P2, etc. refer to piglet numbers. SNT titres 
are expressed as the reciprocal of the serum dilution capable of 
neutralizing virus infectivity in 50% of the microtitre plate 
wells at that dilution. The litters of the two other sows of the 
group (307, 164) were negative (e.g. titre <1:10) for
neutralizing antibodies.
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TABLE 4.3: Summary of the SNT results for piglets sera
j Neutralizing antibodies to virus strain j |
No
137/4 BDM 87/6 C24V Baker A Alfort Negative Results Total|
j GROUP I 
1(87/6)
9 11 16 2 1 - 23 - 39 |
|GROUP II 
1(137/4)
25 23 19 5 3 3 13 2 40* |
j Total 34 34 35 7 4 3 36 2 79 |
Observation: The 13 piglets of the uninfected control sow were 
negative for neutralizing antibodies to all viruses 
tested (titre <1:10).
* Two of the 40 fetuses of the group were mummified.
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Fig. 4.5. Results of serum-virus neutralization tests (SNTs) 
using sera from piglets in group II. Tests were performed on 
serum samples collected at birth. Numbers on top of graphs refer 
to sows' identification; Pi , P2, etc. refer to piglets
identification numbers. SNT titres are expressed as the recipro­
cal of the serum dilution capable of neutralizing virus infec­
tivity in 50% of the microtitre plate wells at that dilution. (*) 
refers to mummified fetuses where no serum was available for 
testing.
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general pattern of neutralization was similar to that of 
group I. Cross-neutralization varied within and between 
litters (Fig. 4.5). In the majority of sera, the most 
consistent cross-neutralizing responses were to BDM and to 
the porcine isolate 87/6 (Fig. 4.5; Table 4.3).
Cross-neutralizing antibodies to the other strains were less 
consistent, usually absent in sera of low homologous 
neutralizing antibody titres (Fig 4.5; Table 4.3).
Piglets from the uninfected litter:
All the samples from the uninfected litter were negative 
for neutralizing antibodies to all the viruses tested.
Results of tests for porcine parvovirus antibodies :
No antibodies to porcine parvovirus were detected by 
haemagglutination inhibition tests in sera from any of the 
piglets of these experiments (data not shown).
Virus isolation and fluorescent antibody staining studies: 
In the virus isolation experiments, the sensitivity of the 
assay employed for virus isolation was calculated as 
follows. A 10% suspension of tissues in TPB supplemented 
with antibiotics (see Appendix) was prepared and 0.2 ml of 
that inoculated onto coverslips. Therefore, a final dilution 
of tissue of 10"i-7g/ml was inoculated on each coverslip. 
Assuming that one TCID50/9 is necessary for the induction of 
one fluorescent plaque, the method employed would only
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detect virus in the sample if the concentration of virus was 
50 TCIDso/g of tissue i < (antilogio 1 .7 = 50). Thus, 
"virus-positive" in the present work represents 
concentrations of virus equal to or above that limit, 
whereas "virus-negative" refers to results that did not 
allow virus recovery using the same parameters.
Sows of groups I, II and uninfected control:
Virus isolation attempts from serum, buffy coat or blood 
clots from all the experimental sows were negative 
throughout the period of this study.
Piglets of group I:
Piglets from sows 307, 163 and 164 were all negative for
antigen by immunofluorescence staining of cryostat sections 
of tissues or virus isolation in cell culture (data not 
shown). Sow 305 had the only litter where piglets with 
DFAT-positive cryostat sections were found (Table 4.4). Only 
three piglets from that sow were positive in both 
immunofluorescence staining of cryostat sections and virus 
isolation. It was noted that these three piglets were the 
only piglets of this litter which were negative for neu­
tralizing antibodies (see above). In many tissues, the 
presence of patches of poorly fluorescing cells made reading 
of the tests difficult. At virus isolation the results were 
easier to interpret, with a greater number of tissue samples 
giving rise to positive results, and at the same time
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TABLE 4.4: Virological examination of samples from piglets of %roup I
a, b) sow 305. Other litters of group I were negative in 
both tests (data not shown).
a) Results of fluorescent antibody staining of cryostat sections
305
TISSUES Pl(a) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pli P12
- ( * ) ............................................
? — — — — — — — — — —
?  - -  -  -  -  - - -
+   -
+ - 2+ 4+ - - - - -
Liver
Spleen
MLN(b)
Sm. Int.(c)
Kidney
Heart
Lung
Thymus
SMLN(d)
Tonsils
Brain
b) Results of virus isolation in cell culture
305
|TISSUES | PKa) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pll P12 |
|Liver | + + „
|Spleen | 4+ - - - 2+ - - - - - |
|MLN(b) | 4+ - - - 2+ - - - - - |
|Sm. Int.(c)| 1+ - - - 2+ - - - . . - j
|Kidney | 3+ - - - 2+ - - - ■ - |
|Heart | 3+ - - |
1 Lung | 3+ - - |
|Thymus | 3+ - - |
|SMLN(d) | 4+ - - 4+ 2+ - - - - - |
|Tonsils | 4+ - - 2+ 2+ - - - - - |
|Brain | + - - - |
|Blood clot | 4+ - - 3+ 2+ - - - - - |
|Serum | 4+ 3+ 2+
Observations: (a) = Piglet number
(b) = Mesenteric lymph node
(c) = Small intestine
(d) = Submandibular lymph node
(*) = key for table : - = negative
? = inconclusive result
+ = <10% of cells positive
2+ = <30% of cells positive
3+ = <50% of cells positive
4+ = 50% or more of cells positive
ND = not done
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TABLE 4.5: Virological examination of samples of piglets of group
II. a, b) samples of piglets of sow 302; c ,d) samples of 
piglets from sow 111. Other litters of group II were 
negative in both tests (data not shown).
a) Results of fluorescent antibody staining of cryostat sections
302
I TISSUES PKa) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pll P12(e)|
|Liver -(*) . . + 2+ + + . ND |
j Spleen - - - - + 2+ 4+ + ? ? ND |
|MLN(b) - - - - - + + 4+ + ? + ND |
|Sm. Int.(c) - - - - - + 4+ 4+ + + + ND |
|Kidney - - - - - + 4+ 4+ 3+ - + ■ ND j
j Heart - - - - - - 4+ 4+ 2+ + + ND |
j Lung - - - - - + 4+ 4+ 3+ + + ND |
j Thymus - - - - - + 4+ 4+ 2+ - + ND |
|SMLN(d) - - - - - + 4+ 4+ 2+ 2+ + ND |
|Tonsils - - - - - + 4+ 4+ 4+ 3+ + ND |
j Brain - - - - - - 4+ 2+ + + ND ND |
b) Results of virus isolation in cell culture
302
I TISSUES PKa) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pll P12(e)|
|Liver - (*) - 2+ 4+ 2+ . ND j
|Spleen - - - - - - 2+ 2+ 2+ - - ND |
|MLN(b) - + 4+ ND - - ND |
|Sm. Int.(c) - - 4+ 4+ + - - ND |
|Kidney - - 4+ 4+ 24- - - ND |
|Heart - - - - - 4+ ? 24- - - ND |
1 Lung - - 4+ 4+ 24- - - ND |
|Thymus - 2+ - - - ND |
|SMLN(d) - - 4+ 4+ 34- - - ND |
|Tonsils - - 4+ 2+ 4-, - - ND |
|Brain - - 4+ 4+ 24- - - ND |
|Blood clot - - 4+ - 34- - - ND |
|Serum - - - - 4+ 4+ ND |
Continued on next page
135
TABLE 4.5: Continued
c) Results of fluorescent antibody staining of cryostat sections
111
I TISSUES
1
IPKe) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pll
j Liver
1
| ND + + +
j Spleen | ND + - + - + - + + - -
|MLN(b) | ND + - + - + + - - + -
|Sm. Int.(c) j ND + - ? + + - - + -
j Kidney | ND + + + + + + + + - -
[Heart | ND + - - - + + - - - -
j Lung | ND + + + + + + - + - -
j Thymus | ND + - ? + + - + + - -
|SMLN(d) | ND + + + + ? - + + + -
|Tonsils | ND 
1
+ + + 2+ + + + +
'
d) Results of virus isolation in cell culture
111
1 TISSUES I PKe) P2 P3 P4 P5 P6 P7 P8 P9 P10 Pill
jLiver j 4+ + 2+ + 4+ + 4+ 4+ . „
j Spleen j - 4+ 2+ 4+ 4+ 4+ + 4+ 4+ - - 1
|MLN(b) | - 4+ 2+ + + 4+ + 4+ 4+ - - 1
j Sm. Int.(c)| - 4+ 2+ 4+ Tox 4+ + 4+ 4+ - - 1
|Kidney j - 4+ 2+ 4+ 4+ 4+ 4+ 4+ 4+ - - 1
[Heart j - 4+ 2+ 4+ + 4+ 2+ 4+ 4+ - - 1
1 Lung j - 4+ 2+ 3+ - 4+ + 4+ 4+ - - 1
j Thymus | - 4+ 2+ 3+ - 4+ + 4+ 4+ - - 1
|SMLN(d) | - 4+ + 3+ + 4+ + 4+ 4+ - - 1
[Tonsils j - 4+ 3+ 3+ + 4+ + 4+ 4+ - -  1
j Blood clot | - 4+ + 3+ + 4+ + 4+ 4+ - -  1
|Serumls j - - + 3+ + 4+ 4+ 4+ 4+
(a) = Piglet number
(b) = Mesenteric lymph node
(c) = Small intestine
(d) = Submandibular lymph node
(e) = Mummified fetus
(*) = key for table : - = negative
? = inconclusive result
+ = <10% of cells positive
2+ = <30% of cells positive
3+ = <50% of cells positive
4+ = 50% or more of cells positive
ND = not done
Tox = Toxic for cell cultures
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displaying more positive cells, with a more intense 
fluorescence.
Piglets of group II:
The results obtained from the examination of tissues of 
piglets from sows of this group are represented in Table 
4.5. Two sows, 302 and 111, had antigen-positive piglets. 
Sow 302 had six piglets positive for antigen by 
immunostaining of cryostat sections, whereas at virus 
isolation only three of these gave positive results. The 
FATs on tissues from those piglets from which virus could 
not be recovered (P10, Pll) were considerably less intense 
than those from which virus isolation was possible (302 P7, 
P8, P9). One of the fetuses (302 Pi 2) was mummified and no 
results were obtained in either of the tests.
Sow 111 had nine piglets positive by DFATs in cryostat 
sections, of which eight were also positive at virus 
isolation. Piglet 111 Pi 0 had three cryostat sections of 
tissues positive by DFAT, but no virus could be isolated 
from any of its tissues. Most tissues from piglets with 
positive DFATs in cryostat sections displayed a fluorescence 
of low intensity. On the other hand, the results of virus 
isolation were usually very clear, not only in the intensity 
of staining but also in the number of positive cells. 
Piglets 111 P5 and P7, however, although positive for virus 
isolation, gave rise to a discrete fluorescence even after
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virus isolation in cell culture (Table 4.5.d) . Piglet 111 Pi 
was mummified and no results were obtained from its tissues 
at virus isolation.
Piglets from the control litter:
No virus was isolated from any of the samples of the 
uninfected control litter (data not shown).
Morphometric studies :
Piglets of group I:
The results of the morphometric studies in piglets of this 
group are represented in Fig. 4.6a. The normal
distribution limits for uninfected piglets (parallel lines 
in graphs of Fig. 4.6) have been published previously
(Wrathall, 1972; see Appendix). Ages calculated for each of 
the measured bones (tibia, femur, ulna, radius and humerus) 
are shown in the Appendix section. The values for femur 
length are shown in Fig. 4.6 as a representative of all the 
bones measured. For all piglets of this group, the 
relationship C-R length versus whole body weight (Fig. 4.6a) 
did not vary from the normal expected values. Other 
variables (femur length versus body weight; brain and cer­
ebellum weight versus body weight) revealed various pig­
lets of all four sows with values below the 95% confidence 
limits (2 standard deviations). Cerebellum weight was par­
ticularly affected in the litter of sow 305 (7/12 piglets).
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Fig. 4.6. Morphometric studies on piglets, a) Group I. Piglets of 
different sows are represented as follows: sow 307 (A), 305 (A), 
163 (B ) and 164 (□); b ) Group II. Piglets of different sows are 
represented as follows : sow 303 (A), 302 (A), 304 (■), 111 (□).
Parallel lines represent mean expected normal values (central), 
and 2 standard deviations (outer upper and lower lines) for 
uninfected piglets (Wrathall, 1972). Weights are presented in 
grams, lengths in millimetres.
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TABLE 4.6: Growth arrest lines (GALs) in litters of infected sows
GROUP I
Sow No
Piglet No.
GROUP II
Piglet No.
307 305 163 164
GALs* GALs GALs GALs |
PI -(t) P12 77 PI 87, 89 PI
P2 - P2 84 P2 - P2 |
P3 - P3 - P3 - P3 |
P4 - P4 - P4 - P4 |
P5 - P5 70 P5 81, 87 P5 |
P6 - P6 82 P6 - P6 |
P7 - P7 - P7 83, 103 P7 |
P8 - P8 - P8 - P8 j
P9 - P9 92 P9 |
P10 - P10 |
Pll -
P12 -
Sow No.
I 303 302 304 Ill
GALs GALs GALs GALs |
| PI PI 82 PI 87, 89 Pl( + )
| P2 - P2 - P2 - P2 |
| P3 90 P3 - P3 53 P3 |
| P4 - P4 - P4 63, 70 P4 |
| P5 - P5 - P5 65 P5 |
1 p6 - P6 - P6 67 P6 |
P7 - P7 55 P7 |
P8 P8 65 P8 |
P9 - P9 - P9 |
P10 ■ - P10 - P10 |
Pll Pll
P12(+)
Pll
* = Numbers represent the calculated gestational day corresponding 
to observed GALs
(+) = Mummified fetus
(f) No GALs observed
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Growth arrest lines (GALs) (Table 4.6) were observed in 
eight piglets of the group, four from sow 305 and four from 
sow 163, with some animals presenting more than one GAL at 
different days in gestation (163 Pi, P5, P7). The litters of 
sows 307 and 164, which presented no virological or 
serological evidence of intrauterine infection (see below) 
had the relationship brain weight versus body weight
affected in 4 out of 8 and 6 out of 10 piglets, respec­
tively (Fig. 4.6).
Piglets of group II:
In group II, the ratios brain and cerebellum weight versus 
total body weight were below the 95% confidence limit in 
most piglets from three of the sows (302, 304, 111 ; Fig
4.6b). Piglets from sow 303 were within normal
distribution limits in all four parameters evaluated. Femur 
length versus whole body weight was below normal
distribution limits particularly in one litter (sow 302, 
Fig. 4.6b). GALs were observed in nine piglets of this 
group, seven from sow 302, one from sow 303 and one from 
sow 304 (Table 4.6). Two piglets from sow 302 had two GALs. 
The litter of sow 111, which showed evident signs of growth 
retardation (Fig. 4.6b), did not present any GALs.
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TABLE 4.7: Summary of effects on swine following inoculation of pestlvtruses
a) GROUP I
| No. Abortion
Mummification/
Autolysis If No. GrowthRetardation GALs(c)
Virus
isolation
results
Neutralizing | 
Antibody | 
status |
| 307 No No . PI - -
P2 Yes -
P3 Yes
P4 - -
P5 Yes
P6 - -
P7 - -
P8 Yes
| 305 No No SB** PI Yes Yes +
P2 Yes Yes  ^ 1
P3 Yes - + |
P4 Yes + 1
P5 Yes Yes *
P6 Yes Yes * I
P7 . - + 1
P8 Yes + 1
P9 Yes - + |
P10 Yes - + |
Pll Yes - + |
P12 Yes + |
| 163 No No . PI - Yes
+■ |
P2 + '
P3 - - + |1 P4 Yes + |
1 P5 Yes Yes +■ |
1 P6 . - + |
P7 - Yes
1 P8 . - + |
1
1
P9 Yes Yes + |
1
| 164 No No . PI - * j
P2 Yes
P3 - -
P4 Yes 1
P5 - -
P6 Yes
P7 - -
1 P8 Yes
1 P9 Yes •
1
1
P10 Yes
Continued on next page
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TABLE 4.7 Continued
b) GROUP II
No. Abortion
Mummification/
Autolysis
SB(a)/
PD(b) No.
Growth
Retardation GALs(c)
Virus
isolation
results
303 No 
(see obs.)
No PI
P2
P3
P4
P5
P6
Yes
302 No Yes** PI Yes Yes
P2 Yes -
P3 Yes Yes
P4 Yes Yes
P5 Yes Yes
P6 Yes Yes
P7 Yes Yes +
P8 Yes Yes +
P9 Yes - +
P10 Yes *
Pll Yes -
*P12 NA(d) NA NA
304 No No PD** PI Yes
Yes
P2 Yes
P3 Yes
P4 Yes
P5 No
P6 Yes
P7 -
P8 Yes
P9 -
P10 Yes
Pll Yes
*P1 NA NA NA
P2 Yes *
P3 Yes *
P4 Yes
P5 Yes
P6 Yes
P7 Yes *
P8 Yes *
P9 Yes
P10 Yes
Pll Yes
111 No Yes**
(-) - negative
(a) - stillbirth
(b) - perinatal death
(c) - growth arrest Une»
(d) - not available
(*) - mummified or autolysed fetus 
(**) - one piglet only
Observation: Cannibalism was observed on litter of sow 303
Summary of the results:
A summary of the results obtained with the inoculation of 
pregnant sows and findings on their offspring is presented 
in Table 4.7.
4.4. DISCUSSION:
In this section, the serological and virological results are 
discussed first, as they provide the most convincing 
evidence for transplacental infections. The
clinico-pathological aspects are examined later.
Serology:
Sows :
The experimental infection was considered successful in all 
sows, since they all developed antibodies to the inoculated 
virus. The results of SNTs revealed a homologous
neutralizing antibody response of high titre, followed by 
lower levels of cross-reactive antibodies to other 
pestivirus strains. Very little cross-reactivity was 
detected with the HCV strain Alfort ’ (Figs. 4.3). When
present, it usually was manifested later than the ho­
mologous reaction. This serological profile of neutralizing 
antibody response in sows is similar to previous findings 
(Liess and others, 1974, 1976; French and others, 1977;
Snowdon and French, 1976; Wrathall and others, 1978). The
poor antigenic relatedness of the HCV strain Alfort (and to
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a lesser extent of the HCV strain Baker A) to the other 
pestiviruses tested was shown by the low degree of 
cross-reactivity in inoculated animals.
Piglets :
In group I, the two litters with evidence of infection 
(sows 305 and 163) had some piglets whose sera contained 
neutralizing activity. The neutralization profiles observed 
between those two litters were very similar to each other, 
including some piglets which were negative for neutralizing 
antibodies to the homologous or heterologous viruses tested 
(Fig. 4.4, Table 4.3). The other two litters, as commented 
above, were negative for neutralizing antibodies in the 
standard SNTs employed here. However, under special 
conditions (see Chapter 6), some of these piglets would 
present low levels of pestivirus specific antibodies. These 
observations plus the evident signs of growth retardation in 
some siblings, gave cause for some doubt regarding their 
status of "uninfected".
In group II, all litters had at least some piglets with high 
titres of neutralizing antibodies. The patterns obtained 
were generally analogous to those observed in 
antibody-positive piglets of group I, with a marked 
neutralizing antibody response to the homologous virus fol­
lowed quite closely by cross-reacting titres to the pig 
isolate (87/6) and to the BDM strain. Cross-reactions to
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other pestivirus strains were sporadic (Fig. 4.5, Table 
4.3). Cross-neutralization titres in both groups suggest 
that the sheep and swine isolates are antigenically more 
closely related to each other and to BDM than to the other 
strains tested.
Virological studies:
Sows :
Virus was not isolated from blood clots, buffy coats or sera 
of the sows of either group of infected animals (or the 
control uninfected sow) from any of the samples collected 
during the period of this study.The occurrence of viraemia 
is a condition sine qua non for transplacental transfer of 
the virus to the fetuses (Liess and Moennig, 1990). It is 
likely that the viraemic period was short-lived, 
therefore remaining undetected by the sampling strategy 
adopted.
Piglets:
In litters of group I, virus was isolated from three piglets 
of one sow only (305, Table 4.4). DFAT results in cryostat 
sections of these piglets were poorer than those obtained 
by virus isolation (Table 4.4). Later, these piglets were 
shown to possess low levels of antibodies (see Chapter 6) . 
It was not determined whether such poor reaction at DFAT was 
related to the presence of the low levels of antibodies, 
but it is tempting to speculate that this might have influ-
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enced the outcome of the tests.
In group II, virus was isolated from litters of two of the 
four sows inoculated. Some litters had piglets where virus 
could be detected only by DFAT, and not by virus isolation 
(sow 302, see Table 4.5). Difficulties in recovering virus 
from animals with specific neutralizing antibodies have been 
described in pestivirus infections in various occasions 
(Schultz, 1973; Braun and others, 1973; Badman and others, 
1981; Ohmann and others, 1982; Rinaldo and others, 1976; 
Brown and others, 1979; Terpstra, 1981). It is speculated 
that the presence of excess antibody might have neutralized 
any potentially infectious virus in those animals.
It is difficult to match the observations of those piglets 
of group I and II which showed an unusual combination of 
DFAT in cryostat sections and virus isolation results, since 
the end results were quite opposite. It has been hypoth­
esized that antibodies might be involved in both cases. 
Amongst other important variables (such virus strain, fetal 
age at infection and individual animal variation), differ­
ences in the nature, affinity and amount of antibodies gen­
erated might have accounted for the differing observations 
in the two groups.
Clinical observations on sows:
Although all the sows in either group of inoculated animals
151
were successfully infected, no manifestations of clinical 
disease were observed throughout the duration of the ex­
periment . Similar findings have been reported following 
infection of sows with BVDV and BDV (Snowdon and others,
1968; Stewart and others, 1971; Wrathall and others, 1978; 
Terpstra, 1981; Leforban and others, 1990b). It is likely 
that under field conditions, infections of sows with vi­
ruses such as these employed here would pass unnoticed at 
least until farrowing. This finding is of major veterinary 
importance since the introduction of ruminant pestiviruses 
into the pig population could pass unnoticed and lead to a 
misleading diagnosis of HC, with the implications arising 
from that (Bendixen, 1977; McDaniel, 1977; Liess, 1981). 
In this study, the profile of neutralizing antibody 
response induced by the isolate 87/6 in infected animals 
was more comparable to other pestiviruses of ruminants 
than to the two HCV strains tested. It is particular 
noteworthy that, if the standard pestivirus strains used for 
serology were Baker A (representing HCV) and C24V
(representing BVDV), then a misleading diagnosis of HCV
could be arrived at (see Fig. 4.3a, b ) . This indeed was one
of the factors leading to the diagnosis of HC in the
original outbreak from which the 87/6 virus was isolated, 
and led to the subsequent decision to change the reference 
strain used for HCV serology at the CVL to the strain Alfort 
(S. Edwards, personal communication).
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Pairs of animals in each group were inoculated by different 
routes (IN or IM) in order to ensure that transplacental 
infection would be achieved in some of the animals. The 
route of inoculation did not seem to play any decisive role 
in the outcome of the infection, since transplacental 
infection was observed following both routes of inoculation.
Clinico-pathological observations on fetuses:
Fetal death:
Abortions were not observed in either of the two groups. 
Similar results were obtained by Wrathall and colleagues 
(1978), who did not observe "abortions or fetal deaths that 
could be attributed to BDV", after infection of pregnant 
sows. Although HCV infections with highly pathogenic strains 
would be expected to kill pregnant sows (Van Oirschot, 
1988), strains of low virulence and some strains of 
vaccinal virus are known to be causes of reproductive dis­
orders (Biront and Leunen, 1988; Van Oirschot, 1988). 
However, even in those cases abortion is not a common 
finding in HCV-associated reproductive disease (Plateau and 
others, 1980; Emerson and Delez, 1965).
Stillbirth, early postnatal death and fetal mummification 
are often associated with HCV infections (Emerson and
Delez, 1965; Cowart and Morehouse, 1967; Dunne and Clark, 
1968; Dunne 1975; Plateau and others, 1980; Von Benten, 
1980; Van Oirschot, 1988). Such causes of fetal death were
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not marked features of the experimental infections 
described here. Similarly, fetal mummification was observed 
in two fetuses from two litters. However, as the control 
non-infected sow also had one mummified fetus, indicating 
that the mummification was not necessarily related to the 
pestivirus infection. In addition, no evidence was found of 
infection with porcine parvovirus, another major cause of 
mummification in piglets. Thus, the cause of the 
mummification observed could not be determined.
Fetal lesions:
The main lesions observed in infected piglets consisted of 
reduced organ weights of brain and cerebellum. A reduced 
brain weight versus whole body weight ratio was the most 
consistent indicative of fetal pathology in infected litters 
(Fig 4.6). This ratio was affected in about half of the 
piglets born in all litters, including some piglets from 
the litters for which there was no serological or 
virological evidence of infection.
The ratio cerebellum weight versus total body weight was 
abnormally low in most piglets of group II, whereas in group 
I the offspring of only one sow (305) showed this effect in 
a large number (7/12) of piglets (see Fig. 4.6). It was not 
possible to determine whether the differences in cerebellum 
weight ratios in the two groups were due to differences in 
virus strain virulence, since these might have been caused
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by individual animal variation or by slight differences in 
gestational age at inoculation of sows in both groups.
In HC, cerebellar hypoplasia is commonly associated with 
congenital infections of piglets, following vaccination of 
sows with live attenuated vaccines during pregnancy or in­
fections with HCV strains of low virulence (Emerson and 
Delez, 1965; Johnson and others, 1974; Harding and others,
1964, 1966; Done and Harding, 1966). This lesion in
HCV-infected piglets is associated with the "congenital 
tremor" sometimes observed (Plateau and others, 1980; 
Vannier and others, 1981; Van Oirschot and Terpstra, 1977). 
In BD, reduction in both brain and cerebellum weight are 
known to occur in lambs (Terlecki and others, 1973; Barlow 
and others, 1980; Plant and others, 1983a, b) . The tremor 
which gives rise to the "shaking" of infected lambs is one 
of the classical signs of BDV infections (Hughes and others, 
1959; Markson and others, 1959). In the present study, 
however, the tremor observed in most piglets could not be 
associated with the viral infections, since piglets from the 
uninfected control litter displayed the same type of 
clinical manifestation. The tremor observed may have been 
associated with the abnormal conditions at delivery, 
combined with a lack of postnatal mothering or feeding, and 
a too-short recovery time. The reason for adopting such 
methodology was to avoid colostral interference with the 
serological and virological tests. Proper characterisation
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of the tremor would require the piglets to be observed for 
a longer period and was not feasible under the conditions 
employed here.
On the other hand, the parameters involving osteal 
measurements were the least affected. The relation C-R
length versus body weight did not deviate from the normal 
distribution limits. The ratio femur length versus body 
weight was only noticeably affected in in two litters, one 
from each group (group I: 4/12 piglets of sow 305; group II:
5/11 piglets of sow 302; Fig. 4.6b). Another indicator used
for assessment of the pathological effects on fetuses was 
the appearance of GALs in radiographs of long bones of pig­
lets. Such lines were observed in piglets of both groups. 
In two litters, more than one GAL in the same animal were 
registered (group I sow 163, group II sow 302, Table 4.6). 
GALs are non-specific indicators of growth arrest (Terlecki 
and others, 1973). It was not possible to correlate the
presence of GALs to any specific virus or antibody status of 
the fetuses, although most of the piglets presenting GALs 
were antibody-positive (Table. 4.7). However, piglets with 
GALs often showed other signs of growth retardation (Table 
4.7). The low number of animals with osteal alterations and 
the lack of a definite pattern in the presentation of GALs 
indicates that the osteal morphometric parameters examined 
and analysis for the presence of GALs are not adequate 
indicators for pestivirus fetal infections.
One piglet (group I, sow 305) presented a gross anatomical 
defect in one forelimb (suggestive of arthrogryposis), as 
well as a tail shorter than expected (Fig. 4.2). In 
addition, hyperextension of the digits of the hindlimbs was 
observed in 7 out of 12 piglets of sow 305. Such anatomical 
abnormalities are signs of deviant morphogenesis and were 
probably associated with the virus infection. Arthrogryposis 
has been occasionally described after transplacental in­
fection of piglets with HCV, and lambs with ruminant 
pestiviruses (Young and others, 1955; Emerson and Delez,
1965; Johnson and others, 1974; Van Oirschot, 1980; Ward and 
others, 1971; Vantsis and others, 1980). The hyperextension 
of the digits of the hindlimbs observed in various piglets 
of sow 305 are indicative of an excessive joint flexibility, 
which might be related to inadequate ossification of bones 
(Wrathall, 1972).
Despite no evidence of infection (e.g. virus or antibodies) 
being found in the offspring from sows 164 and 307 (group 
I), both litters had some piglets with signs of growth 
retardation (brain versus body weight in six piglets of sow 
164, four of sow 307; cerebellum versus body weight in one 
piglet of sow 307; femur length in one piglet of sow 164, 
see Fig. 4.6). It was not possible to determine the cause of 
such growth impairment. An indirect effect of the infection 
on the mother leading to impaired fetal nutrition and
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consequent fetal injury might have been associated with 
such signs (Creasy and others, 1972). However, the pos­
sibility remains that some of these piglets might in fact 
have been infected at levels below the detection threshold 
of this study. Alternatively, they might have eliminated any 
infectious virus after an emerging immune response to the 
infection. Some evidence in favour of this hypothesis is 
presented in Chapter 6, where low levels of specific anti­
bodies were detected in the sera of some animals following 
special treatment of the samples.
The results of the experiments described here are in 
agreement with other studies where BDV was experimentally 
inoculated into swine during pregnancy (Wrathall and others,
1978; Leforban and others, 1990b). However, in contrast to 
the recent work of Leforban and colleagues (1990b), no haem- 
orrhagic or congestive lesions were found in any of the 
infected piglets.
4.5. CONCLUSIONS:
Both pestiviruses (swine and sheep isolates) were able to 
cross the placenta and induce active infection of piglets 
after inoculation of their mothers between 39 to 45 days of 
gestation, with the development of detectable although 
relatively mild pathology. The fetal pathology observed was 
attributed to the experimental pestivirus infections in view
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of the serological and virological findings obtained. The 
clinical signs of infection in sows and in the congenitally 
infected offspring infected with the porcine isolate 87/6 
were similar (but not identical) to those resulting from 
the infection with the ovine isolate 137/4. Attempts to 
distinguish the fetopathogenic effects of the two viruses 
would require a more extensive series of experiments with 
gestational age-matched paired comparisons.
It is concluded that both the pestivirus isolates have the 
potential for vertical transmission in swine. Moreover, the 
isolates 87/6 and 137/4 appear to be more closely related 
antigenically to each other and to BDV than to either HCV 
ôr BVDV, as deduced from the cross-neutralization patterns 
observed in infected animals. This constitutes additional 
evidence that the pig isolate 87/6 is a virus with many 
characteristics similar to BDV strains. It might have 
arisen from a case of natural cross-infection in swine with 
a pestivirus originated from ruminants.
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CHAPTER 5. INOCULATION OF PREGNANT SHEEP WITH PESTIVIRUSES 
OF DIFFERENT HOST SPECIES ORIGIN
5.1. INTRODUCTION:
In the previous chapter, studies were carried out to 
determine the capacity of two pestiviruses isolated from 
pigs (isolate 87/6) and sheep (isolate 137/4) to cause 
transplacental infections in swine. The pig isolate, 87/6, 
had been previously shown to bear closer antigenic rela­
tionship to BDV than to HCV (Edwards and others, 1988). Such 
relationship was also evident in the SNT cross­
neutralization pattern displayed by the isolate in the 
experiments described in Chapter 4. Both isolates showed 
similar growth characteristics in the in vitro studies de­
scribed in Chapter 3. Moreover, both viruses were also able 
to induce similar pathology in congenitally infected piglets 
(Chapter 4). This chapter presents comparative studies with 
the same two isolates in pregnant sheep, following the 
same strategy adopted in the experiments on swine. The main 
aim of these experiments was to determine whether or not 
the putative identification of the swine isolate 87/6 as 
BDV-like was supported by its fetopathogenic capacity in 
sheep. The sheep isolate 137/4 was included as a BDV 
"positive control". As in Chapter 4, the virological and 
serological findings constituted the core of these ex­
periments, supported by clinico-pathological evidence.
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5.2. MATERIALS AND METHODS:
Cells and media:
Cells and media used for the multiplication of viruses were 
as described in Chapter 2.
Viruses :
The swine isolate 87/6 and the sheep isolate 137/4 were used 
in the present experiments. Additional virus strains used 
in SNTs (C24V, BDM, Alfort and Baker A) were the same as 
those used in Chapter 4. Virus stocks were prepared as 
described previously (see Chapter 2).
Animals and animal inoculation:
Two groups of pregnant ewes of a Suffolk cross breed were 
infected with either the porcine 87/6 (group I) or the 
ovine isolate 137/4 (group II). The virus dose, route of
inoculation were the same as described in Chapter 4. Details 
of the inoculation procedures are summarized in Table 5.1. 
Clinical examinations and sampling of ewes were performed as 
described previously (Chapter 4).
Hysterectomy, clinical examination, sampling and x-ray 
analysis of the offspring:
Hysterectomy was carried out (whenever possible) two days 
before the expected delivery date for a calculated 
gestational period of 144 days (i.e. at day 142 of gesta-
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TABLE 5.1: Ewes inoculated, age, inoculum and route of inoculation
j Number Age Gestational age 
at inoculation
Route of 
inoculation
Inoculum |
| Group I
| 357 22 months 41 IN 87/6 |
| 361 22 39 IN
| 813 20 45 IM
| 779 20 41 IM
| Group II
| 329 21 months 62 IN 137/4 |
| 330 21 60 IN
| 1482 21 62 IM
| 709 21 62 IM
j Control 
| 2661 22 months NA NA NA |
Obs.: NA = not applicable 
IN = Intranasally 
IM = Intramuscularly
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gestation). Lambs were designated by the dam's number 
followed by the letter L (lambs) plus a random number given 
at delivery. Clinical examinations of the offspring, 
sampling and X-ray analyses were carried out as described 
in Chapter 4, except that for radiographs the tibiae were 
used as a representative of the lambs' long bones and were 
exposed in lateral position for 100 seconds at 66 KV. 
Determination of bone length and age correlation of the 
tibiae of lambs was performed according to Richardson and 
others (1976).
Serology (SNTs):
The procedures for SNTs and calculations of neutralizing 
antibody titres were as described in Chapter 2. Serum 
samples considered negative (i.e. titre <1:10) for 
antibodies in SNTs were examined by IIF as described 
(Chapter 2).
Virological examinations :
Staining of cryostat sections and virus isolation in tissue 
culture (in PK15 cells) were performed as described in 
Chapter 2.
Additional tests:
Samples of ewes and lambs were also tested for antibodies to 
Chlamydia psittaci (complement fixation) and Toxoplasma 
gondii (latex agglutination).
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5.3. RESULTS:
Clinico-pathological assessment:
Ewes :
In group I, no clinical signs of disease were observed in 
any of the ewes throughout the duration of this study. In 
group II, two ewes aborted at 105 (ewe 330) and 139 (ewe
709) days of gestation, respectively. Until the abortions, 
however, no other abnormal clinical signs were observed. The 
temperature curves of ewes of both groups during the first 
15 days of the experiments are presented in Fig. 5.1. A 
slight pyrexia was registered (temperature above 40°C) in 
ewes of group II at the day of inoculation (Fig. 5.1b). Ewe 
330 (group II) also showed a slight rise in temperature on 
the third day post-infection (d.p.i.) (Fig. 5.1b).
Lambs :
The outcome of pregnancy in infected and control ewes is 
presented in Table 5.2., together with the results of the 
clinical examination of the lambs obtained and the gross 
macroscopical lesions observed at necropsy. In group I six 
lambs were obtained, of which one (813 Li) failed to breathe 
and died soon after hysterectomy. Those which were alive 
showed signs of weakness (as demonstrated by difficulty in 
standing or walking) accompanied by a mild tremor, eventu­
ally superseded by a more pronounced trembling spasm of 
short duration. A similar tremor, however, was also observed
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Fig. 5.1. Temperatures of ewes recorded on the first 15 days of 
the infection, a) group I. b) group II. Temperatures are repre­
sented in °C.
165
EWE 357
41.0
39.0
38.5
38.0
dp. I.
EWE 361
41.0
3 40.0
39.6
39.0
38.6
38.0
d.|iL
EWE 813
41.0
40.6
2
I
g. a»
|  39.0
38.6
38.0
d p . I.
EWE 779
41.0
40.6
38.6
38.0
d p .L
166
EWE 329
41.0
40.5
39.6
39.0
38.6
38.0
U p . I '
EWE 330
41.0
40.5
|  40.0
I  39.5 
® 39.0
38.5
38.0 dp. I.
EWE 1482
41.0
= 40.0
8. 39.5
I  39.0 
38.6
38.0
dp. I.
EWE 709
41.0
40.5
39.5
39.0
38.5
38.0
d . p l .
167
in the control lambs born to the uninfected ewe (see below). 
Lamb 779 L1 showed a distinctive tremor of the eyelids and 
lips which was not present in uninfected controls. Most 
lambs presented a slightly "hairy" wool on the neck, legs 
and top of the head. The hairiness could not be associated 
with the infection since the control lambs also showed 
hairywool in those areas.
In group II seven lambs were born, of which two were 
dead. In addition, one was mummified and another was in 
process of autolysis (Table 5.2). The three lambs which were 
alive showed signs of weakness, torticollis and clonic 
spasms of the musculature of the legs (lambs 329 Li and L2, 
Table 5.2, Fig. 5.2). Lambs 709 Li (in autolysis) and L2 
(born at term but dead) presented the only macroscopic 
lesions observed in this study, consisting of
hydranencephaly and cortical cavitation (Fig 5.3). Lamb 709 
L2 had a slightly domed skull in the frontal region. This 
lamb also showed a pronounced "hairiness" compared with the 
other lambs born during these experiments (Fig. 5.3).
Lambs of the control uninfected ewe:
Three lambs were delivered, showing signs of weakness, dif­
ficulty in standing up, slight tremor and slightly "hairy" 
wool in the regions of neck, legs and top of head.
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TABLE 5.2: Outcome of gestation, clinical observations and
macroscopical lesions observed in the offspring of ewes
Ewe 
No.
Hysterectomy 
or Abortion 
Gest. d.p.i. 
date
Lambs Clinical
signs
Lesions
357 142 101 LI Unable to stand -(f)
L2 Unable to stand -
361 142 103 LI _
GROUP I
813 143 98 LI Failed to breath -
and died
779 142 101 LI Tremor of eyelids -
L2 Splayleg of hindlimb
329 142 80 LI Torticollis -
L2 Torticollis -
Spasms of leg muscles
330 105* 45 LI Mummified -
GROUP II
1482 142 80 LI Born dead -
L2 - -
709 139* 77 LI In autolysis Cortical
cavitation
L2 Born dead Cortical
cavitation
CONTROL 2661 142 NA LI .
L2 - -
L3 -
Obs.: * = aborted
(f) - not observed 
NA = not applicable
169
Fig. 5.2. Lambs of ewe 329 (group II). a) LI (right) and L2
(left), b) Detail of L2 showing spasm of the leg muscles and 
torticollis.
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Fig. 5.3. Lambs of ewe 709 (group II). a) Li (below) and L2 
(above); b) cortical cavitation (L2).
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Serology:
Ewes :
The results of the SNTs with sera from the ewes of group I 
are shown in Fig. 5.4a and b. The first neutralizing 
antibodies (i.e. titres 1:10) to the homologous virus (pig 
isolate 87/6) were detected between ten and fourteen d.p.i. 
Titres tended to rise steadily up to 28 or 42 d.p.i. re­
maining as a plateau at the highest levels, with a further 
increase by the day of hysterectomy. The antibody response 
to the other strains was usually delayed. Neutralizing 
antibody titres were higher to the homologous virus than to 
the other strains tested. The cross-neutralizing antibody 
titres followed roughly the same pattern of the homologous 
antibody response. The strain Alfort of HCV consistently 
gave the lowest levels of cross-neutralizing antibodies.
In ewes of group II (5.4.C, d), neutralizing antibodies
were detected first between 10 and 21 d.p.i. Neutralizing 
and cross-neutralizing titres in sera followed basically a 
similar pattern to that observed in group I, tending to 
reach a plateau at about two to three weeks after the first 
detectable antibodies then continuing to rise or remaining 
constant until the hysterectomy. Cross-neutralizing
antibodies were usually 1 to 2 logio lower than titres to 
the homologous virus. As in group I, the lowest levels of 
cross-neutralization were obtained (if at all) with the HCV 
strain Alfort.
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Fig. 5.4. Results of SNTs in sera from inoculated ewes, a, b) 
ewes of group I. c, d) ewes of group II. SNT titres are expressed 
as the reciprocal of the serum dilution capable of neutralizing 
virus infectivity in 50% of the microtitre plate wells at that 
dilution (data not shown).
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No pestivirus neutralizing antibodies were detected in any 
of the samples from the control uninfected ewe.
Tests for antibodies to other agents:
Complement fixation tests for antibodies to C. psittaci 
gave negative results with sera of all the ewes and lambs 
(with the exception of the autolysed fetuses where testing 
was not possible) used in the present study (not shown).
All ewes were shown to possess antibodies to T. gondii in 
latex agglutination tests. The antibodies levels remained 
at constant levels throughout the duration of the 
experiments (data not shown).
Lambs :
In group I, all six lambs were negative (i.e. titre <1:10) 
for neutralizing antibodies at the day of delivery. In group 
II, it was not possible to carry out SNTs on serum samples 
from two of the lambs due to mummification ( 330 Li), 
autolysis (709 Li). In addition, the serum sample of lamb 
709 L2 was toxic for cell cultures and no SNT results were 
obtained (Table 5.2). Of the four remaining lambs, 1482 Li 
and L2 were negative for neutralizing antibodies. Lambs 329 
LI and L2 both had high titres of neutralizing antibodies 
to the homologous virus (Fig. 5.5). Cross-neutralizing
antibodies were present in these lambs at lower (about 1 to 
2 logqo) titre levels.
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Fig. 5.5. Results of SNTs in sera from lambs. Results of lambs 
of ewe 329 (group II) only are shown. Lamb 329 L2 was negative 
for neutralizing antibodies (titre <1:10) to BVDV strain C24V. 
Serum samples from other lambs in both groups were negative for 
neutralizing antibodies. SNT titres are expressed as the 
reciprocal of the serum dilution capable of neutralizing virus 
infectivity in 50% of the microtitre plate wells at that dilu­
tion.
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No pestivirus specific neutralizing antibodies to any of 
the viruses tested were detected in serum samples from the 
control uninfected lambs.
Virology:
The criteria used to consider samples positive or negative 
at virus isolation were described in Chapter 4.
Ewes :
All attempts to isolate virus from samples of ewes of both 
groups of inoculated animals as well as from the uninfected 
control ewe were negative throughout the duration of these 
studies.
Lambs :
The results of the DFAT in cryostat sections of tissues and 
virus isolation in cell culture from lambs of groups I and 
II are presented in Tables 5.3. and 5.4. Antigen was 
detected by DFAT in tissue sections of six out of seven 
lambs of group I and three out of six lambs of group II 
(Tables 5.3a and 5.4a). The fluorescence displayed after 
virus isolation in cell culture was usually more intense and 
with a greater number of positive cells than at DFAT in 
tissue sections (Tables 5.3b and 5.4b).
No virus was detected in lambs from the uninfected control 
ewe, by either DFATs in cryostat sections or virus isolation
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TABLE 5.3: Virological examination in samples from lambs of group I
a) Results of fluorescent antibody staining of cryostat sections
EWE NO. 357 361 813 779 |
TISSUES
LAMB NO. LI L2 LI LI L2 LI |
Liver + (*) + ? + + +  j
Spleen + - + + + + |
MLN(l) + + + + ND + |
Sm.Int.(2) + ? + + ND 4- |
Kidney + + + + + + |
Heart - - - - - |
Lung + + + + + + |
Thymus + ? + + + 1
SMLN(3) + - + + + |
Tonsils + + + ND ND + |
b) Results of virus isolation in cell culture
TISSUES
EWE NO. 357 361 813 779 |
LAMB NO. LI L2 LI LI L2 LI |
Liver + +
Spleen 3+ + 2+ 2+ + 2+ |
MLN 3+ + 2+ + 2+ 4+ |
Sm. Int. 3+ + 2+ 2+ 2+ + |
Kidney 4+ 4+ 2+ 3+ 2+ 4+ |
Heart 3+ 2+ + 2+ ND + j
Lung 4+ 4+ 2+ 3+ 3+ 4+ |
Thymus 4+ 4+ 2+ 4+ - + |
SMLN + + - + + |
Tonsils 2+ 4+ 3+ ND ND 4+ |
Blood clot + + 2+ - + 2+ |
Serum ND ND ND ND ND ND |
Obs: (1) - Mesenteric lymph node
(2) - Small intestine
(3) - Submandibular lymph node
* = key for table : - = negative
? = inconclusive result 
+ - <10% of cells positive 
2+ - <30% of cells positive 
3+ = <50% of cells positive 
4+ - 50% or more positive cells 
ND - not done
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TABLE 5.4: Virological examination in samples from lambs of group II
a) Results of fluorescent antibody staining of cryostat sections
EWE N8. 330 709 329 1482
TISSUES
LAMB No. LI LI L2 LI L2 LI L2
Liver - (*) + + +
Spleen ND - + ? + + +
MLN(l) ND - + ? + + +
Sm.Int.(2) - - + - + + +
Kidney - • - + - - + +
Heart - - + - - + +
Lung - - + ? - 2+ +
Thymus - - + - - 3+ +
SMLN(3) ND - + - - 4+ +
Tonsils ND - + - - 2+ +
b) Results of virus isolation in cell culture
1
EWE N o. 3 3 0 709 813 1482
I TISSUES
I LAMB No. LI LI L2 LI L2 LI L2
| Liver 4+ ? + +
j Spleen ND - 4+ ? - + +
j MLN ND - 4+ - - + 4+
j Sm.Int. - - 4+ - - + 4+
j Kidney - - 4+ - ? ND 4+
j Heart - - 4+ - - + 2+
I Lung - - 4+ - - + 2+
j Thymus - - 4+ - ? + 3+
| SMLN ND - 4+ - - + 3+
| Tonsils ND - 4+ - - + 2+
| Blood clot ND - 4+ - - + 4+
j Serum 
1
4+ + 4+
Obs: (1) - Mesenteric lymph node
(2) - Small intestine
(3) = Submandibular lymph node
* — key for table : - = negative
? - inconclusive 
+ - <10% of cells positive 
2+ - <30% of cells positive 
3+ = <50% of cells positive 
4+ - 50% or more positive cells 
ND - not done
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Fig. 5.6. Morphometric studies of lambs of groups I and II. (full 
circles) lambs of group I, (empty circles) lambs of group II. "x" 
axis refer to whole body weight; "y" axis refer to: a) crown-rump 
length, b) brain weight, c) cerebellum weight, and d) tibia 
length, respectively. Units for weight and length are specified 
at the top ("y" axis) or at right ("x" axis) of the scales. Lines 
represent the area of the normal distribution limits (two 
standard deviations from the mean) for uninfected lambs 
(Richardson and others, 1976; Richardson, 1977). The squares 
(thicker lines) represent the normal distribution of the 
parameter evaluated versus total body weight for uninfected 
lambs.
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TABLE 5.5: Growth arrest lines (GALs) in lambs of infected and
control uninfected ewes
Ewe No. Lamb No. GALs |
813 LI
L2 93, 107 |
j GROUP I
779 LI j
357 LI 115 |
L2 |
361 LI j
329 LI 105, 111 |
L2 105, 111 |
| GROUP II
330 LI 75, 77 |
1482 LI 79, 97 |
L2 89 |
709 LI I
L2 J
| CONTROL 2661 LI
L2 |
L3
Numbers represent the calculated day of 
occurrence of GALs.
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in cell culture (data not shown).
Morphometric studies on lambs :
The results of the morphometric studies on both groups are 
represented in Fig. 5.6. The graphs show the values obtained 
from the experimentally infected lambs compared with data 
from normal lambs at 140 days of gestation. The highlighted 
areas represent the 95% confidence limits for each of the 
measurements. Normal values for uninfected lambs at that 
age (with the exception of total body weight values) have 
been published previously (Richardson and others, 1976; 
Richardson, 1977). The normal values for total body weight 
have been revised after a greater number of observations (C. 
Richardson, personal communication). The values used for the 
production of the graphs are shown in the Appendix section.
In both groups of infected animals, nearly all lambs 
showed signs of growth retardation in virtually all param­
eters examined (Fig. 5.6). GALs were identified in lambs 
813 L2 (two GALs) and 357 LI (one GAL; Table 5.5). In 
group II, GALs were present in seven of the eight lambs 
born, four of them with two arrest lines (Table 5.5).
5.4. DISCUSSION
As in Chapter 4, the serological and virological results are 
discussed first, as they represent the principal findings of
189
the study, followed by the examination of the
clinico-pathological data.
Serology:
Ewes :
Infection of the ewes was confirmed by the detection of 
pestivirus specific neutralizing antibody responses. The 
serological profiles were similar profiles in both groups of 
infected ewes. Neutralizing antibody responses were usually 
1 to 2 logio higher to the homologous virus than to the 
other strains, with the cross-reactive antibodies being de­
tected at lower titre levels, usually later in the course 
of infection. Similar homologous and heterologous 
neutralizing antibody kinetics have been reported by others 
in pestivirus serology (Liess and others, 1974, 1976;
French and others, 1974; French and Snowdon, 1977). There is 
a clear serological relationship between all the viruses 
tested, although the levels of cross-reactivity were 
variable between, and within, each group of ewes (5.4.). 
The HCV strain Alfort appears to be more distantly related 
to the other strains tested in terms of antigenicity. The 
distant relatedness of HCV to pestiviruses of ruminants is 
well recognized (Sheffy and others, 1962; Kumagai and 
others, 1962; Pinter, 1963; Snowdon and French, 1968, 1976; 
Liess and others, 1977; French and Snowdon, 1977; Stewart 
and others, 1977, 1980; Dahle and others, 1987). Inter­
estingly, particularly in ewes of group I and in the two
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lambs of group II where high neutralizing antibody titres 
were detected (329 Li and L2), the levels of 
cross-reactivity of the HCV Baker A strain were equivalent 
to, and sometimes even greater than, those to ruminant 
pestiviruses (Fig. 5.4).
Lambs :
All lambs of group I were negative for neutralizing 
antibodies (i.e. titre <1:10) in the present study. The 
serological status of the lambs of group II is more dif­
ficult to analyse since most of the animals born had been so 
badly affected that serology was not possible. Two 
neutralizing antibody-positive lambs were obtained from one 
ewe (329 LI and L2). The cross-neutralization profile on 
sera of lambs 329 Li and L2 was similar to that of the ewes 
except for the poor cross-neutralizing activity of Li 
against the porcine isolate 87/6 and for the high level of 
cross-reactivity to the HCV strain Alfort (Fig. 5.5). Un­
expectedly high levels of cross-neutralizing antibodies to 
HCV have also been occasionally detected in lambs naturally 
infected with BDV (Osburn and others, 1973). The reasons why 
this differences in cross-neutralization pattern remain un­
determined, but probably represents individual animal 
variation in an outbred population.
The lack of uniformity observed in the SNT results with sera 
of ewes and lambs obviates the need for large populations in
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studies with cross-neutralizing responses, in order to 
minimize any possible bias introduced by individual 
variation. At the same time, it brings into question 
proposed pestivirus classification attempts based on 
cross-neutralization patterns obtained with a small number 
of experimental animals (Wensvoort, 1989).
Virology:
Ewes :
Virus isolation attempts carried out in ewes were all 
negative throughout the duration of the studies. Viraemia 
was expected to occur during the first two weeks after in­
oculation, the viraemic period being very brief (French 
and others, 1974; Roeder, 1984). Blood for virus isolation 
was collected only on days 5 and 10 post-inoculât ion, 
therefore it is possible that virus was not detected simply 
due to the sampling strategy adopted.
Lambs:
Antigen detection by DFAT was positive in all lambs of 
group I, although the number of fluorescent cells and the 
intensity of fluorescence was not striking (Table 5.3). At 
virus isolation, virus was recovered from a number of 
tissues of all lambs of the group. A much clearer picture 
was observed after virus isolation in cell culture than that 
obtained in DFATs on cryostat sections of tissues.
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In group II, samples of mummified and partially autolysed 
fetuses were toxic for cell cultures, therefore virus 
isolation was not possible. In the other lambs of group II 
where fresh tissues were available (1482 Li and L2; 709 L2), 
virus was recovered successfully (Table 5.4). Ewe 329 gave 
birth to twins which were positive in some tissues by DFAT, 
although with a very weak fluorescence (Table 5.4). On cell 
culture, however, no virus was recovered from either lamb. 
These lambs had high titres of pestivirus-specific neutral­
izing antibodies.
From these observations, different patterns of 
immunofluorescence and virus isolation can be identified. In 
all lambs of group I and in lamb 709 L2 from group II, a 
poor picture at DFAT was followed by clear results at virus 
isolation. On the other hand, in those two lambs (329 Li, 
L2) which had high titres of neutralizing antibodies, there 
was some evidence for the presence of antigen in tissues at 
DFAT but virus isolation was unsuccessful. These different 
combinations of DFAT and virus isolation results have also 
been noted for piglets in the previous chapter. It was 
there suggested that low levels of antibodies might have 
blocked or modulated DFAT-detectable antigen expression in 
tissue sections. The same might apply for lambs, since it 
was observed later (see Chapter 6 ) that all lambs of the 
group infected with the porcine isolate (i.e. from ewes 357, 
361, 813, 779) and one lamb infected with the ovine isolate
193
(1482 Li) had low titres of neutralizing antibodies. In 
lambs with high levels of neutralizing antibodies virus 
isolation would be difficult. Similar difficulties in re­
covering virus from infected animals have been attributed to 
the presence of antibodies by others (Terpstra, 1978; 
Terpstra, 1981; Braun and others, 1973).
Lambs with no detectable, or low levels of, neutralizing 
antibodies and from which virus could be isolated from 
various tissues suggest that such animals might be born 
persistently infected. The establishment of persistent 
infections is of major importance in the perpetuation of vi­
rus in nature. In lambs infected with the pig isolate (group 
I) the efficiency of the transplacental infection and the 
production of potentially persistently infected animals was 
remarkable. There was a relative absence of lethal effects 
observed in utero, since five out of six lambs were born 
alive, presenting favourable conditions for the per­
petuation of the virus. This lack of lethal pathogenic 
effects was also observed in the experiments with piglets 
(Chapter 4). However, the efficiency of inducing potentially 
persistently infected animals with the pig isolate (i.e. 
virus positive, antibody negative) was much greater in sheep 
than in swine. Whereas five out of the six lambs born in the 
group were positive at virus isolation (Table 4.2) and had 
no or low levels of neutralizing antibodies (Chapter 6 ), 
only three piglets were born with this same virological and
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serological status (see Chapter 4, Table 4.7). Although a 
comparison between infections during gestation in distinct 
species must be treated with caution, these results clearly 
show the adaptability of the swine isolate 87/6 to infect 
lambs in utero.
In group II (infected with the ovine virus), transplacental 
infection was also, as expected, very efficient, but the 
pathogenic effects of the virus on the lambs were more 
drastic. The classical effects of BDV infection were clearly 
manifested, including aborted fetuses, stillbirth, fetal 
mummification and postnatal death. Only three out of seven 
lambs born were alive at birth, of which two had high titres 
of neutralizing antibodies. Therefore, it seems that only 
one lamb (1482 L2) might have possibly been persistently 
infected in postnatal life. Although strain variation has 
been reported in BDV infections (Barlow and Gardiner, 1969; 
Plant and others, 1983a; Bonniwell and others, 1987), it was 
not possible to determine whether the difference in the out­
come of infection in both groups was due to the effect of 
the virus strain, individual variation or to the gesta­
tional age at inoculation. The more pathogenic effects were 
registered in animals inoculated later in gestation. For 
logistical reasons concerned with the availability of 
pregnant sheep at a suitable gestational age, it was 
necessary to carry out the inoculation of the ovine strain 
in ewes more advanced in pregnancy than those in group I .
Timing of the infection in utero plays a decisive role in 
the outcome of infection (Van Oirschot, 1983). Consequently, 
the differences in conceptual age at the time of infection 
might have had a major effect on the outcome of infection 
in both groups.
Clinical observations on ewes:
No manifestations of clinical disease (apart from a slight 
rise in temperature at about day seven post-inoculâtion, see 
Fig. 5.1.) were observed in either group of infected ewes, 
throughout the duration of the experiment. These findings 
are consistent with previous reports on postnatal BDV 
infections (Shaw and others, 1967; French and others, 1974; 
Vantsis and others, 1979; Terlecki and others, 1980; 
Nettleton, 1985). Mild clinical signs (pyrexia, leucopenia, 
nasal discharge, anorexia, tachypnoea, diarrhoea), when 
present, would be expected during the first 15 days after 
infection (Shaw and others, 1967; Vantsis and others, 1979; 
Roeder, 1984).
The route of inoculation did not have a marked influence on 
the outcome of the infection, since transplacental 
transmission occurred successfully in ewes infected by both 
the IN and IM routes. These findings were in agreement with 
previous observations reported in the literature (Lewis and 
others, 1970).
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Clinico-pathological observations in fetuses :
In group I, no abortions were recorded. The offspring of 
three out of the four inoculated ewes showed no clinical 
signs distinguishable from those observed in lambs of the 
control uninfected ewe. One case of neonatal death was 
registered (813 Li, Table 5.2). In contrast, in group II, 
abortions, stillbirth, mummification and birth of lambs with 
signs of nervous disturbances (e.g. torticollis and 
spasmodic contractions of the leg muscles) were registered 
(Table 5.2). Despite the differences between the groups 
(where gestational age at infection probably played a major 
role) in both the outcome was compatible with previous 
records on BD affected lambs (Barlow and Gardiner, 1969; 
Plant and others, 1983b; Bonniwell and others, 1987). In 
addition, the absence of evidence of fetal infection with 
the other two major pathogens potentially involved in sheep 
reproductive disorders (i.e. C. psittaci and T . gondii) 
provided further support for the association between the 
pestivirus infections and the fetopathology observed.
The morphometric analysis of lambs indicated severe growth 
impairment in the litters of both groups. Nearly all fetal 
measurements were below the 95% confidence limits for lambs 
of comparable gestational age (Terlecki and others, 1973; 
Richardson and others, 1976; Richardson, 1977). In par­
ticular, reduction in the ratios brain and cerebellum weight
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versus total body weight (as well as C-R and tibia length 
versus total body weight) were consistent pathological 
findings. Reduced brain and cerebellum weight have also been 
registered in BD cases in a number of occasions (Scott and 
others, 1973; Terlecki and others, 1973; Richardson, 1977; 
Sweasey and others, 1979; Barlow, 1980; Plant and others,
1983b).
In addition, hydranencephaly with cortical cavitation and 
cerebellar hypoplasia were observed in two lambs in group II 
(Table 5.2, Fig. 5.3). These were the only two cases of 
gross macroscopic lesions observed throughout the
experiments with sheep. The lesions in these lambs were 
similar to the hydranencephaly, always associated with cer­
ebellar hypoplasia or aplasia, described by others in 
cases of BD (Barlow, 1980; Roeder, 1984; Bonniwell and oth­
ers, 1987).
The "tremor" classically observed in BD infected lambs 
(Hughes and others, 1959; Markson and others, 1959), one of 
the most consistent and characteristic features of BD 
(Terpstra, 1985) was not clearly observed in either group 
of lambs. The methodology used for examination of fetuses 
was directed towards the preservation of the pre-colostral 
virus and antibody status of the fetuses. In these cir­
cumstances, the observation of tremor or other clinical 
signs was not favoured, since lambs were not fed and were
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killed shortly after forced delivery. Similarly, the 
"hairiness" observed in some animals in the present study, 
did not appear strikingly abnormal (with the exception of 
lamb 709 L2, group II, Fig. 5.3) and was similar to that
observed in the uninfected controls. These findings are in 
agreement with other authors who have reported the absence 
of fleece abnormalities and tremor in lambs infected with 
strains of BDV of low pathogenicity (Bonniwell and others, 
1987).
GALs were observed in two lambs of group I and five out of 
seven lambs in group II (Fig 5.5). Some lambs showed more
than one GAL at distinct gestational ages. GALs are
indicative of non-specific disturbances of osteogenesis 
which lead to temporary impairment of bone growth
(Terlecki, 1973). Such lines have also been associated with 
maternal malnutrition during gestation (Richardson, 1982) or 
to reduced flow of nutrients to the fetus (Creasy and oth­
ers, 1972). In the present study (as in the previous study 
with swine; see Chapter 4), the lines were observed in both 
groups of inoculated animals. Lambs with GALs had different 
combinations of virus and antibody status, therefore their 
presence could not be associated with the presence or ab­
sence of virus and/or antibodies. The presence of more than 
one GAL in the same animal, as observed in a number of lambs 
in both groups, is difficult to conciliate with a possible 
mechanism of pathogenesis. It suggests that two separate
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events of growth impairment have occurred at different 
times in fetal development. A similar phenomenon might give 
rise to one or more lines on the bones. The actual cause 
for the presence of more than one GAL in these experiments 
remains undetermined and requires further study.
The pathological, serological and virological findings 
described here were compatible with BDV infections in sheep 
described previously. The porcine isolate 87/6 was able to 
cause disease in lambs which was indistinguishable from 
other reports on lambs infected with BDV strains of low 
pathogenicity (Bonniwell and others, 1987). This provides 
further evidence for the similarities between the swine 
isolate 87/6 and other BDV strains in that the the former 
also has the potential to cause transplacental infections in 
lambs.
5.5. CONCLUSIONS:
Both pestiviruses (of porcine and ovine origin) were able to 
cross the placenta of ewes experimentally infected between 
39 and 62 days of gestation and infect fetuses without 
causing noticeable disease in the ewes. Pathological 
findings were associated with the virus infections as 
indicated by the results of virus isolation and serological 
studies and by comparison to previous reports in the 
subject. Nearly all lambs born in both groups showed signs
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of growth retardation in all parameters examined, although 
the group infected with the ovine isolate was more severely 
affected. However, the differences in fetal pathogenicity 
induced by the two isolates might have been due to differ­
ences in gestational age of the ewes at inoculation and 
could not be attributed to distinct properties of the vi­
ruses. Both groups had animals which would probably have 
been born persistently infected as shown by lambs which 
were virus-positive and at the same time possessing no 
neutralizing antibodies detectable in the SNTs employed. 
The neutralizing antibody cross-reactivity pattern observed 
in ewes suggest that both isolates are more distantly 
related to the HCV strain Alfort than to the other 
pestiviruses tested. It is concluded that the isolates in­
oculated cannot be clearly distinguished in basis of their 
ability to cause transplacental infections in the ovine spe­
cies, since both were successfully transmitted to the off­
spring of infected ewes. In addition, the fetal pathology 
induced by both is compatible with previous reports on BDV 
infections. These results provide further evidence in favour 
of the "BDV-like" nature of the porcine isolate 87/6.
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CHAPTER 6 . EFFECT OF FREE ZING/THAWING ON SERA FROM THE 
OFFSPRING OF INOCULATED ANIMALS
6.1. INTRODUCTION:
The experiments described previously in this thesis required 
a great number of SNTs to be performed. For that reason, and 
to make tests with a large number of sera against five 
distinct viruses operational, samples were inevitably 
frozen/thawed a number of times. It was observed that some 
sera, which at first appeared negative for neutralizing 
antibodies, would subsequently display some degree of 
neutralizing activity. Therefore, a number of experiments 
were performed to study the observed phenomenon in more 
detail.
6.2. MATERIALS AND METHODS:
Viruses and cells:
The isolates 87/6 and SI 37/4 were propagated in CT cells and 
kept at -70°C until required as described in Chapter 2.
Sera:
All the serum samples were obtained from the offspring of 
the animals used in the previous experiments (chapters 3 
and 4). They comprised a total of 88 piglets1 sera (77 from 
the inoculated sows and 11 from the litter of the uninfected
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control sow) and 15 sera from lambs (12 from lambs of in­
fected ewes and 3 from the uninfected control offspring) . 
For the purposes of the present experiments samples were 
tested only against the homologous virus in each group, that 
is, the pig isolate 87/6 in group I, and the sheep isolate 
137/4 in group II. Control uninfected sera were tested 
against both viruses. All sera were inactivated at 56°C for 
30 min in order to avoid the interference of any potentially 
infectious virus.
Freezing/thawing:
Sera were aliquoted, frozen at -20°C, thawed by immersion 
in water at room temperature and returned to the freezer at 
-20°C. Every freeze/thawing (F/T) event was considered one 
cycle. F/T cycles varied from one to twelve. Serum samples 
that were not cycled were kept at -70°C. Additional tests 
were performed to check the effect of faster F/T cycling of 
sera. Samples were frozen in ethanol/dry ice bath and thawed 
at 37°C. SNTs were carried out with samples which had been 
F/T cycled at -20°C and using the "fast" method. Samples of 
the same sera before and after F/T treatment were tested 
concomitantly in the same microtitre plate.
SNTs:
SNTs were performed as described in chapter 3, except that 
the challenge dose of virus was reduced from 100 to 50 
TCIDso/SOjil, in order to highlight any possible differences
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between the treatments. Serum titres were calculated as 
described in Chapter 2.
ELISA tests:
Serum samples were tested in a "sandwich" enzyme linked 
immunosorbent assay (ELISA). Plates were coated with test 
serum followed by a polyclonal anti-pestivirus serum 
produced in cattle and anti-cattle IgG conjugate (produced 
in rabbits) as the detector antibody. Serum samples to be 
tested were diluted 1/25 or 1/50 in SOjjlI volumes of 0.05M 
carbonate buffer (50mM NA2CO3, 50mM NaHCOg, pH 9.6) in flat 
bottom microtitre ELISA plates, and incubated overnight at 
+4°C. Between all stages the plates were washed three times 
in wash fluid (0.5% Tween 20 in PBS, pH 7.2). Fifty 
microlitres of an appropriate dilution (1/1000) of cattle 
anti-pestivirus polyclonal serum in dilution fluid (see ap­
pendix) was then added to each well and incubated for 60 
minutes at 37°C. After washing, 50pl of 
peroxidase-conjugated rabbit anti-bovine immunoglobulin 
diluted as required (1/2000) in dilution fluid was added to 
each well and incubated for further 60 minutes at 37 °C. 
Plates were then washed as described above. The substrate 
was 50}ilof 3, 3 1 ,5, 5 1-Tetramethylbenzidine (TMB) diluted as 
recommended (Bos and others, 1981). The reaction was 
incubated for a further 15 minutes at 37°C and stopped by 
the addition of 50pl of 2M Hz SO*. Appropriate controls were 
included on each ELISA plate.
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ELISA with biotinylated polyclonal and monoclonal 
antibodies :
Polyclonal antiserum: Biotinylation of polyclonal pestivirus 
serum was carried out as described by Edwards and Gitao 
(1987). Biotinylated pestivirus antiserum (1:200 in dilution 
fluid) was added in 50pl volumes to the serum coated plates 
and incubated for 60 minutes at 37°C. After washing, SOjjlI 
of streptavidin-peroxidase conjugate (Amersham) was added 
(1:4000 in dilution fluid). Plates were then incubated 
for further 60 minutes at 37°C. Washing and developing pro­
cedures were carried out as above.
ELISA for nonspecific IgG detection:
Some samples were also tested in an ELISA aimed to detect 
variations in the level of total IgG antibodies in the sera. 
Serum coated plates were washed and incubated with an 
appropriate dilution of peroxidase-conjugated anti-swine 
IgG or anti-sheep IgG (Dakopatts). After incubation for 60 
minutes at 37°C the plates were washed and developed as de­
scribed above.
6.3. RESULTS:
Sera were identified by the number of the mother followed by 
the letter "P" (piglets) or "L" (lambs) and the random 
sequential number given to each animal at hysterectomy. 
Serum samples considered negative for antibodies were those
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unable to neutralize 100% of viral infectivity after incuba­
tion of equal volumes of virus and serum. Serum dilutions 
started at 1/2 unless otherwise stated. Any sample which 
failed to give positive results under these testing 
conditions was considered not to contain any neutralizing 
antibodies. Tables with values from which the graphs 
presented here were derived are shown in the Appendix 
section.
SNTs with different F/T procedures:
In order to establish the best conditions for the expression 
of the phenomenon, sera were F/T cycled 5 times and tested 
under different cycling conditions (Table 6.1). Of the nine 
sera examined, six revealed the presence of a higher 
quantity of neutralizing antibody after F/T cycling at 
-20°C than before the treatment. From the remaning three 
sera, two had no detectable neutralizing antibodies, whereas 
the other had titres equal or greater than 1:5120 
independent of the treatment. In comparison, samples proc­
essed by the "fast" method did not behave regularly in that 
neutralizing antibody titres varied either less than, or 
greater than the other two processes. Therefore, this latter 
method was not investigated further.
SNTs before and after F/T cycling:
Subsequently, all available sera from piglets and lambs 
o f  infected animals were tested before and after F/T cycling
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Table 6.1. Comparison between titres obtained in SNTs with 
different serum treatments.
SERA_________NET (1 )_______5x F/T (2)______5x fast F/T (3)
111 P3 <2 (4) 32 128
111 P5 12 64 256
304 P8 3200 25600 3200
304 P9 1200 9600 1000
304 P7 <2 <2 <2
302 P9 6400 12800 6400
302 P8 <2 <2 <2
302 P10 19200 51200 ND (5)
302 P11 51200 51200 600
Obs. (1): Not F/T cycled
(2): Five times F/T cycled at -20°C
(3): Five times F/T cycled in ethanol/dry ice
(4): Expressed as the reciprocal of the neutralizing 
titre against 50 TCID5o/50pl.
(5): Not done
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Fig. 6.1. S NT titres in sera before and after F/T cycling, a) 
piglets inoculated with the pig isolate 87/6 ( group I), b) 
piglets inoculated with the sheep isolate 137/4 (group II). c) 
lambs of groups I and II. Bars represent SNT titre before (black) 
and after (white) five F/T cycles. Samples not tested: group I: 
163 P8 after F/T; Group II: 303 Pi after F/T, P4; 302 P3 after 
F/T.
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at -20°C. Testing of sera from piglets (Fig. 6.1) revealed 
that two piglets from group I (305 P4, P5, Fig. 6.1a) and 
five piglets from group II (111 P3, P5; 302 P9; 304 P8, P9, 
Fig. 6.1b) showed differences equal or greater than 
fourfold in the SNTs after F/T cycling. With the exception 
of 111 P3 (Fig. 6.1b) which was negative for neutralizing 
antibodies before F/T, all these sera were positive for 
neutralizing antibodies before the treatment and showed even 
higher titres after F/T processing. The majority of the 
samples demostrated no significant increase in neutralizing 
antibody titre. In no case was a serum sample found positive 
before and negative after F/T processing. Sera from the 
litter of the uninfected control sow remained negative for 
neutralizing antibodies both before and after F/T cycling 
(after up to 12 cycles, data not shown).
The results with the lambs sera are shown in Fig. 6.1c. 
With the exception of lambs of ewe 329, all others were 
negative for neutralizing antibodies before treatment 
(titre <1:2). After F/T cycling, however, all lambs of the 
group infected with the swine isolate (357, 779, 813, 361 , 
group I) and one lamb infected with the sheep isolate (1482 
LI ) were shown to have low titres of specific neutralizing 
antibodies to the homologous virus (1:4 to 1:48, see 
Appendix). Lambs 329 Li and L2 had high levels of neu­
tralizing antibodies before and after treatment and no 
noteworthy variation was observed.
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Results of ELISA tests on F/T samples :
The results of the ELISA tests on sera from the offspring 
of inoculated animals are represented in Fig. 6.2. Some 
samples were not available in unprocessed form (i.e. not F/T 
cycled) when the test was carried out. Various serum 
samples presented differences of more than double the 
optical density readings after F/T treatment. For example, 
piglet 305 P2 demonstrated a large increase in ELISA titre 
but did not demonstrate any increase in neutralizing anti­
bodies after F/T (Fig. 6.1a). In contrast, piglet 111 P3 had 
no increase in ELISA titre following F/T (Fig. 6.2.b) 
whereas there was an increase in neutralizing antibodies 
following F/T (Fig. 6.1.b). Examination of the ELISA and 
SNT results showed that there was a poor correlation 
(correlation coefficient "r"= 0.28) between the results of 
the tests in the ELISA (Fig. 2) and the SNTs (Fig. 1) before 
the treatment. After F/T cycling, the correlation between 
SNT and ELISA tests improved considerably ( r= 0.67). 
However, F/T cycling was also found to affect four ELISA 
control sera to which no specific pestivirus antiserum 
was added (r= 0.99, Fig. 6.2.d) . For the lamb samples, no 
comparison could be made between the results of the ELISA 
before and after F/T treatment since most sera were not 
available in uncycled form at the time of testing. Neverthe­
less, a high correlation (r= 0.93) was registered be­
tween* the results of the SNTs and the ELISA after the F/T 
treatment (Figs. 6.1.C and 6.2.c). Sera from uninfected
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Fig. 6.2. ELISA with polyclonal pestivirus antiserum followed by 
anti-cattle IgG. a) piglets of group I. Samples 305 P4 and P5 and 
163 P9 before F/T treatment were not tested. b) piglets of 
group II; c) lambs of groups I and II. No serum samples were 
tested before F/T treatment. Samples of 709 LI were not tested, 
d) samples tested in the ELISA control to which no pestivirus 
specific serum was added (e.g. test sera and anti-cattle IgG 
conjugate only). Bars represent OD readings before (black) and 
after (white) five F/T cycles.
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control piglets and lambs showed little variation between 
tests before and after twelve F/T cycles (see Appendix). 
From these results it was apparent that the F/T sensitiv­
ity in this ELISA was associated with cross-reactivity be­
tween the anti-cattle IgG conjugate and antibodies present 
in the sera from the offspring.
The specificity of the F/T-sensitive immunoglobulin levels 
in the sera was examined further (Fig. 6.3). ELISA tests 
with anti-species immunoglobulin only (anti-swine IgG) 
(Fig. 6.3a) were performed in parallel with the ELISA with
polyclonal pestivirus anti-serum (Fig. 6.3b). Most samples
were of piglets from sow 164 which were negative for virus 
isolation and for neutralizing antibodies, as described
previously (see Chapter 4). Additional samples were of 
piglets from sow 302, two negative (302 P7, P8) and three 
positive for pestivirus-specific neutralizing antibodies 
(302 P6, P9, PI 0). Although there was a marginal increase in 
OD values of the sera from the litter of sow 164 after F/T 
cycling, those values were much lower than those observed 
with the neutralizing antibody-positive sera (302 P6, P9,
Pi 0) . The ELISA with polyclonal serum run in parallel 
(Fig. 6.3b) showed that the residual F/T sensitive antibod­
ies were not detected in the antibody-negative samples, 
whereas in the antibody-positive sera the F/T sensitivity
was mantained. It was concluded that the antibody popula­
tion involved in the specific anti-pestivirus response in
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Fig. 6.3. a) ELISA with rabbit anti-porcine IgG only (no 
pestivirus specific antiserum). b) ELISA with pestivirus spe­
cific polyclonal antiserum. Both tests were carried out 
concomitantly. Bars represent OD readings before (black) and 
after (white) five F/T cycles.
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Fig. 6.4. a) ELISA on selected piglets sera with biotinylated 
pestivirus specific polyclonal antiserum; b) ELISA with 
pestivirus specific polyclonal antiserum (data extracted from 
Fig. 6.2. Bars represent OD readings before (black) and after 
(white) five F/T cycles.
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eluded only a proportion of the total antibodies present.
In order to check the role of putative antigen within the 
sera in the reaction, selected samples were tested with 
biotinylated polyclonal anti-pestivirus serum to avoid the 
need for anti-species IgG as detector antibody (Fig. 
6.4). Samples tested were five sera positive (111 P5, 302
P9, PI 0, P11 , 163 P4) and one negative (302 P7) for F/T
sensitive antibodies. The correlation between the results 
of the previous ELISA (Fig. 6.2) and the test with the
biotinylated pestivirus antiserum decreased after treatment 
(r= 0.67 before F/T; r= 0.15 after). Therefore, the elimina­
tion of the anti-IgG serum in the test eliminated the F/T
sensitivity of the samples. This confirmed that the F/T re­
activity in the ELISA employed above (Fig. 6.2) was due to 
antibody present in the sera and not to the presence of 
putative antigen within the sera.
6.4. DISCUSSION:
The unexpected finding that sequential freezing/thawing 
would alter the behaviour of serum samples in SNTs led to 
the investigations described in this chapter into the na­
ture of the phenomenon. The experiments indicate that 
anti-pestivirus antibodies present in piglets and lambs sera 
were blocked until they were liberated after the mild 
disruptive treatment provided by F/T cycling. Cycling was
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performed by freezing at -20°C followed by thawing at room 
temperature. As the process is time consuming a faster 
cycling in ethanol/dry ice was examined. The results ob­
tained were inconsistent after faster F/T cycling, sug­
gesting that the F/T sensitive antibodies are affected in a 
different way at different F/T temperatures. The "slow" F/T 
processing may be more efficient in breaking apart 
antigen-antibody complexes than the fast method. It is 
possible that a larger number of "fast" cycles would 
give rise to results more comparable to F/T at -20°C. This 
would decrease the time necessary for the preparation of 
samples for testing considerably, making it more practical.
Although the SNTs are undoubtedly virus-specific, the ELISA 
tests used revealed F/T sensitivity due to cross-reaction 
of the anti-species IgG conjugates with the test sera 
(Figs. 6.2d, 6.4). This showed that the phenomenon was as­
sociated with antibodies rather than putative antigen 
within the sera. The antibody population involved in the 
SNTs seem to represent only a fraction of the total anti­
bodies present. Similar findings have been reported in 
lymphocytic choriomeningitis virus infections in mice, 
where there was a correlation between Cl q binding activity 
and specific antibodies but not total IgG level (Oldstone 
and others, 1983). Other virus infections are capable of 
inducing a wide range of other unrelated antibodies, includ­
ing autoantibodies to proteins such as actin and myosin
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(Oldstone, 1984) or to unrelated viruses (Mims and White, 
1984). In pestivirus infections, increased antibodies of 
low or no pestivirus specificity have been reported (Braun 
and others, 1973; Brown and others, 1979; Osburn and others, 
1973). The poor correlation between the SNTs and the ELISA 
tests with polyclonal pestivirus antiserum probably reflects 
the reactivity of different antibody populations. Although 
all tests employed here involving anti-species
immunoglobulins were against the IgG antibodies, the class 
of immunoglobulin molecule involved has not been determined 
because of the unavailability of appropriate typing antisera 
for such determination. IgM molecules have been reported to 
be sensitive to freeze-thawing (Groves and others, 1987), 
and might play a role in the F/T-sensitive neutralizing 
activity of the sera, although to date no mention of in­
creased neutralizing capacity after F/T processing has been 
made. It is conceivable that IgM molecules disrupted by F/T 
cycling might cross-react with anti-IgG conjugates, although 
no evidence is provided here to substantiate such a hy­
pothesis.
A number of serum samples (7/77 of piglets, 7/8 of lambs) 
increased their specific neutralizing antibody titres con­
siderably (greater than fourfold) after F/T processing. At 
least one piglet (111 P3, Fig. 6.1b) and all the lambs
(Fig. 6.1c) were reported negative for antibodies before the 
treatment and became positive after F/T cycling. Conversely,
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in those sera which were shown to vary in an inverse way and 
displayed higher SNT titres before than after F/T, the 
variation was less than a fourfold difference and therefore 
was not considered significant. The picture observed is 
suggestive of the presence of virus-antibody complexes or 
immune complexes (ICs) (Mims and White, 1984; Oldstone and 
others, 1983). It is hypothesized that the F/T sensitivity 
registered here might be due to the breakdown of circulating 
virus-antibody complexes. ICs have been found to play a 
role in a variety of diseases (Mims and White, 1984) and are 
probably formed in most viral infections at an early stage 
when the first specific antibodies are generated and meet 
circulating virus (Mims and White, 1984). In the normal 
host, this is likely to be a transient stage, soon giving 
rise to antibody excess. However, minimal antibody 
production or antibodies of low affinity might give rise to 
defective clearance of ICs (Mims and White, 1984). It is 
possible that the phenomenon described here might be 
associated with such an anomalous clearance of ICs due to 
the immunologically immature status of the fetus infected in 
early gestation. It is conceivable that the first antibodies 
might be masked by complexing to excess circulating antigen. 
As a consequence, the sera might give negative results in 
tests for antibodies. Different proportions of antigen or 
antibody excess might give rise to the different 
combinations of results obtained at virus isolation, DFAT 
and antibody detection systems such as those observed here
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in the infected offspring (see chapters 4 and 5).
It has been reported that swine fetuses can only produce 
antibodies to HCV after 90 days of pregnancy or after 
infection of sows at 72 days of gestation (Van Oirschot,
1979b, Frey and others, 1980; Plateau and others, 1980). In 
lambs, the earliest pestivirus-specific antibody response 
obtained was from the offspring of ewes inoculated at 52 
days of gestation (Terpstra, 1981). In the present study, 
sows infected between 37 to 49 days of gestation and 
ewes infected between 39 to 45 days of gestation gave rise 
to offspring where evidence of a pestivirus-specific 
antibody response was present. It is tempting to speculate 
that early fetal responses in those studies might have been 
masked by a phenomenon similar to the presently described. 
However, they involved "typical" or well characterised 
pestivirus strains and an analogy with the results reported 
here may not stand true in those circumstances. It is 
interesting that the majority of animals which appeared to 
bear circulating ICs were those from mothers infected with 
virus of heterologous origin. It is possible that the
presence of ICs might be related to a "poor adaptation" of 
the strain to the species.
Of the seven piglets which showed increased (greater than
fourfold) neutralizing activity in their sera after F/T
cycling, five (305 P4, P5; 302 P9; 111 P3, P5; Fig. 6.1)
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were also positive for virus isolation, of which four also 
resulted in recovery of virus from serum. Two others (302 
Pi 0, P11 ) had DFAT detectable antigen in some tissues, al­
though virus could not be recovered from their tissues. 
These two piglets had high neutralizing antibody titres
(see Chapter 4). As regards lambs, seven out of eight
animals tested here had low titres of F/T sensitive 
pestivirus specific neutralizing antibodies, which also al­
lowed recovery of virus from their tissues to greater or 
lesser extent (see chapter 5). The concomitant presence of 
virus in tissues and sera and antibodies which sometimes 
could only be detected after special treatment provide ad­
ditional indirect evidence for the presence of circulating
ICs (Oldstone, 1984). Situations where the presence of ICs 
would be likely with the simultaneous presence of virus and 
antibodies allied to difficulties in recovering virus from 
antibody-positive animals are abundant in the pestivirus
literature (Ohmann and others, 1982; Braun and others, 
1973; Schultz, 1973; Rinaldo and others, 1976; Brown and 
others, 1979). Some of those involved inoculation of preg­
nant animals at gestational ages similar to those employed 
here (Barlow and Gardiner, 1969; Terlecki and others, 1973) 
as well as field observations (Boeder and others, 1987). 
Those reports plus the observations described here seem to 
indicate a role for the combined participation of virus and 
antibodies in the pathogenesis of pestivirus disease, as 
indeed previously suggested (Barlow, 1983; Boeder and oth-
ers, 1986, 1987; Harkness and Roeder, 1988). In addition, it 
is possible that these virus-antibody interactions might 
take place earlier than expected in fetal life (Sawyer and 
others, 1978; Harkness and Roeder, 1988). Future experiments 
will help to clarify the conditions in which the phenomenon 
can be best expressed, as well as to fully evaluate its role 
in the pathogenesis of congenital pestivirus infections.
6.5. CONCLUSIONS
F/T cycling on serum samples from the offspring of 
pestivirus-infected swine and sheep altered the results of 
SNTs and different ELISA tests performed. Some of these sera 
demonstrated increased pestivirus-specific neutralizing 
activity after the treatment. The phenomenon was putatively 
attributed to the liberation of antibodies from circulating 
ICs, which were probably disrupted by successive F/T 
cycles. The pestivirus-specific F/T-sensitive antibodies 
appeared to represent a fraction of the total antibodies 
present in the sera. No evidence for the involvement of 
antigen in the phenomenon was found. These experiments 
suggest that there may be a role for the concomitant 
participation of virus and antibodies in the pathogenesis of 
pestivirus fetal infections. In addition, F/T cycling 
provided evidence for the presence of an immune response in 
some fetuses, at an earlier age than expected.
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CHAPTER 7. FINAL COMMENTS ON THE ANIMAL INOCULATION 
EXPERIMENTS :
7.1. INTRODUCTION:
As commented previously, transplacental infections - par­
ticularly with ruminant pestiviruses - can be regarded as 
the central event in the pathogenesis of pestivirus 
infections. Once the virus is able infect the fetus in 
uterof a variety of different outcomes of infection are 
possible, depending on the imbalance between virulence of 
the agent and host defences available. The main aim of the 
present studies was to provide futher evidence for the 
similarities between the swine isolate 87/6 and BDV strains. 
Among the aspects examined, most important was regarded to 
be the possibility of causing transplacental infections in 
swine and sheep. Evidence was presented for the capacity of 
both swine and ovine pestivirus isolates to cause congenital 
infections in lambs and piglets. The results were confirmed 
by a number of virus isolation and serological results. 
While attempting to demonstrate transplacental virus 
transmission, a number of related issues were raised,
such as the role of immune complexes in the pathogenesis, 
the possible spread of virus "horizontally" in utero , and 
the participation of the immune responses in the development 
of lesions. In the following sections of this chapter, some 
of these issues are highlighted. It was not intended to
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cover all possible variables that may have influenced the 
outcome of the infections, but those aspects which were 
considered most relevant in the author's opinion, and which 
for the sake of clarity were not extended in the previous 
chapters.
7.2. COMMENTS ON SEROLOGICAL AND VIROLOGICAL RESULTS: 
Evidence for an early immune response:
It has been reported that porcine fetuses can only produce 
antibodies to HCV after day 90 of gestation (Van Oirschot, 
1979b, Frey and others, 1980). The earliest report of a 
serological response against HCV was observed in sows 
infected at 72 days of gestation (Plateau and others, 1980). 
However, immune responses have been detected in piglets 
born from sows infected with Kilham rat virus at a much 
earlier gestational age (33-34 days, Wrathall, 1972). In 
the present study, piglets producing neutralizing antibodies 
(and antibodies detectable by IIF, IIPX and ELISA) were de­
tected following infection of sows as early as 34 days of 
gestation, some animals with considerably high titres 
(Chapters 4 and 6).
In sheep, the earliest previously reported intrauterine 
pestivirus—specific antibody response was obtained in lambs 
from ewes inoculated at 52 days of gestation (Terpstra, 
1981), despite much earlier responses to other antigens
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(41-42 days, Silverstein and others, 1963). In the present 
study, all four ewes infected between 39 and 45 days of 
gestation gave birth to lambs with evidence of low titres 
of neutralizing antibodies (Chapter 5).
Therefore, the findings reported here for both piglets and 
lambs are indicative of an ability of the fetuses to re­
spond to the pestivirus infections with the production of 
specific antibodies, much earlier in gestation than pre­
viously expected.
Antibodies and efficiency of the immune response:
However, the presence of antibodies does not necessarily re­
flect the presence of an efficient immune response. The 
affinity of pestiviruses for cells of the reticulo­
endothelial system is well documented (Ressang, 1973; Van 
der Molen and Van Oirschot, 1981; Ohmann and others, 1982; 
Ohmann, 1988; see Chapter 1). The viruses might infect 
cells that would be responsible for the generation of 
cytotoxic T cell activity, thus avoiding clearance 
mechanisms (Ohmann and others, 1988). Neutralization might 
also be prevented by the binding of non-neutralizing anti­
bodies to the virus, which could "trap" the antigen in 
antigen-antibody complexes in such a way that the access of 
neutralizing antibodies would be made impossible, thereby 
blocking the activation of cytotoxic or immune complex (IC) 
hypersensitivity. This type of phenomenon has been described
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in lactate dehydrogenase elevating virus infections 
(Notkins and others, 1979). Such non-neutralizing antibodies 
may also enhance the spread of the infection on Fc-receptor 
bearing cells by attachment of ICs to these receptors (Mims 
and White, 1984). These unusual situations might arise due 
to the lack of mature components of the immune system which 
may not be present or may not yet be functional in the fe­
tus early in gestation. Some cells of the immune system of 
lambs such as macrophages, eosinophils and neutrophils were 
only detected at 63, 112 and 132 days of conceptual age,
respectively. In contrast, morphologically mature 
lymphocytes were present at 32 days (Sawyer and others,
1978). The absence of subsets of differentiated cells might 
lead to the production of antibodies with no (or defective) 
further activation of other contituents of the immune sys­
tem.
Conversely, the absence of a detectable neutralizing 
antibody response does not imply the absence of other arms 
of an immune response. For instance, lambs of group I 
developed detectable antibody responses, despite being 
infected earlier than those in group II. In the latter,
however, serology was compromised in 4 out of the 8 lambs
born due to the pathogenic effects on fetuses, and evidence 
for neutralizing antibodies was scarce (apart from lambs of 
ewe 329 which had high neutralizing antibody titres; see 
Table 5.2, Figs. 6.1 and 6.2) . Based on the findings in
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lambs of group I, lambs 329 Li and L2 of group II, and 
observations of other authors (Terpstra, 1978; Terpstra, 
1981; Gardiner, 1982), infections at 62 days of gestation 
would be expected more likely to induce some sort of immune 
response. It is speculated that such a response might have 
gone undetected, perhaps by the unavailability of free anti­
bodies, complexed in ICs (in this case refractory to F/T), 
or by an exacerbated clearance of such complexes. The 
relatively "more developed" cytotoxic activity (e.g. at 62 
days of conceptual age) might have been stimulated by the 
presence of antibodies, with the elimination of infected 
cells leading to the presence of very few of those bearing 
antigen (Tables 4.5 and 5.5). In addition, in those 
lambs of group II where testing was possible, the levels of 
antibodies detected in the F/T ELISA with anti-species IgG 
(Chapter 5) were very similar, in absolute values of OD 
readings, to those observed in lambs that did react spe­
cifically to the virus. Therefore, it seems likely that al­
though no neutralizing antibodies were detected, other 
pestivirus-specific antibodies (which would give rise to the 
OD readings observed) might have been present in their 
sera. Future experiments attempting to examine further these 
possibilities should make more use of assays not dependent 
on neutralization of virus infactivity, such as those 
described here (e.g. ELISAs and IIPX tests), or others such 
as Clq binding assays (Oldstone and others, 1983).
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7.3. IMMUNE COMPLEXES AND PESTIVIRUS INFECTIONS:
The involvement of ICs in pestivirus-induced disease has 
been recorded sporadically. A number of reports were con­
cerned with the similarity of the lesions induced by 
pestivirus infections to IC-mediated lesions, particularly 
the glomerulonephritis in chronic HC (Cheville and others,
1970; Prager and Liess, 1976; Coria and McClurkin, 1978; 
Cutlip and others, 1980; Hewicker and others, 1987). Other 
findings suggestive of ICs can be found spread through a 
number of reports involving the three pestiviruses (Van 
Oirschot, 1980; Von Benten and others, 1980; Osburn and
others, 1973; Clarke and Osburn, 1978; Richter-Reichelm and
others, 1980; Barlow, 1980; Roeder and others, 1987; Braun 
and others, 1973; Kendrick, 1971).
Others disputed the significance of ICs in the pathogenesis 
of events in BVDV-persistently infected cattle (Hewicker and 
others, 1987; Ohmann, 1988). In congenital HCV infections, 
evidence for infectious virus trapped in ICs was not found 
(Van Oirschot, 1980).
Other workers have suggested that the pathogenesis of
pestivirus infections is under the influence of fetal 
responses, the consequences of this being the exacerbation 
of the pathological processes (Barlow, 1983; Roeder and
others, 1987; Harkness and Roeder, 1988). While the host
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immune response is maturing (up to the second trimester of 
gestation), the lesions would be aggravated by fetal re­
action. After that, the fetus would probably be able to re­
spond effectively to the aggression, with subsequent
clearance of the infection. In this sense, fetal 
pathogenesis would have a strong "self-inflicted" or 
autoimmune component. The same basic mechanism of 
pathogenesis has been proposed for congenital infections of 
cattle with BVDV (Roeder and others, 1986), and for BDV
infections of sheep (Roeder and others, 1987), although a 
role for the immune response in the pathogenesis of
pestivirus infections has been evoked by various others 
(Kendrick, 1971 ; Braun and others, 1973; Brown and
others, 1973, 1974, 1975; Scott and others, 1973; Barlow,
1980; Duffell and others, 1984; Liess and others, 1984). The 
results of the present studies seem to corroborate the 
latter suggestions and extend previous observations in that 
the fetal immunological responsiveness to pestiviruses
appears to be potentially present in piglets and lambs at 
an age considerably earlier than previously reported. The 
lack of identification of such an early immunological 
responsiveness might perhaps be related to the methodology 
employed by previous workers. In the experiments with lambs 
described here, the method used for the detection of low 
levels of antibodies described in Chapter 6 (F/T cycling) 
was the main factor that led to the identification of 
animals with low levels of neutralizing (as well as
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ELISA-detectable) antibodies which would not be detected in 
usual neutralization tests. The phenomenon of f /t sensitiv­
ity, putatively attributed to the presence of immune
complexes in sera, was fortuitously observed to influence 
the results of the tests. The results in Chapter 6 con­
stitute the first evidence for the existence of such a
phenomenon. Future experiments should extend the
observations on the effects of freezing/thawing on serum 
samples, antibody affinity and its participation in 
pestivirus-induced disease. The results in Chapter 6 appear 
to indicate a gradient of levels of F/T sensitivity, with 
the (putative) ICs in some serum samples apparently being 
disrupted more easily than others. This is suggestive that 
the avidity of the bond between antigen and (different) 
antibodies was variable, and indeed this behaviour would be 
expected from polyclonal sera with distinct antibody 
populations (Roitt, 1980). Moreover, a "plateau" of F/T
sensitivity can be expected, where the total ICs present
would be disrupted and subsequent F/T would not induce any 
increase in titres. It would be interesting to determine the 
precise number of cycles necessary to reach such a plateau, 
although it seems likely that they would be different for 
each serum sample examined.
7.4. PATHOGENESIS OF THE CNS LESIONS:
The most striking feature of the pathology of congenital
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infections common to both lambs and piglets in the present 
study was the marked effect on brain and cerebellum weight. 
Reduced brain weight induced by pestivirus congenital 
infections has been reported in BD and BVD (Scott and
others, 1973; Terlecki and others, 1973; Sweasey and
others, 1979; Done and others, 1980). The pathogenesis of 
such reduction in organ weight is not known (Wrathall, 1972; 
Terlecki and others, 1973). It might result from a general 
fetal growth retardation such as impairment of maternal to 
- fetal transfer of nutrients (Creasy and others, 1972; 
Wrathall, 1972). In this case, the reduction in organ 
weights on the CNS would represent non-specific signs of 
growth arrest, such as GALs. However, pathology in the CNS 
for this reason would probably be preceeded by other evident 
anomalies in other organs of less growth priority 
(Richardson, 1977).
Another possibility is the involvement of fetal immune re­
sponses in the process. This immune-related hypothesis was 
previously proposed as an explanation for the pathogenesis 
of the cerebellar lesion after congenital BVDV infections in 
cattle (Brown and others, 1974). Likewise, in the ex­
periments described here, the immature fetal immune 
response might have been involved in the pathogenesis of 
the fetal lesions. Although no direct association can be 
drawn from the experimental data, this possibility is raised 
with basis on the presence of pestivirus specific antibodies
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in various of the animals with pathological signs (Chapters 
4-6) . In order to examine this question further, each virus 
should be inoculated into groups of animals at different 
gestational ages and samples tested for the presence of 
virus and antibodies, including serum samples before and 
after F/T cycling.
A division has been suggested between the pathogenetic 
mechanisms for induction of lesions in the CNS (Barlow, 
1980; Barlow, 1983; Boeder and Drew, 1984). The less severe 
lesions observed before mid-gestation in lambs and cattle 
where no serological evidence for antibodies was detected 
were distinguished from the more drastic hydranencephaly 
and cerebellar dysplasia observed following infections after 
mid-gestation. It was proposed that those less severe 
leukoencephalomalacic lesions were "more likely due to be 
virally mediated than immune mediated" (Boeder and others, 
1987; Harkness and Boeder, 1988). With the evidence 
presented here for a precocious immune responsiveness, it is 
possible that even the less severe lesions quoted by
those authors might also involve the participation of fetal 
immune defenses. It is hypothesised that the basic 
immune-related mechanism would be the same, the outcome 
varying in relation to the intensity and maturity of the im­
mune response.
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7.5. FACTORS THAT MAY HAVE INFLUENCED THE OUTCOME OF 
INFECTION:
Gestational Age:
Gestational age at infection is one of the major factors in 
determining the outcome of infection (Van Oirschot, 1983). 
In the experiments with pigs, all sows were inoculated 
between 34 and 49 days of gestation. Although there was 
still a variation of 15 days (13% of the gestational 
period) between the earliest and the latest gestational age 
the difference was uniformly distributed in the two groups 
(Table 4.1). Therefore, the variation introduced by this 
factor was minimized. Such variation was accepted in at­
tempting to ensure that at least some of the sows would have 
their offspring congenitally infected. In both groups of 
piglets born to infected animals the clinical signs were 
very similar, generally indistinguishable from those shown 
by uninfected controls. Lesions noticeable at birth were 
only seen in one sow infected with the homologous porcine 
isolate (305, see Table 4.2). This is suggestive that in 
congenitally infected piglets, the pathology induced by the 
two viruses is similar when sows are infected at equivalent 
gestational ages.
In sheep, the gestational age of ewes at inoculation var­
ied from 39-45 days (group I), to 60-62 days (group II) 
(Table 5.1). The gap between earliest and latest gestational
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ages (23 days) was not significantly different from that of 
the sows (16% of the ewes' gestational period). However, 
the gestational ages between the two groups of ewes were 
not uniformly distributed. Whereas in group I the ges­
tational age varied from 39 to 45 days, in group II the 
variation was from 60 to 62 days. This was unfortunate but 
was due to difficulties in obtaining the ewes at the desired 
gestational age. It is possible that the more severe pa­
thology observed in lambs born from ewes of group II 
(infected with the ovine isolate 137/4) was related not to 
the virulence of the isolate but to the gestational age at 
inoculation. To test such hypothesis, further experiments 
should involve the inoculation of animals with the two 
viruses at equivalent gestational ages.
Timing of infection in utero :
Another very important variable, however, might be raised 
when the differences in virus and antibody status within 
each litter are compared. It can be expected that 
genetically determined variation would be minimal when 
looking at siblings of a polytocous species, such as swine. 
Despite that, the variation within each litter was 
significant, with different combinations of virus and anti­
body status being found in piglets. This might be due to 
the infection of piglets at different times in utero, 
suggesting that the infection might have been transmitted 
"horizontally" from fetus to fetus. This possibility has
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been suggested in congenital HCV by other authors (Plateau 
and others, 1980; Van Oirschot, 1980), and other
experimental congenital infections of pigs (Wrathall,
1972). However, it is also possible that the virus infected 
and grew in fetal tissues until the the development of im­
munological competence (Wrathall, 1972). This mechanism has 
also been proposed for BVDV transplacental infections, where 
the virus would "persist in the fetus or placenta and fluids 
(or both) until the fetus is capable of producing antibody" 
(Casaro and others, 1971). The determination of the origin 
of such variation in the outcome of infection was beyond 
the scope of the present studies. Nonetheless, lateral 
transmission in utero seems more likely, since the latter 
hypothesis (Casaro and others, 1971) appears to conflict 
with the currently accepted mechanisms for development of 
immune tolerance (Brownlie, 1990).
In view of that possibility in piglets, it seems also 
conceivable that some of the twin lambs might not have been 
infected at the same time in utero. In lambs of group II, 
the outcome of infection was quite distinct in some of the 
twins (Table 5.2). In addition, a number of previously 
documented cases of twins born to infected ewes gave rise to 
lambs with quite distinct signs of infection (Shaw and 
others, 1967; Barlow and Gardiner, 1969; Barlow, 1980; 
Boeder and others, 1987; Bonniwell and others, 1987). There 
is no doubt that gestational age of the mother at the time 
of infection is distinct from conceptual age at infection,
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since the viruses take some time to cross the placenta 
(Hadjisavvas and others, 1975; Parsonson and others, 1979;
Boeder and Drew, 1984). It is possible that fetal conceptual 
age at infection may be not be the same for all fetuses 
within the offspring. It is hypothesised that this addi­
tional factor might have influenced the outcome of the 
transplacentally transmitted pestivirus infections described 
here, not only in swine but perhaps also in sheep.
Virulence of the isolate:
The severity with which animals were affected may be related 
to the virulence of the isolates for the species. Whereas 
virulent HCV strains would be expected to kill the majority 
of the affected animals, strains of low or attenuated 
virulence might manifest their virulence only by causing 
reproductive disorders (Johnson and others, 1974; Van 
Oirschot, 1988). In sheep, ewes of the same breed in­
oculated with BDV strain BP-77 gave birth to lambs with 
hypomyelinogenesis, whereas strain H-77 produced 
hydranencephaly and arthrogryposis (Barlow and others,
1979). Others related strains of low pathogenicity to the 
development of persistent infections in congenitally in­
fected lambs with no clinical signs and with minimal 
evidence of pathology (Bonniwell and others, 1987). As 
suggested previously, a proper comparison of virus virulence 
would require inoculation of animals at the same gestational 
age.
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It has also been reported that the strain biotype might 
influence the outcome of infection in pregnant cattle and 
sheep. Only BVDV virus of the NCP biotype could give rise to 
persistent infections or immunotolérance in cattle (Brownlie 
and others, 1989). In sheep, infection of pregnant ewes at 
52 days of gestation with a cloned NCP BDV strain led to 
barrenness, abortion, stillbirths and the birth of 
"hairy-shaker" lambs, whereas infection with the CP biotype 
of the same strain led to the birth of apparently normal 
lambs, many of them with BDV-specific neutralizing 
antibodies (Nettleton and others, 1987). In the present 
experiments, the isolates used for animal inoculation were 
not cloned in order to decrease the probability of muta­
tions which might have been favoured through artificial se­
lection. As far as it was possible to determine, the 
isolates 137/4 and 87/6 were consistently of the NCP biotype 
(that is, after multiplication in SCP, PK15 and BT cells, 
Chapters 2 and 3). Based on the above, it was assumed that 
no CP biotype was present in the inocula used for infection 
of sows and ewes. Consequently, the differences in 
pathogenicity observed (particularly between the two groups 
of ewes) could not be attributed to differences in the in 
vitro viral biotype.
Species and breed susceptibility:
Differences in pathogenicity may have been related to 
differences in species susceptibility. Abortion has been
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recorded more frequently in pestivirus-infected sheep and 
cattle than in swine, whereas stillbirth is more commonly 
observed in swine (Van Oirschot, 1983). This might have 
influenced the differences in the outcome of infection in 
swine and sheep. Breed-related differences have also been 
shown to influence the outcome and susceptibility to BDV 
infections (Barlow and others, 1979). The use of animals of 
the same breed in each group, however, eliminated this 
variable from the present studies.
Individual Variation:
In the group infected with the ovine isolate (group II), 
despite the homogeneous gestational age of the ewes of the 
group, the manifestations were most varied on the offspring 
of different ewes. This suggests that individual host 
variability may have played a role in the outcome of the fe­
tal infections. It has been shown with lymphocytic 
choriomeningitis virus (LCMV) infections of mice, that 
amounts of antibody produced varied not only in relation to 
the virus strain but also to the genetic makeup of the im­
mune response (Ir) genes of the major histocompatibility 
complex (MHC) (Oldstone and others, 1983). Similarly, the 
induction of insulin-dependent diabetes mellitus in mice by 
encephalomyocarditis virus was dependent not only on the 
virus strain but also on the genetic background of the mice 
(Notkins and others, 1979). Therefore, genetically deter­
mined variation in the susceptibility of the animals used in
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the present experiments is a possibility, since no swine or 
sheep of uniform genetical makeup (apart from the breed) 
were available.
With basis on the data presented here, further experiments 
can be designed to extend these studies in more detail. For 
instance, the participation of immune complexes in 
pestivirus induced disease should be extended to examine 
the effect of freezing/thawing in serum samples of naturally 
persistently infected animals, which might contribute to 
uncover the reason for the variability observed after 
infections early in gestation. In addition, the follow up of 
the animals born to infected sows and ewes during the 
postnatal period would be of great interest, particularly 
the aspects of virus transmission and persistence in 
extra-uterine life.
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7.6. CONCLUSIONS:
The two pestivirus isolates (87/6 and 137/4) caused 
transplacentally transmitted infections in the offspring of 
swine and sheep. Some of the congenitally infected animals 
apparently would have been born persistently infected, as 
indicated by the isolation of virus from their tissues
associated with no or very little pestivirus-specific 
neutralizing antibodies detectable in their sera. The swine 
isolate was similar to the sheep isolate, not only in its 
antigenic composition but also for its pathogenic effect in 
congenitally infected piglets. It is concluded that the 
porcine isolate 87/6 cannot be distinguished from the sheep 
isolate 137/4 on the basis of their cell culture growth
characteristics and ability to induce transplacental infec­
tions in both sheep and swine, or by their antigenicity in 
infected animals. In addition, both isolates were more
closely related antigenically to BDV than to other
pestiviruses. These findings provide strong evidence to sup­
port that the isolate 87/6 is a virus more closely related 
to BDV than to HCV strains. Therefore, it is likely that 
this isolate probably originated from a natural case of 
cross-infection in pigs with a virus of ovine origin. This 
constitutes the first comprehensive report on 
transplacentally transmitted cross-infections in pigs with 
BDV or "BDV-like" viruses.
It was also shown that immune complexes appear to be in­
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volved in the pathogenesis of the congenitally acquired 
pestivirus infections described here, and may be of sig­
nificance in determining the outcome of infection at the 
emergence of fetal immune responses. Immune complexes ap­
pear also to be able to hamper the detection of the earliest 
antibodies produced by the host.
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CHAPTER 8. COMPARISON OF NUCLEOTIDE SEQUENCES OF SEGMENTS OF
PESTIVIRUS GENOMES
8.1. INTRODUCTION
In the previous chapter of this thesis, evidence was pre­
sented which demonstrated the similarities between the 
porcine isolate 87/6 and the border disease isolate 137/4. 
Both have been compared with respect to their growth char­
acteristics in vitro and in their capacity to induce 
congenital infections in swine and sheep following inocula­
tion of pregnant sows and ewes. The next objective was to 
attempt the characterization of these isolates at the 
molecular level in order to determine the degree of genetic 
relationship between them and other pestiviruses.
The polymerase chain reaction (PCR) (Saiki and others, 1985) 
is a method of DNA amplification which allows the production 
of relatively large amounts of nucleic acid fragments of 
defined length, by performing many cycles of DNA synthesis 
using a pair of DNA primers (i.e. short DNA fragments 
complementary to a particular region on the DNA molecule) 
flanking the region of interest. The method is becoming 
widely used as a diagnostic method for genetic disorders 
(Chamberlain and others, 1989), detection of viruses (Ting 
and Manos, 1989) and comparative studies of segments of DNA 
(Lyons and others, 1989) . The PCR can also be used for RNA
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studies, provided a complementary DNA strand (cDNA) is 
first generated with the enzyme reverse transcriptase 
(Sambrook and others, 1989). This combined reverse 
transcription/PCR amplification has been successfully used 
for comparisons between RNA viruses, including
picornaviruses (Hyypia and others, 1989; Torgersen and oth­
ers, 1989, Gama and others, 1989) and human immunodeficiency 
virus (Kellogg and Kwok, 1989). In the present work, the 
reverse transcription/ PCR amplification of defined seg­
ments of the viral genome was used in the study of 
pestiviruses. This chapter describes the PCR amplification 
of genomic fragments of viruses 137/4 and 87/6 which were 
subsequently cloned, sequenced and compared with equivalent 
regions from other pestiviruses.
8.2. MATERIALS AND METHODS
Virus growth and multiplication:
The viruses used in the present experiments were isolates 
87/6 and 137/4, of porcine and sheep origin, respectively, 
and the strain NADL of BVDV which was included as control. 
In some experiments, the BVDV strain Oregon C24V (C24V) was 
also included. The conditions for growth in cell culture 
and production of virus stocks were essentially as described 
in Chapter 2. Prior to preparation of stocks, viruses (87/6, 
137/4 and NADL) were purified by limiting dilution by three 
successive passages in CT cells. Strain NADL and strain
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C24V had been previously purified (G. Ibata, personal 
communication). Working stocks were produced in CT cells. 
Monolayers were infected by adsorption for 1 hour at 37°C 
with 0.5 ml of a virus suspension containing 103 to 106 
TCID50/ 5 0 ) jl1  in MEM-FCS. Monolayers were then washed, 
covered with fresh MEM containing 10% fetal calf serum and 
incubated for four days at 37°C. The NADL and C24V strains 
were processed in the same way except that infected cells 
were incubated until the first signs of CPE were evident 
(usually 24 to 30 hours post-infection). After incubation, 
the medium was removed and cells processed for RNA 
extraction as described below. In some experiments, the 
supernatant of the cultures was used as source of virus for 
RNA extraction see below.
RNA extraction:
A number of published RNA extraction procedures were tested 
(Chirgwin and others, 1979; Gama and others, 1989; Hyypia 
and others, 1989; Stallcup and Washington, 1983). For most 
subsequent experiments an adaptation of the method of 
Stallcup and Washington (1983) was employed because of its 
ease and rapidity. With the exception of cell culture me­
dia, all solutions, plastics and glassware that came in 
contact with RNA-containing suspensions were treated with 
0.1% diethyl-pyrocarbonate (DEPC, Sigma) and subsequently 
autoclaved. Gloves were used throughout and changed fre­
quently to minimize ribonuclease (RNase) contamination.
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Cells were scraped off the flasks with a rubber policeman, 
washed in MEM without serum and pelleted by centrifugation 
at 1000 x G for 10 min. The cells were then washed in 
ice-cold saline solution (NaCl 0.85%), pelleted for 5 sec­
onds at 12000 x G and the supernatant removed. The packed 
cell volume was approximately 100 to ISOpl, of which 50pl 
were used for each extraction. To that cell volume, SOOpl 
of 10mM EDTA (pH 8.0), 0.5% SDS were added and subsequently 
made 0.1M sodium acetate (pH 5.2). The mixture was 
vortexed briefly, passed three times through an 18-gauge sy­
ringe needle and the nucleic acid extracted with an equal 
volume of water-equilibrated phenol. The aqueous phase 
containing the RNA was transferred to fresh tubes, adjusted 
to 0.1M Tris/HCl (pH 8.0), O.2M NaCl and precipitated by 
addition of 2 volumes of ice-cold ethanol. After 30 min in 
an ice bath, the RNA was collected by centrifugation in a 
refrigerated microcentrifuge at 12000 x G for 10 min. The 
ethanol was removed and the RNA pellet was resuspended in 
200)j.l of TE buffer ( 10mM Tris-HCl, ImM EDTA pH 8.0). The 
solution was made 0.2M NaCl and precipitated with 
ice-cold ethanol. The RNA was pelleted by centrifugation, 
the supernatant removed and the pellet was resuspended in 
10Opl of RT/PCR buffer ( 10mM Tris-HCl pH 8.3, 50mM KC1, 
1 . 5mM MgClf, 0.001% gelatin).
Strategy for genetic studies :
The strategy adopted for generation of DNA "copies" and
248
Fig. 8.1. Schematic representation of the strategy adopted for
generation of pestivirus cDNA for sequencing. a) Reverse 
transcription of the viral RNA (a hypothetical region on the 
viral genome is shown as an example ) ; b) Utilization of the cDNA 
obtained for PCR amplification of the fragment of interest; c) 
Cloning by insertion of the fragment (after digestion of 
artificially created enzyme restriction sites to generate sticky 
ends) into the plasmid vector pUC18 (pre-digested with the same 
enzymes). After ligation of the fragment into the plasmid, the 
vector is ready for transformation into E. coli .
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sequencing of pestiviruses is shown schematically in Fig. 
8.1az b and c. The first step (Fig. 8.1a) involved 
| the generation of complementary DNA (cDNA) from a specific 
region of the viral RNA using the enzyme reverse 
transcriptase. Next (Fig. 8.1b), the complementary strand to 
the cDNA was synthesized and amplified using the PCR, which 
consists of successive cycles of dénaturation (i.e. strand 
separation), reannealing (in presence of primer excess to 
favour primer binding to targeted DNA) and DNA
polymerization (i.e. primer extension) with DNA polymerase. 
In order to obtain sufficient material for subsequent 
sequencing, the DNA was cloned into E. coli using a plasmid 
vector (pUC 18) (Fig. 8.1c). The PCR product was digested 
with restriction enzyme sites artificially created at the 5 1 
end of the primers, to generate "sticky ends". The plasmid 
vector was cut in the equivalent sites available in its 
multiple cloning site, and the PCR product inserted into the 
plasmid (with the enzyme T4 DNA ligase).
Primers :
Published sequences of BDV are not available. Assuming 
some homology between BVDV and BDV, the primers used for 
cDNA synthesis and amplification of segments of viral 
genomes were designed using the BVDV NADL (Collett and 
others, 1988a) and Osloss (Renard and others, 1987)
nucleotide sequences. Sequences were aligned using
programs Microgenie (Beckman) and Staden-Plus (Amersham).
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Fig. 8.2. Positioning of primers and orientation relative to the 
BVDV NADL genome. The region corresponding to the first 4kb at 
the 5' end of the genome is shown ( for full genomic map see 
Chapter 1 page 11). Numbers correspond to nucleotide positions. 
Primers are as in Table 8.1. Arrows denote primer orientation. 
Arrow size is not proportional to primer size.
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Primers were designed using regions sharing significant 
homology (90% or more). Regions about 20-30 nucleotides 
long,with approximately 50% G-C content and avoiding regions 
prone to "hairpin loop" formation (Barnes, 1987) were 
identified (Table 8.1). Primer positions and orientation 
relative to the BVDV NADL genome are represented in Fig.
8.2. In order to facilitate cloning, "tails" with restric­
tion enzyme recognition sites were included at the 5 1 end of 
the primers. Additional nucleotide triplets (AAA or TTT) 
were included to minimize restriction site losses during PCR 
amplification. Primers were synthesized by a PCR-mate 
oligonucleotide synthesizer (Applied Biosystems) following 
the manufacturers instructions. Removal of primers from col­
umns and "primer deprotection" followed manufacturers 
recommendations. Primers orientated 5* to 3 1 in relation to 
the viral genome ("forward primers") were "copies" of the 
RNA sequence; "reverse primers" (i.e. complementary to the 
3 1 end flanking the desired region and orientated towards 
the viral 5* end) were complementary to the viral genome 
(Table 8.1). The concentration of the primers was determined 
using "DNA Dipstick" (National Diagnostics) and by 
titration in Ethidium bromide-stained 1% agarose gels.
Reverse transcription:
Reverse transcription was performed essentially as de­
scribed by Sambrook and others, 1989. Viral RNA (see above) 
was boiled for 1 min and 5pi of the RNA suspension were
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Table 8.1. Oligonucleotide primers employed.
Primer Equivalent region G/C
Code Sequence (51 to 3 1) on NADL genome* content
Primers without enzyme recognition sites
"G" TCAGCGAAGTAATCCCGGTG 3485-3466 58%
"F" CATATGGTCTGCAAGGCATAGG 3304-3283 50%
"E" TCTTGCAAGTGGTGTGGT 3070-3086 53%
"D" ATAGGATGGACAGGAACTGT 2855-2874 45%
Primers with enzyme recognition sites (underlined):
"Gr" AAAGAATTCATCAGCGAAGTAATCCCGGTG 3485-3466 52%
"Df" TTTGTCGACTATAGGATGGACAGGAACTGT 2855-2874 40%
"Dr" AAAGGATCCAACAGTTCCTGTCCATCCTAT 2874-2855 43%
"Kf" TTTGAATTCGGAGGACGGTTTGTACCA 1096-1082 43%
"Kr" TTTGAATTCTTATGGTACAAGCCGTCCTG 1082-1099 41%
"Jf" TTTGGATCCTACGAATACAGCCTGATAGG 313-332 45%
* = NADL genome from (Collett and others, 1989). Number in
increasing order denote forward primers; decreasing order 
denotes reverse primers.
continued next
page
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Table 8.1. Footnotes continued.
Approximate size of expected fragments in number of base 
pairs (bp) (including the primers):
G to E= 415bp 
G to D= 634bp 
F to E= 234bp 
F to D= 449bp
Jf to Kr= 788bp 
Jf to Dr= 2563bp 
Jf to Gr= 3174bp 
Kf to Dr= 1792bp 
Kf to Gr= 2403bp 
Gr to Df= 630bp
Enzyme recognition sites: 
Primers Kr, Jr and Dr: Eco R1 
Primers Jf and Kf: Bam HI 
Primer D f : Sal 1
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added to a reaction mixture (total volume 20)il) comprising 
2>il of 10 x RT/PCR buffer, Ijil of the required reverse 
primer (20 pmol/pl), 2.5mM dNTPs (Pharmacia), 35 units of
RNA-Gard (Pharmacia), 2.5mM MgCl2, and 200 units of murine
reverse transcriptase (United States Biochemical). The re­
action was incubated for 30 min at 37°C and stopped by heat­
ing at 95 °C for 5 min. In preliminary experiments to 
demostrate the efficiency of reverse transcription, O.Sptl of 
the reaction volume were labelled with SpCi [32P]CTP 
(Amersham), incubated and run on a 1.4% agarose gel, blotted 
onto nylon membranes by Southern transfer and 
auto-radiographed as described below.
Amplification of cDNA by polymerase chain reaction (PCR): 
Amplification of the cDNA was performed with the total 
volume (20>jl1) of the reverse transcription reaction. PCR was 
performed by the addition of 1 p.1 (20 pmol/pl) of the second 
primer, 79jil of 1 x RT/PCR buffer and 2.5 units of Thermus 
aquaticus (Taq) DNA polymerase (Perkin Elmer Cetus). PCR 
reactions (total volume lOOpl) were overlaid with lOOpl of 
mineral oil to prevent evaporation. Temperatures for the re­
actions were determined experimentally. Those which gave 
rise to optimal amplification were 95 °C for 5 min for 
initial dénaturation (previous to the addition of Taq 
polymerase), followed by 30 cycles of 95°C for 1 min (dé­
naturation), 45°C for 2 min (reannealing/primer binding) and 
70°C for 4 min (polymerization), and by a final polym-
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erization period at 70°C for 4 mins. Additional 2.5 units of 
Taq polymerase were added after 14 cycles. After amplifica­
tion, products were cooled to 4°C and stored at this tem­
perature until required.
Cloning of PCR amplified fragments:
The fragment obtained after PCR with primers Jf and Kr was 
purified by adsorption/elution onto glass beads 
(Prep-a-Gene, BIORAD), following the instructions of the 
manufacturer. The PCR products were then cut with the appro­
priate pair of enzymes in a double digest consisting of 1y.l 
(10 units) of ECO R1 , 1^1 (10 units) of Bam HI, 2\xl of x 10
reaction buffer (React buffer no. 3, Gibco BRL) and 16>il 
(about 500 ng to 2pg) of the eluted DNA solution (in 
Prep-a-gene elution buffer). The reactions were incubated 
for 2 hours at 37°C. Plasmid (pUC18, BRL) DNA was cut in its 
multiple cloning site with the same enzyme combination as 
described above. The double digests of PCR products (2pg) 
and plasmid (0.25pg) were mixed and absorbed onto 
Prep-a-Gene as above, in order to reduce the volume of the 
reaction. The resulting DNA was resuspended in 10pl of 
Prep-a-Gene elution buffer. Ligation of DNA product/plasmid 
vector was set up using 7y.l of the DNA/plasmid eluate, 2)il 
of ligation buffer and 1pi (0.5 Weiss unit) of T4 DNA ligase 
(BRL). The reaction was incubated for 16 hours at room tem­
perature. Five microlitres of the ligation mixture were used 
to transform competent E . coli DH5 cells (BRL) using the
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protocol recommended by the supplier. Transformants were 
selected by plating out on LB agar (see Appendix for 
formula) supplemented with ampicillin (100pg/ml), in order 
to select for ampicillin resistance conferred by the 
plasmid, and X-gal (5-bromo-4-chloro-3-indolyl-B-D- 
galactoside, a chromogenic substrate) so that recombinants 
containing inserts in the pUCI8 multiple cloning site formed 
white colonies (as opposed to the blue colonies indicative 
of the absence of the appropriate insert, Sambrook and oth­
ers, 1989). After overnight incubation, recombinant colonies 
were duplicated and transferred onto nylon membranes prior 
to hybridization with 87/6 or 137/4 probes (see below) using 
standard procedures (Sambrook and others, 1989).
Agarose gel electrophoresis:
Gel electrophoresis was performed in 1.4% agarose (Sigma) or 
in 1% low melting point agarose (Nusieve) as described 
(Sambrook and others, 1989). Gels were stained with Ethidium 
Bromide (O.Spg/ml in TAE buffer, see Appendix for formula) 
for 10 to 15 min and examined under UV light. Photographs 
were taken using a C.U.5 camera (Polaroid) loaded with 
667 film (Polaroid).
Hybridization procedures:
Preparation of probes :
Segments amplified from NADL, 87/6 and 137/4 genomes were 
used as probes. The amplified DNA fragments were excised
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from 1% low melting point agarose gel, diluted fivefold with 
water, boiled for 5 min and about 25-50 ng were
radiolabelled using a commercially available labelling kit 
(Multiprime DNA labelling System, Amersham) with 20pCi of
[32P]GTP (Amersham) as precursor, following the instruc­
tions recommended by the kit manufacturers.
Southern transfer:
Agarose gels were denatured by soaking for 45 min in de­
naturing solution (1.5M NaCl, 0.5M NaOH), followed by 
immersion in neutralizing solution (1.5M NaCl, 0.5M Tris-HCl 
pH 7.2, 0.001M EDTA) for a further 45 min. The denatured
gels were then blotted onto "Hybond-N" nylon membranes 
(Amersham) as follows : gels were laid on Saran Wrap (Du
Pont) covering a flat surface and overlaid with a piece of 
"Hybond-N" nylon membrane of the same dimensions as the gel. 
Four pieces of 3MM chromatography paper (Whatman) were then
put on top of the blot, followed by a stack of absorbent
paper. A weight of about 1 kg was put on top of the 
assembly. Nucleic acid transfer by capilarity was performed 
for 16 hours at room temperature. After transfer, the 
membrane containing the transferred DNA was air dried at 
room temperature for 30 min, covered with Saran Wrap and the 
DNA fixed by exposure to UV light from a transilluminator 
for 4 min.
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Pre-hybridization and probing:
All the procedures for pre-hybridization, hybridization and 
post-hybridization washes were carried out in a Hybaid 
rotary hybridization oven (Hybaid). Pre-hybridization was 
performed for 1 hour at 42°C in pre-hybridization solution 
(6 x SSC, 5 x Denhardt1 s solution, see Appendix; 1% SDS, 
lOjig/ml of denatured salmon sperm DNA) in a volume of 5ml 
of solution per 100cm* of membrane. The appropriate labelled 
probe (either NADL, 137/4 or 87/6 fragment) was denatured 
(i.e. made single stranded) by heating at 95°C for 5 min and 
added to the pre-hybridization solution bathing the blots. 
Hybridization was at 42°C for 16 hours. Subsequently the 
membranes were washed with 2 X SSC at 45°C, 2 X SSC, 0.1%
SDS at 65°C and with 0.2 X SSC, 0.1% SDS at 65°C. Membranes 
were dried for 30 min at room temperature, covered with Sa­
ran Wrap and exposed to X-ray film (Fuji RX 100) for 24 to 
48 hours at -70°C. For re-probing with a different probe, 
membranes were washed at 45°C for 30 min in 100 ml of 0.4M 
NaOH, transferred to 0.1 x SSC, 0.1% SDS, 0.2M Tris-HCl (pH 
7.5) at 45°C for 15 min and dried. Efficiency of probe 
removal was monitored by exposure of the membrane to X-ray 
film for 24 hours. The membranes were then subjected to hy­
bridization with the required probe as above.
Plasmid preparations:
Bacterial colonies containing plasmids which hybridized to 
the 137/4 and 87/6 probes were grown in LB broth (see
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Appendix for formula) containing 100pg/ml ampicillin. Small 
scale plasmid preparations were made from 3 to 5 ml cultures 
following the alkaline lysis method described by Sambrook 
and others (1989). Large scale plasmid extractions were 
carried out as described previously (Sambrook and others,
1989) and modified as follows : E. coli containing plasmids 
were grown overnight at 37°C in 250 ml of LB broth sup­
plemented with 1OOpg/ml ampicillin. The bacteria were then 
pelleted by centrifugation at 5000 x G for 15 min and the 
pellet was resuspended in 6 ml of solution I (50mM glucose, 
25mM Tris-HCl, 1OmM EDTA pH 8.0). Crystals of lysozyme were 
then added and the mixture left at room temperature for 5 
min. Subsequently, 12 ml of freshly prepared solution II 
(0.2M NaOH, 1% SDS) were added and the solution mixed and 
incubated on ice for 15 min. Next, 15 ml of solution III 
(29.4 g potassium acetate, 5 ml 90% formic acid, HgO to 100 
ml) were added and incubated on ice for further 30 min. The 
mixture was then centrifuged at 15000 x G for 20 min. The 
DNA was precipitated from the supernatant (approximately 20 
ml) by the addition of 17 ml of isopropanol followed by 
incubation for 5 min at room temperature and centrifugation 
at 12000 x G for 30 min. The DNA pellet was resuspended in 
1.5 ml of TE buffer (pH 8.0) and was extracted three times 
with TE-saturated phenol-chloroform (1:1). To each 1ml of 
aqueous phase, 1.1 g of Caesium Chloride (CsCl) and BOpl of 
Ethidium bromide (10 mg/ml) were added. The preparations 
were centrifuged at 100000 x G for 16 hours in a Beckman
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TL100 (Beckman) ultracentrifuge and the plasmid containing 
bands collected by puncture of the centrifuge tube and with­
drawal of the DNA using a syringe with an 18-gauge needle. 
Ethidium Bromide was removed from the plasmid DNA by four 
extractions with water-saturated iso-butanol and the CsCl 
was removed by precipitation of the DNA after addition of 
10 volumes of 50% isopropanol (v/v) and centrifugation at 
13000 x G for 30 min. The pellets were then resuspended in 
200jjl1 of TE (pH 8.0), made 0.3M sodium acetate and the DNA 
precipitated overnight at -20 °C with 500jj.1 of absolute 
ethanol. Plasmids were cut with Eco RI and Bam HI in a double 
digest as described above and the products examined in a 
1.4% agarose gel.
DNA Sequencing:
DNA sequencing was performed using the double stranded DNA 
prepared from CsCl purified plasmid preparations as 
described above. Prior to the sequencing reactions, DNA was 
chemically denatured with NaOH and precipitated with ethanol 
in the presence of ammonium acetate as described (Sambrook 
and others, 1989). Sequencing was carried out using the 
dideoxynucleotide chain termination method of Sanger (1977) 
with the Sequenase enzyme, using a commercially available 
kit (Sequenase Version 2.0, USB). About 4pg of plasmid DNA 
were used per set of reactions.
Primers used for the sequencing reactions were primers "Jf"
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and "Kr" used for PCR amplification (Table 8.1). Additional 
primers "H" (5'-TCAGCGAAGTAATCCCGGTG-31) and "I"
(51-CACCATCGAGGCAACATACA-31) were designed from the deduced 
nucleotide sequences obtained with "Jf11 and "Kr" in order to 
extend further the length of the sequenced regions. The 5 1 
and 3 1 end regions of the sequences were confirmed using 
primers corresponding to the regions flanking the multiple 
cloning site of pUCI8, based on the sequence provided by the 
suppliers (Gibco BRL). Sequencing was performed from six 
different clones for each virus, in both "plus" and "minus" 
senses.
Comparison with other pestivirus sequences:
The complete nucleotide sequence of BVDV NADL (Collett and 
others, 1989a) was kindly provided by Dr. M. Collett. The 
sequence of HCV strain Brescia (Moormann and others, 1990) 
was a kind gift from Dr. R. Moormann. Sequences of BVDV 
strain Osloss (Renard and others, 1987) and HCV strain 
Alfort (Meyers and others, 1989) were obtained from the lit­
erature. Comparisons of nucleotide and deduced amino acid 
sequences were made using computer programs Microgenie 
(Beckman) and Staden (Amersham).
8.3. RESULTS
RNA extraction and reverse transcription:
Initial experiments were carried out to determine the best
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Fig. 8.3. Evaluation of different procedures for RNA extraction 
at reverse transcription (as monitored by the incorporation of 
[32p]CTP into newly synthesized DNA). a) Reactions with primer 
"F"; b) reactions with primer "G". Lanes 1 to 3 extraction from 
cells, 4 to 6 extraction from supernatants. Lanes represent 
different RNA extraction methods tested. Lanes 1 and 4 (Hyppia 
and others, 1989), 2 and 5 (Chirgwin and others, 1979); 3 and 6 
(Gama and others, 1989), 7 control uninfected cells (RNA
extracted by the method of Hyypia and others, 1989). The smear 
about half way through the gel is indicative of cDNA synthesis
(Sambrook and others, 1989). Smearing at top is probably
incorporation into DNA of high molecular weight (mostly of cell
origin). Smear at the bottom is unincorporated isotope. Gels have
been purposely overexposed to highlight cDNA synthesis.
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conditions for RNA extraction and reverse transcription of 
pestivirus genomes. RNA was prepared following different 
methods (Chirgwin and others, 1979; Gama and others, 1989; 
Hyypia and others, 1989; Torgensen and others, 1989; 
Sambrook and others, 1989) and reverse transcription per­
formed using (reverse) primers "F" and "G" (see Table 8.1). 
The reaction was monitored by the incorporation of [32P]CTP 
into newly synthesized DNA, as shown in Fig. 8.3. RNA ex­
tracted following the method described by Hyypia and others 
(1989) showed a smear about half way through the gel, 
indicating cDNA synthesis (Sambrook and others, 1989) with 
both primers tested (lane 1 Fig. 8.3a and b) . In all ex­
periments with cell culture supernatants no cDNA was ob­
tained. It was, therefore, essential that the extraction was 
made from whole cells. For most subsequent experiments, the 
method of Hyppia and others (1989) was substituted by the 
similar procedure described in the section Materials and 
Methods (Stallcup and Washington, 1973) because of its 
relative ease of performance and rapidity. Both methods were 
later shown to give rise to PCR-amplifiable products, as 
described in subsequent experiments.
PCR amplification of pestivirus genomes :
Initial attempts to amplify pestivirus genomes were carried 
out with different pestivirus strains using primer combina­
tion G and D, derived from sequences at the 3 1 end of the 
region coding for the putative viral glycoproteins on the
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Fig. 8.4. a) PCR amplification of pestivirus genomes using 
primers G and D. Lane 1 C24V, 2 NADL, 3 137/4, 4 and 5 NADL (from 
reverse transcription reaction diluted 1/10), 6 Control
uninfected cells, 7 molecular weight marker. Arrow indicates 
approximate size of predicted fragment. b) Hybridization of the 
same gel with NADL 634bp (G-D) probe. Autoradiograph was
purposely over-exposed.
270
271
Fig. 8.5. PCR amplification with cDNA from viruses 137/4, 87/6
and control uninfected cells, a) above : lanes 1 to 9, virus
137/4; 10 to 14, control; below: lanes 16 to 19, control; 21 to 
28, virus 87/6. Primer combinations : G-D lanes 1, 11, 21; G-E
lanes 2, 12, 22; F-D lanes 3, 13, 23; F-E lanes 4, 14, 24; F-Df 
lanes 5, 16, 25; Gr-D lanes 6, 17, 26; Dr-Kf lanes 7, 18, 29;
Kr-Jf lanes 8, 19, 28. Arrows indicate approximately 780bp. b)
Hybridization of the same gel with 137/4 probe. c) Hybridization 
of the same gel with 87/6 probe. For clarity, only lanes 9 and 28 
are numbered in "b" and "c".
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NADL/Osloss genomes, which should give rise to a fragment of 
634 base pairs (bp) (including the primers) (Table 8.1). 
Although a fragment of the expected size was amplified 
from strains NADL, C24V (Fig. 8.4) and other BVDV strains 
(Roehe and Woodward, 1991), virus 137/4 presented a weakly 
stained diffuse band of about the expected fragment size, 
as well as other spurious bands of different molecular 
weights. Hybridization using the 634bp NADL probe gave a 
strong signal with the homologous virus and a weak 
hybridization to the strain C24V. However, no hybridization 
at all was observed with any of the PCR products derived 
from virus 137/4 (Fig 8.4b). Other combinations of primers 
were then tested for their ability to amplify specific 
segments of the isolates 137/4 and 87/6. A clearly 
identifiable fragment of the expected size was obtained 
with both viruses using the pair of primers Jf-Kr (Fig. 
8.5a). Both PCR products hybridized one another, whereas no 
hybridization was observed with products from control 
uninfected cells prepared in identical conditions (Fig. 8.5b 
and c) . As the primers Jf-Kr had restriction enzyme 
"tails", these PCR products were selected for cloning in 
subsequent experiments.
Cloning:
Recombinant colonies were obtained at proportions of 
200-1000 colonies per jig of virus-derived DNA. Fourty seven 
colonies potentially containing plasmids with the desired
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Fig. 8.6. Hybridization of colonies containing recombinant
plasmids. Colonies above central line: from experiments with
137/4; below line: 87/6. a) with 137/4 probe; b) with 87/6 probe. 
Probes were derived from PCR-amplified fragments with primers 
Kr-Jf. The difference in intensity of labelling between the two 
probes was considered an artifact.
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Fig. 8.7. Eco RI/BamHI double digests of plasmids containing 
inserts of viral origin. Lanes 2, 4, 5, 6, 9, 11: plasmids with 
137/4 inserts ; 1 , 3, 7, 10, 12, 13, 14: plasmids with 87/6
inserts; 8, 15: molecular weight marker. Arrows indicate the ap­
proximate size of fragments. 2.7kb is the approximate size of the 
cut plasmid.
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fragment derived from 137/4 and 87/6 were transferred to 
replica plates, blotted onto nylon membranes and tested by 
hybridization for homology with 137/4 and subsequently 87/6 
probes. The results of the hybridizations are shown in 
Fig.8.6a and b. Plasmids from transformant colonies which 
hybridized strongly to the respective probes were extracted 
from small scale preparations and cut with Eco R1 /BamHI 
(Fig. 8.7). Double digests from most of the selected 
colonies gave rise to fragments of the predicted size (about 
780bp including the primers). However, some of the digests 
from colonies from 87/6 virus unexpectedly gave rise to 
fragments with about half the expected size (Fig. 8.7). 
Large scale plasmid preparations were made from six 
independent colonies from each of the viruses for subsequent 
sequencing.
Nucleotide sequencing:
Most of the sequencing reactions were performed using 
primers Jf and Kr. This allowed sequencing of fragments of 
about 280 to 300bp in each reaction. The remainder was 
sequenced using primers ("H" and "I") designed from the de­
duced nucleotide sequences obtained with Jf-Kr primers. 
Sequencing was carried out from six independent clones for 
each virus in both "plus" and "minus" senses. For virus 
137/4, all clones obtained were representative of the full 
length of the predicted fragment. The sequences obtained 
from the six different clones were identical. For 87/6, one
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clone corresponded to the full length of the amplified frag­
ment, whereas the others encompassed the first half of the 
length of the expected fragment. All sequences obtained from 
the first half of targeted fragment were identical. The 
nucleotide sequences of the amplified fragments of both 
137/4 and 87/6 viruses is shown in Fig. 8.8. Nucleotides 
were numbered from the start of the single large ORF. The 
sequences at the 5 1 and 3 ' "ends" of both fragments were 
confirmed using pUCI8 primers as described in the "Materials 
and Methods" section.
Nucleotide and amino acid sequence analysis:
The sequenced region of both 137/4 and 87/6 between primers 
Jf-Kr is 745 nucleotides long, with a base composition for 
137/4: A 34.1%, C 19.2%, G 26.4% and T 20.3%, and for 87/6: 
A 32.9%, C 18.3%, G 27.8% and T 21.1%. The sequenced frag­
ment corresponds to a short non-coding region of 55 
nucleotides before the start of the single ORF of 
pestiviruses (ATG at position 386-388 in BVDV NADL, 361 in 
HCV Brescia), plus 690 nucleotides on the putative 
pestivirus capsid protein (p20 or core) gene, representing 
about 86% of the presumed total gene length of 800-810 
nucleotides (Collett and others, 1988b; Moormann and others,
1990). Prior to the start of the large ORF, a stop codon was 
found in both 137/4 and 87/6 sequences at positions 
equivalent to nucleotides 355-352 in NADL. After the begin­
ning of the large ORF, no stop codons (TGA or TAA) were
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Fig. 8.8. Nucleotide sequences of PCR amplified fragments de­
rived from 137/4 and 87/6 virus isolates. Sequences were numbered 
"I" at the start of the pestivirus single large ORF (Collett and 
others, 1988a). The regions corresponding to primers Jf, Kr, H 
and I are underlined.
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137/4 5 1-TACGAATA CAGCCTGATA GGGTGCTGCA
87/6 5'-TACGAATA CAGCCTGATA GGGTGCTGCA
Jf
137/4 GAGGCCCACG CATAGGCTAG TATAAAAATC TCTGCTGTAC 
87/6 GAGGCCCACG TATAGGCTAG TATAAAAATC TCTGCTGTAC
1 40
137/4 ATGGCACATG GAGTTGAATA AGTTTGAACT TTTATACAAA 
87/6 ATGGCACATG GAGTTGAATA AATTTGAACT TCTGTATAAA
80
137/4 ACAAGCAAAC AAAGACCGGT AGGGGTTGTC GAACCAGTCT 
87/6 ACAAGTAAGC AAAGGCCGGT AGGGGTAGTT GAACCAGTTT
120
137/4 ATGACTTGGC AGGTGACCCC CTATACGGTG AAAGAAGCAC 
87/6 ATAACTGGAC GGGTGACCCA CTATACGGCG AAAGAAGCAC
160
137/4 ATTACACCCT CAAGCCACCC TAAGATTACC ACACAAGAGG 
87/6 ACTACACCCT CAGGCCACCC TAAAATTACC ACACAAGAGG 
I
200
137/4 GGGATGGCTG AAGTTGTAAC GGTCCTGAAG GATTTACCCA 
87/6 GGGATGGCTG AAGTTATGAC AACTCTGAGG GATTTACCCA
240
137/4 AAAAAGGAGA TTGTAGAAGT GGGAACCACC GGGGTCCAGT 
87/6 AGAAAGGGGA TTGTAGGAGT GGGAACCATC GAGGCCCAGT
280
137/4 GAGTGGTGTA TACATCAAGC CGGGACCAAT CTATTACCAG 
87/6 AAGCGGTATA TACATCAAGC CAGGGCCAAC TTTTTACCAG
320
137/4 GATTATAAGA AACCTGTGTA CCATAGGGCA CCACTAGAGC 
87/6 GACTACAAGG GAGCCGTGTA TCACAGGGCA CCACTGGAAC
360
137/4 TATTCACTGA GGCACAGCTT TGCGAAGTCA CAAGAAGAAT 
87/6 TATTCACTGA GACACAGTTT TGCGAGGTTA CTAAAAGGAT
400
137/4 AGGGAGAGTG ACTGGTAGTG ACGGCAAGCT ATACCACCTG 
87/6 AGGGAGGGTG ACTGGTAGTG ATGGCAGGCT ATACCATCTG
440
137/4 TATGTTTGCT CCGATGGGTG CATCCTGTTG AAATTAGCAA 
87/6 TATGTTTGTT CTGATGGGTG TATCTTGTTG AAATTAGCAA
H
480
137/4 GTCGGACTGA AAAGAAAGTG TTAAAATGGA TATGCAACAC 
87/6 GCCGGATTGG AATGATAGTG TTGAAATGGA CACACAACAC
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137/4 CCTTGATTGT CCCTTATGGG TCACAAGCTG TTCAGATGAA 
87/6 CCTTGATTGT CCCTTATGGG TTACAAGCTG CTCCGGTGAA
560
137/4 GATAAGAGCA AAAAGAGCGG TGAAAAGAAG CCGGACAGAG 
87/6 GAAGAGAGTA AAAAGAGTGA AGGAAAGAAA CCGGATAGAG
600
137/4 TCAGGAAGGG AGCTATGAAG ATCACACCCA AGGAGAGTGA 
87/6 TCAAGAAGGG AACCATGAAG ATAACACCCA AGGAGAGTGA
640
137/4 AAAGGACAGT AAGTCTAAGC CACCTGACGC TACTATAGTA 
87/6 GAAGGATAGC AAGTCTAAGC CGCCTGATGC TACCATAGTA
680
137/4 GTAGATGGTA TCAAGTACCA GGTAAAGAAG AAAGGTAAGG 
87/6 GTTGAAGGTG TCAAGTACCA GGTGAAGAAG AAAGGTAAGG
710
137/4 TGAAGAGTAA AAACACGCAG GACGGCTTGT AC 
87/6 TGAAGAGTAA GAACACCCAG GACGGCTTGT AC
Kr
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found in-frame in either 137/4 and 87/6 throughout the 
length of the sequenced region. There was a marked identity 
(86.5%) between the nucleic acid composition of viruses 
137/4 and 87/6 within the sequenced regions. Such homology 
was similar to that observed between the two BVDV strains 
(NADL and Osloss 87.5%), and somewhat lower than that 
between the two HCV strains for the core gene (Brescia and 
Alfort 91%, Moormann and others, 1990).
The deduced amino acid sequences of viruses 137/4 and 87/6 
are presented and compared to other pestiviruses in Fig.
8.9. Various motifs in the sequenced region were conserved 
for all viruses analysed. Amino acid additions (in relation 
to HCV strains) were found in the sequences of 137/4, 87/6 
and both BVDV strains. They were situated at about amino 
acid positions 179-182, at the carboxy end of a highly 
variable region of 40-43 amino acid residues, flanked by 
highly conserved motifs (C-P-L-W-T-S-C-S at the amino and 
P-D-R at the carboxy end) . In relation to the two HCV 
strains Brescia and Alfort, 137/4 and 87/6 had one extra 
amino acid (probably K at position 180), whereas the two 
BVDV strains had three (probably R-Q-K or Q-Q-K at positions 
180-182).
The percentage of amino acid homology deduced from the 
nucleotide sequences of 137/4, 87/6 and other previously
published pestivirus sequences is shown in Table 8.2.
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Fig. 8.9. Comparison of the deduced amino acid sequences of of 
pestiviruses. Sequences of viruses 137/4 and 87/6 were compared 
with the equivalent region from other published pestivirus 
sequences. The region compared correspond to the first 230 
carboxy terminal amino acids of the pestivirus single large ORF 
(about 86% of the core gene). Numbers start at the beginning of 
the large ORF. Boxes highlight areas of four or more conserved 
aminoacids between the six viruses analysed, as well as the motif 
P-D-R after the additions/ deletions. Possible deletions are 
represented by gaps.
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1 40
137/4 MELNKFELLYKTSKQRPVGWEPVYDLAGDPLYGERSTLH 
87/6 MELNKFELLYKTSKQRPVGWEPVYNWTGDPLYGERSTLH 
NADL MELITNELLYKTYKQKPVGVEEPVIDQAGDPLFGERGAVH 
OSLOSS MELITNELLYKTYKQKPAGVEEPVYNQAGDPLFGERGWH 
BRESCIA MELNHFELLYKTNKQKPMGVEEPVYDVTGRPLFGDPSEVH 
ALFORT MELNHFELLYKTSKQKPVGVEEPVYDTAGRPLFGNPSEVH
41
137/4 PQATLRLPHQRGMAEWTVLKDLPKK GDCRSGB 
87/6 PQATLKLPHKRGMAEVMTTLRDLPKKGDCRSGB 
NADL PQSTLKLPHKRGERDVPTNLASLPKRGDCRSGN 
OSLOSS PQATLKLPHKRGEREVPTNLASLPKRGDCRSGN 
BRESCIA PQSTLKLPHDRGRGNIKTTLKNLPRRGDCRSGN HLGPVSG 
ALFORT POSTLKLPHDRGRGDIRTTLRDLPRKjGDCRSGNHLGPVSG
80 
HRGPVSG 
HRGOVSG 
SRGPVSG 
SKGPVSG
81
137/4 VYIKPGPIYYQDYKK 
87/6 IYIKPGPTFYQDYKGA 
NADL IYLKPGPLFYQDYKG 
OSLOSS IYLKPGPLFYQDYKG 
BRESCIA IYVKPGPVFYQDYMG 
ALFORT IYIKPGPVYYQDYTG
120
PVYHRAPL
iVYHRAPL
YHRAPL
YHRAPL
YHRAPLE
YHRAPLE
PV
PV
PV
PV
EtFTEAQLCEVT 
FTETQFCEVT 
FEEGSMCETT 
FQEASMCETT 
FFDEAQFCEVT 
FFDEAQFCEVT
EL
EL
EF
RR
KR
KR
RR
KR
KR
IIGR
[IGR
IXGR
[IGR
[IGR
IIGR
121   160
137/4 VTGSDGjKLYHLYVCStDGCljLLKLASRTEKKVLKWICNTLD 
87/6 VTGSDGRLYHLYVCSDGCILLKLASRIGMIVLKWTHNTLD 
NADL VTGSDG KLYHIHVCIDGCIIIKSATRSIQRVFRWVHNRLD 
OSLOSS VTGSDG KLYHIYVCIDGCIIVKSATKYHQKVLKWVHNKLN 
BRESCIA VTGSDGKLYHIYVCIDGCILLKLAKRGEPRTLKWIRNLTD 
ALFORT VTGSDG KLYHIYVCVDGCILLKLAKRGTPRTLKWIPNFTN
137/4
87/6
NADL
OSLOSS
BRESCIA
ALFORT
161 200
CPLWVTSCS
CPLWVTSCS
CPLWVTSCS
PDRVRKGAMKITPKESE 
PDRVKKGTMKITTKESE
DEDKSKKSGEKK 
CPLWVTSCS GEEESKKSEGKK 
CPLWVTSCS DTKEEGAPKKKRQKtPDRtiERGKMKI VP KESE 
CPLWVSSCSDTKAEGATRKKQQKjPDRjLEKGRMKITPKESE 
DDGASASKEKK 
DDGASGSKDKK
PDR1INKGKLKIAPKEHE 
PDF MNKGKLKIAPREHE
201 234
137/4 KDSKS 
87/6 KDSKS
NADL KDSKTK 
OSLOSS KDSKTK 
BRESCIA KDSRTK 
ALFORT KDSKTK
KPPDATIV
KPPDATIV
PPDATIV
PPDATIV
PPDATI
PPDATI
VD
VE
VE
VD
W E
W E
)GIKYKV
’GVKYKV
:RVKYKV
)GVKYQV
1GVKYQV
IGVKYQI
KKKGMV 
KKKGKV 
RjKKGK T 
KGK 
KG 
KG
KKI
KS
KS
KS
IKS
K
K
KNTQD 
KNTQD 
KNTQD 
KNTQD 
K|KK K|VKG KNTQD 
lécK KjVKGjKNTgD
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Table 8.2. Percentage of amino acid homology
between pestiviruses genomes (at the 
first 230 amino terminal aminoacids).
BVDV BVDV HCV HCV
Viruses 137/4 87/6 NADL OSLOSS BRESCIA ALFORT
HCV ALFORT 73.4 73.8 73.4 70.3 90.8
HCV BRESCIA 72.5 73.4 72.0 71 .6 100
BVDV OSLOSS 71 .3 72.6 87.5 100
BVDV NADL 71 .7 73.5 100
87/6 86.5 100
137/4 100
Observations : Additions/deletions were discounted for calcu­
lations .
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Fig. 8.10. Hydrophobicity plots of the polypeptides deduced from 
pestivirus sequences. The region compared correspond to the 
first 290 carboxy terminal amino acids of the pestivirus single 
large ORF (about 86% of the core gene). Sequences of BVDV NADL 
from Collett and others (1989a) and HCV Brescia from Moormann and 
others (1990). a) 137/4, b) 87/6, c) BVDV NADL, d) HCV Brescia.
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The amino acid sequences of 137/4 and 87/6 were compared 
with strains BVDV NADL and HCV Brescia, using the 
hydrophobicity plot algorythm of Kyte and Doolittle (1982) 
as available in the Microgenie program (Beckman) (Fig.
8.10.). The sequences in the four viruses displayed re­
markably similar plots, having a highly hydrophobic overall 
structure. Analysis of the ionic charges of the deduced 
polypeptides of 137/4 and 87/6 showed a very basic protein, 
similar to the p20 in other pestiviruses (Collett and 
others, 1988a; Moormann and others, 1990). Therefore, the 
amino acid substitutions and additions/ deletions observed 
do not appear to alter the overall structure of the pre­
dicted polypeptide in the pestiviruses analysed. These 
findings indicate that, for the sequenced region, 137/4 and 
87/6 viruses are very similar structurally and, probably, 
functionally to other pestiviruses, but are genetically more 
related to each other than to BVDV or HCV. As their degree 
of sequence heterogeneity is equivalent to that found 
between BVDV and HCV strains, it is likely that these vi­
ruses represent distinct members of the group (i.e. BDV).
8.4. DISCUSSION:
A number of RNA extraction procedures were tested in order 
to obtain viral RNA that would allow efficient reverse tran­
scription and subsequent PCR amplification. All the reverse 
transcription reactions used throughout this study were made
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using "reverse" primers. However, later it was observed that 
amplification could be performed with either reverse, for­
ward or a combination of both primers, indicating the 
presence of a "minus" RNA strand (data not shown). 
Alternatively, sites of less sequence homology might exist 
where the primer could still bind; it must be noted that 
reverse transcription was carried out at 37°C and at this 
temperature primers are likely to bind to the viral genome 
at many sites. In order to check the efficiency of cDNA pro­
duction, an analysis of the incorporation of [32P]CTP into 
newly synthesized DNA was employed. Once the PCR amplifica­
tion was successfully achieved with reliability, the PCR 
could then be used to monitor the efficiency of the reverse 
transcription. This made it possible to modify the RNA ex­
traction procedure as required, avoiding the risks associ­
ated with handling of radioisotopes. Based on the results 
of the PCR reactions carried out later, the method of Hyppia 
and others (1989), which involved essentially a proteinase 
K/phenol extraction, was substituted by the simpler and 
quicker method based on phenol extraction at acid pH of 
Stallcup and Washington (1973), which was used throughout 
this study.
Primers:
One of the most important factors determining the outcome of 
reverse transcription/PCR amplification reactions was the 
correct choice of primers. Inadequate primer choice may lead
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to amplification of undesired genomic regions, hairpin loop 
formation within the primer or preferential annealing with 
other primers rather than with the desired DNA (Barnes, 
1987). As no BDV sequences were available, primers were 
selected by comparing the genomes of the BVDV strains NADL 
and Osloss. It was assumed that these regions of nucleic 
acid identity in BVDV strains might represent more conserved 
regions of the genome, therefore more likely to be found in 
BDV. However, many regions of high homology (i.e. greater 
than 90%), demonstrated a likely secondary structure (i.e. 
with tendency to formation of "hairpin loops") which might 
inhibit PCR amplification (Barnes, 1987). The addition of 
restriction enzyme sites to some of the primers was another 
factor which had to be taken into account. Consequently, 
few primers were designed which met the criteria for poten­
tial successful amplification (see Table 8.1). Despite the 
precautions taken in the selection of primers, the effi­
ciency of any primer combination at PCR amplification for 
the targeted viruses had to be determined for each virus 
targeted. In addition, in order to ensure binding of the 
primers, the reverse transcription/PCR amplification
reactions were made under conditions of low stringency (i.e. 
reverse transcription at 37°C and PCR annealing temperature 
at 45°C).
It was fortuitous that at least one of the primer combina­
tions was able to bind to the genomes of the viruses of in­
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terest, which allowed the continuation of this project. How­
ever, it was unfortunate in as much as it was not possible 
to sequence the entire putative pestivirus core protein 
gene, since the likely cleavage site for that protein lies 
about lOObp further towards the 3 1 end (Moormann and others, 
1990). However, this shortfall in sequencing was determined 
by the factors commented above which governed the selection 
of primers. With the correct sequence obtained here, it 
should be possible to design a more adequate primer 
combination that will allow future extension of this work 
aiming at the remainder of the 3 ' end of the gene, or even 
further on the BDV genome.
Preliminary experiments were set up in order to determine 
the optimal conditions for utilisation of the cDNA obtained 
at reverse transcription and the best primer combination 
for the PCR amplification of pestivirus genes. Initially, 
the region closer to the 3 1 end of the glycoprotein-coding 
region of pestivirus genome was targeted. This region codes 
for the part of gp53, the major envelope glycoprotein 
(Collett and others, 1989; see Chapter 1). However, despite 
successful amplification of BVDV NADL and other pestivirus 
strains (Roehe and Woodward, 1991), the level of amplifica­
tion obtained with viruses 137/4 and 87/6 was not sufficient 
for further manipulation. No hybridization was obtained 
with virus 137/4 and the respective NADL probe, suggesting 
that the degree of homology between primers was very low for
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NADL and 137/4. Lack of homology on the glycoprotein gene 
region was not unexpected, since that region was shown to 
have the lowest degree of conservation in all pestiviruses 
genomes sequenced so far (Moormann and others, 1990). The 
region codes for the more exposed components of the virion 
envelope and therefore more likely to be under selective 
pressure (e.g. from antibodies or cellular receptors). The 
variable levels of cross-reactivity between different 
pestiviruses in neutralization tests (see Chapters 4 and 5), 
where the glycoproteins play a major role (Magar and others,
1988a,b; Moennig, 1990) provide further evidence to support 
this hypothesis.
In view of the unsuccessful attempts to amplify genes of the 
glycoprotein gene region, other primer combinations were 
also tested for PCR amplification with isolates 87/6 and 
137/4. The pair which gave rise to a clearly defined band of 
the expected size was the combination Kr-Jf which was pre­
dicted to represent a more conserved region on pestiviruses, 
comprising most of the p20 gene (Mormann and others, 1990). 
This region was then targeted for subsequent cloning and 
sequencing.
Unexpectedly, among the selected recombinant colonies ex­
pected to contain plasmids with inserts from 87/6 virus, 
some possessed inserts of about half of the expected frag­
ment length. These would later be shown to represent copies
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of half the size of the total length of the sequenced 
fragment (Fig. 8.7). This artifact was apparently generated 
after the reverse transcription/PCR amplification, since no 
"half-size" fragments had been detected until then. One pos­
sibility was that there might be a restriction site for 
EcoRl or BamHI inside the amplified fragments. However, 
analysis of the whole sequenced fragments carried out later 
showed that such sites did not exist. Therefore, the reason 
why such clones containing half-size fragments were obtained 
could not be determined. Presumably, they arose by 
illegitimate recombination, probably during transformation.
All of the six clones of virus 137/4 which were sequenced 
were representative of the full length of the fragment en­
compassed by primers Jf-Kr. However, from the selected 
clones of virus 87/6, only one was found to represent the 
full length of the expected fragment. This was unfortunate 
in that the sequence corresponding to the second half of the 
genome of virus 87/6 (i.e. 3 'end) was represented in only
one clone. The reason for sequencing different clones from 
the same genomic region lies in the high frequency of 
misincorporation (about 1 misincorporation for every 400 
nucleotides) expected from the enzyme Taq polymerase 
(Sambrook and others, 1989). In the experiments described 
here all other clones obtained were identical to each other 
(although different between the two viruses) and with 
perfect matches in both "plus" and "minus" senses, sug­
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gesting that no important misincorportation was taken place 
during PCR amplification. However, it is also possible that 
mistakes introduced at the early stages of the PCR were 
selectively amplified and gave rise to the homogeneous 
clones obtained for the two viruses. This hypothesis seems 
unlikely since the rate of misincorporation of the enzyme 
would have to be high at the beginning of the reaction and 
low at later stages, a phenomenon which has not been 
reported so far. Therefore, it was assumed that the se­
quences obtained were representative of the viruses 
targeted.
Based on this uniformity of sequence from different clones, 
it was also assumed that the single "whole length" clone 
containing the second half of the genome of 87/6 fragment 
was a true representative of the actual sequence for that 
region. The similarities between the nucleotide sequence of 
87/6 and 137/4 (as well as other pestiviruses) and the prop­
erties of the corresponding deduced polypeptide provide 
strong support for that.
The nucleotide sequence obtained from both viruses showed a 
very high degree of homology (86%). This is equivalent to 
that observed between the sequences of BVDV strains NADL and 
Osloss, and slightly lower than that between HCV strains 
Brescia and Alfort for the p20 region (Moormann and others, 
1990). Comparison with available pestivirus sequences
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showed that the equivalent region on 137/4 and 87/6 share 
with BVDV and HCV a higher degree of amino acid homology 
than nucleotide homology. This is in agreement with 
observations of Meyers and others (1989) who reported for 
HCV (Alfort) and BVDV (NADL) an overall homology at the 
level of nucleotides of about 66% and at the level of 
amino acids about 85%. Such finding can be explained by the 
occurrence of "silent" mutations, i.e., due to the 
degeneracy of the genetic code, alterations in nucleotide 
sequences may take place without changing the resulting 
amino acid. As a consequence, the polypeptide remains 
unaltered (Watson and others, 1987).
In analogy to the nucleotide sequences, the deduced amino 
acid composition of 137/4 and 87/6 showed a percentage of 
identical amino acids of 86.5%, equivalent to that between 
BVDV strains but lower than between HCV strains (Moormann 
and others, 1990) . This suggests that the HCV strains 
analysed share a greater degree of homology than BVDV or 
BDV. Moreover, HCV strains had no amino acid additions, BDV 
strains (as represented by 137/4 and 87/6) had one extra 
amino acid whereas BVDV strains had three. It is tempting 
to speculate that there may be some evolutionary basis for 
the degree of homology between strains, as well as for the 
presence of the additions/deletions found. The high degree 
of homology and the absence of additions in HCV strains 
might reflect a higher degree of genetic stability. In this
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context, it is interesting to note that the first pestivirus 
identified was HCV (Moennig, 1990). The pestiviruses 
"of ruminants" may be more recent in evolutionary terms, 
therefore with less homogeneity between strains. However, 
the confirmation of such hypothesis awaits further studies. 
As regards the functionality, the hydrophobicity (Fig. 
8.10) and charge of the deduced peptides are remarkably 
similar for all pestiviruses (Moormann and others, 1990), 
indicating functional similarity of the proteins. Although 
only 230 amino acids deduced from the genome of 137/4 and 
87/6 were analysed, their organization (e.g. the start of 
the large ORF and apparent isofunctionality suggest a 
genomic organization similar to all other pestiviruses 
sequenced so far (Collett and others, 1989b; Meyers and 
others, 1989; Moormann and others, 1990). The highly basic 
charge of the deduced protein support the idea that these 
sequences correspond to the viral core proteins (Renard and 
others, 1987; Collett and others, 1989b; Meyers and others, 
1989; Moormann and others, 1990).
The antigenic and structural relationship between HCV, BVDV 
(Derbyshire, 1960; Liess and others, 1977) and later BDV 
(Acland and others, 1972; Hamilton and Timoney, 1972; Osburn 
and others, 1973) are well known. Such relatedness can now 
be analysed in detail by comparing the nucleotide sequences 
of distinct pestivirus isolates. The combined approach 
reverse transcription/PCR amplification followed by cloning
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and sequencing of defined regions of pestivirus genomes 
provided indisputable evidence for the similarities between 
the BDV 137/4 and the swine isolate 87/6 at the nucleotide 
level. Therefore, as indicated by the previous experiments 
in this thesis and confirmed here, the BDV-like nature of 
the 87/6 virus, despite its swine origin, was confirmed.
The evidence presented here indicates a genetic basis for 
the differentiation between BDV and BVDV strains, which has 
so far been unclear (Baton and others, 1991). However, in 
order to achieve such differentiation with more accuracy,'it 
must be a major objective to obtain the complete BDV 
nucleotide sequence of standard BDV strains (Vantsis and 
others, 1976; Nettleton, 1985). From the fragments sequenced 
here, it should now be possible to produce primers that 
would be expected to bind to other BDV strains, and allow 
the extension of the sequenced regions. This remains as an 
immediate task for the future.
8.5. CONCLUSIONS:
From the results of these experiments, it can be concluded 
that the combined approach reverse transcription/PCR 
amplification allowed the successful production of large 
amounts of genetic material of viral origin. This is 
particularly important in the case of pestiviruses, where 
virus yelds are usually low. Cloning of the amplified
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fragments ensured a virtually unlimited and perennial source 
of the targeted region. Sequencing of DNA representative of 
sub-genomic fragments followed by subsequent comparison with 
other pestiviruses provided a precise measure of the 
relatedness between 137/4 and 87/6, as well as of their more 
distant relationship with HCV and BVDV. On the basis of the 
limited sequence data obtained in this chapter, viruses 
137/4 and 87/6 are genetically more related to each other 
than to the HCV or BVDV strains used in the comparative 
studies. As 137/4 is a virus with characteristics common to 
most BDV strains, it is concluded that the isolate 87/6 is 
a BDV-like virus, despite its swine origin.
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CHAPTER 9. FINAL COMMENTS AND CONCLUSION
9,1. FINAL COMMENTS
In the series of studies that comprise this thesis, differ­
ent aspects of the biology of pestiviruses were examined. 
In the first set of experiments, the ability of a number of 
pestivirus strains to cause productive infection in cells of 
different host origin (cattle, swine and sheep) was analysed 
(Chapter 3). It was observed that although some strains were 
apparently restricted to multiplication in cells of ho­
mologous host origin, many of them readily multiplied in 
cells of heterologous hosts, including a number of strains 
which were able to multiply in cells derived from any of the 
three different hosts (see Chapter 3). Amongst other possi­
bilities discussed in Chapter 3, it was speculated that the 
ability to multiply in vitro in a wide range of cells from 
different hosts may correlate with the ability to cross the 
species barrier in nature.
Of among those viruses with a capacity to multiply in cells 
of cattle, sheep and swine origin, the isolates 87/6 (iso­
lated from swine) and 137/4 (isolated from sheep) were se­
lected for further study (Chapter 4).
Due to the lack of a method to distinguish between HCV and 
other pestiviruses which may infect pigs, the English
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pestivirus isolate 87/6 was determined to be HCV, according 
to strain designation required using official procedures 
(Anonymous, 1980; ADAS, 1988). This had important economic 
implications, including the cost of slaughter and the threat 
to the HCV-free status of the country.
Panels of Mabs directed against pestivirus antigens 
(Edwards and others, 1988) allowed partial grouping of 
pestiviruses according to their patterns of reactivity. The 
pattern of reaction displayed by most HCV strains was dis­
tinct from that of the majority of the viruses of ruminant 
origin (BVDV or BDV). However, no clear distinction could be 
made amongst the viruses of ruminants, although most viruses 
of sheep origin were not recognized by BVDV-specific Mabs 
(Edwards and others, 1988). The swine isolate 87/6, when 
tested against this panel, displayed a reaction profile 
similar to most BDV strains, unlike that of most HCV 
strains (Edwards and others, 1988; Edwards and Sands, 1990). 
The present studies were therefore initiated to investigate 
further the proposed reclassification of the swine isolate 
87/6 as BDV-like rather than HCV-like.
Preliminary attempts to reproduce clinically recogniseable 
HC in weaner pigs with the isolate 87/6 were unsuccessful, 
despite seroconversion with the development of neutralizing 
antibodies (S. Edwards, personal communication). These 
observations further substantiated the hypothesis supporting
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the non-HCV-like nature of 87/6.
The possibility of natural infections in pigs with BDV had 
not been previously investigated (Van Oirschot, 1983), 
mainly because of the lack of clear distinction between BDV 
and BVDV in natural infections (see Chapter 1). Moreover, 
there was only one report on experimental infections of 
swine with BDV (Wrathall and others, 1978). In addition to 
ascertaining the nature of the isolate 87/6, it was also 
intended to clarify whether or not BDV or BDV-like viruses 
could cross-infect swine, and if so what pathogenic conse­
quences these infections would have on that species.
As intrauterine infections play a major role in the trans­
mission of pestiviruses, pregnant sows and ewes were in­
fected with the isolate 87/6, in order to determine whether 
it could cause transplacental infections in both species 
and what effect this would have on the offspring. The BDV 
isolate 137/4 was inoculated into similar groups of animals 
as a "positive control". Transplacental infection occurred 
successfully in swine and sheep with both viruses (Chapter 4 
and 5). The outcome of infection with 87/6 and 137/4 in 
piglets and lambs showed many similarities and no clear 
distinction could be established between the two viruses 
based on clinico-pathological evidence.
As regards the serological and virological findings, piglets
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and lambs born to animals infected with either virus pre­
sented a wide spectrum of combinations of virus and antibody 
status. In swine, this variation was shown by the birth of 
piglets positive for virus isolation in the same litter as 
piglets where no virus could be isolated but which had 
pestivirus-specific neutralizing antibodies. Other
littermates were negative for both virus and antibodies 
(Chapter 4). This phenomenon was interpreted as indicative 
of fetal infection in utero at different periods after 
infection of the mothers. Apparently, transmission of the 
infection occurred within the uterus, possibly from fetus to 
fetus, as discussed previously (see Chapter 7). In view of 
the observations on piglets, it was suggested here that the 
same phenomenon might also occur in lambs, since very often 
twins or triplet lambs are born with distinct virological, 
serological and pathological outcomes of infection (Barlow 
and others, 1983), similar to those observed in lambs as 
described in Chapter 5.
Next, a study was set up to examine the effect of multiple 
freezing/thawing (F/T) cycles on serum samples, an effect 
suggested by the results of the many SNTs performed on 
samples from the animal experiments with both 87/6 and 137/4 
viruses (Chapter 6). Successive F/T was observed to lead to 
an increase in neutralizing antibody and ELISA-detectable 
antibody titres in some animals, including some where no 
antibodies had been detected prior to F/T cycling. The
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most likely explanation for such finding was that antibodies 
bound to immune complexes were liberated after successive 
cycles of F/T. Although it was not possible to confirm the 
actual presence of ICs in this series of experiments, this 
remains as an exciting task for the future, providing a 
basis for research on the role of the ICs in the pathogen­
esis of pestivirus-induced diseases.
So far, it had been demonstrated that the isolates 87/6 and 
137/4 had a similarly wide capacity to multiply in cells of 
different host origin in vitro and that both viruses could 
cause intrauterine infections in swine and sheep, with no 
clearly distinguishable differences in the outcome of infec­
tion. In addition, both viruses were apparently able to in­
duce a similar and highly varied range of virus and antibody 
combinations in the infected offspring, including the pos­
sible induction of F/T-sensitive ICs. Final comparisons were 
made at the level of nucleic acid composition.
Recent developments in the field of molecular biology have 
provided tools which could bring a definitive answer to the 
question of the degree of relatedness between isolate 87/6 
and other pestiviruses. Central to this was the need to ob­
tain sufficient amounts of viral genetic material, compli­
cated by the notoriously poor yield of pestiviruses after 
growth in vitro (see Chapter 3). This problem was circum­
vented by the adaptation of the PCR (Saiki and others, 1985)
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to the amplification of pestivirus genomes, allowing the 
production of "DNA copies" of portions of the viral RNA 
sufficient for subsequent cloning and sequencing (Chapter 
8). A subgenomic fraction corresponding to about 90% of the 
putative pestivirus core gene was sequenced and compared 
with previously published pestivirus sequences. The results 
of the comparison showed that both isolates 87/6 and 137/4 
were genetically more related to each other than to BVDV or 
HCV. Analysis of the amino acid sequences deduced from the 
nucleotide composition corroborated these observations. In 
addition, the degree of divergence observed between the two 
isolates and BVDV or HCV was similar to that between BVDV 
and HCV, strogly supporting the contention that 137/4 and 
87/6 are representatives of distinct members of the group. 
However, BDV nucleotide sequences are not available for 
comparison. As 137/4 is a sheep isolate with character­
istics common to most BDV strains, it may be assumed that 
the sequence of 137/4 is a representative of BDV. By 
comparative analysis, at least in the sub-genomic fragment 
sequenced, the isolate 87/6 is genetically more related to 
BDV than to HCV or BVDV. These studies provided 
substantial evidence of the antigenic relatedness of the 
isolates 87/6 and the BDV isolate 137/4 as well as the 
divergence between 87/6 and HCV strains, which constitutes 
the main purpose of this thesis.
Having extended the comparisons up to the level of the
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nucleotide sequences (although only about 5% of the whole 
pestivirus genome), a retrospective evaluation of the meth­
ods employed for pestivirus differentiation can be made. At 
the same time, those which present potential applicability 
in the future as diagnostic aids for pestivirus differen­
tiation can be discussed. The ability of different 
pestiviruses to multiply in cells of different host origin 
(Chapter 3) might give an indication of the degree of adapt­
ability of some strains to heterologous hosts, but its level 
of discrimination between strains was not sufficient to dis­
tinguish BDV from BVDV or HCV. The animal inoculation ex­
periments (Chapters 4 and 5) provided strong evidence to 
demonstrate the similarities between the clinico-pathologi­
cal, serological and virological findings after infection 
with the two isolates. However, this type of experiment is 
of little relevance to routine diagnosis, since it is expen­
sive, time consuming and labour intensive. The PCR 
amplification of subgenomic fragments of pestiviruses will 
undoubtedly find a place among future tests for dif­
ferentiation and/or taxonomic grouping of pestiviruses (see 
Chapter 8). The conditions for PCR amplification can be 
made either more or less specific, depending on the primer 
selection. For instance, primers which might be able to 
bind to regions common to HCV genomic sequences but with no 
homology to BVDV or BDV might become useful in a 
type-specific differential diagnostic test for HCV. Alterna­
tively, selection of primers in areas of genomic homology in
all pestiviruses might be of use as a group-specific diag­
nostic test (Roehe and Woodward, 1991). The amplified frag­
ments might then be examined more specifically for 
type-specific hybridization with appropriate probes (e.g. 
PCR amplified fragments of the desired virus) or by further 
nucleotide sequencing, such as described in Chapter 8. 
Sequencing of cDNA fragments representative of the viral RNA 
and subsequent comparison with other viruses provided the 
most precise measure of relatedness between 137/4 and 87/6 
of all the experiments performed in this thesis, as well as 
demonstrating the more distant relationship between them and 
HCV or BVDV. Knowledge of the viral nucleotide sequence must 
be regarded as essential since it provides a concrete 
reference for future taxonomic, diagnostic and research 
work.
Much has yet to be done to establish an agreed basis for 
pestivirus differentiation. In the particular case described 
here, where a virus isolated from swine showed charac­
teristics of strains usually found in sheep, there remains 
the question of the origin of such a virus in pigs. Although 
it may seem likely that pigs were infected by contact with 
infected sheep, no sheep were kept in the farm where the 
original virus isolation was made. Epidemiological tracing 
of the pigs in the farm could not establish any previous 
opportunities for such contact (S. Edwards, personal 
communication). However, the virus might have been circu­
308
lating in the farm long before it was identified. Another 
possibility would be generation of the BDV-like isolate by 
mutation from an HCV-like pestivirus. However, no HCV had 
been detected previously in the farm or surroundings, and 
the whole country remains HCV-free. In addition, if such a 
mutation had occurred, it seems unlikely that the selective 
pressure would favour the development of viruses similar to 
sheep isolates in a farm where no sheep were found. 
Mutations could also have arisen from pestiviruses of 
cattle or wild animals, but again remains the question of 
what sort of selective pressure would favour BDV-like 
selection in the absence of sheep. However, another 
possibility is that it arose from accidental contamination 
of pharmaceutical products, such as in previous incidents 
with contaminated vaccines (Wensvoort and Terpstra, 1988). 
Despite that, in the author's opinion it is still more 
likely that the virus 87/6 originated from a case of 
cross-infection of swine with a virus originated from sheep, 
although this could not be substantiated by the available 
epidemiological evidence. The possibility of occurrence of 
such cross-infections have been extensively reviewed in 
Chapter 1 . Cross-infections may represent an evolutionary 
advance for pestiviruses, a mechanism in which the genetic 
diversity of the group and its host range can be amplified, 
increasing their chances of perpetuation in nature.
All these interesting epidemiological questions remain un­
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answered. Future understanding of the epidemiology of 
pestiviruses will benefit from the advances in molecular 
genetics, which should allow the development of more refined 
and accurate diagnostic and research tools. A few of the 
potentialities of recent developments in this field to the 
study of pestiviruses have been shown in this thesis. It is 
hoped that the studies described here will provide support 
for continuing research in the area.
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9.2. CONCLUSIONS:
The principal conclusions of theses studies are :
1 . Strains of pestiviruses differ in their ability to in­
fect cells of cattle, sheep and swine origin in vitro. 
Whereas some viruses did not multiply in cells of 
heterologous host origin, others readily adapted for multi­
plication in cells from different hosts. There may be a 
relationship between the ability of some pestiviruses to 
infect cells of different host origin and their capacity to 
cross the species barrier.
2. The swine isolate 87/6 and the sheep isolate 137/4 can 
experimentally infect sows and ewes without the production 
of clinically apparent disease. The viruses can cross the 
placenta and infect piglets and lambs in utero . After 
infection of the mother, fetuses may be infected at 
different conceptual ages.
3. The serological, virological and clinico-pathological 
evidence of infection in piglets and lambs did not allow a 
clear distinction between the effects of the two isolates.
4. Virological and serological evidence for the presence of 
circulating immune complexes was found in some piglets and 
lambs born to mothers infected with either virus.
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5. The polymerase chain reaction can be used to amplify cDNA 
generated after reverse transcription from sub-genomic 
fragments of pestivirus RNA. The products can then be used 
for cloning, sequencing and comparison with equivalent
regions on other pestivirus genome sequences.
6. Comparison of the nucleotide sequences of sub-genomic 
fractions of isolates 87/6 and 137/4 corresponding to 85% 
of the pestivirus core gene and equivalent regions on 
BVDV and HCV strains indicated that the two isolates are
more closely related to each other than to HCV or BVDV.
Sequencing provided the most accurate measure of the
relationship between 137/4, 87/6 and other pestiviruses.
7. The evidence presented throughout this thesis indicates 
that the 87/6 isolate is very similar to the BDV isolate 
137/4 in all aspects examined and was distinct from 
reference strains of both HCV and BVDV. The BDV-like nature 
of the swine isolate 87/6 has been demonstrated at different 
levels of experimentation, thus confirming the hypothesis 
raised at the beginning of these studies.
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APPENDIX
Additional formulas of solutions and reagents:
TAE buffer (x 50):
Tris base
Glacial acetic acid 
0.5M EDTA
h 2o
TBE buffer (for sequencing) (x 5): 
Tris base 
Boric acid 
0.5M EDTA
h 2o
242g 
57.1ml 
100ml 
to 1 litre
54g 
27. 5g 
20ml 
to 1 litre
Denhardt's solution (x 50; for hibrydization procedures) 
Ficoll Type 400 (Pharmacia) 5g
Polyvinylpirrolidone (Sigma) 5G
Bovine serum albumin (fraction V; Sigma) 5g
Peroxidase linked assay (PLA) reagents :
Fixation fluid:
20% acetone in physiological saline 
Bovine serum albumin 200 mg/litre 
pH adjusted to 7.2 with Na2HPC>4
Wash fluid 
NaCl 
Tween 80 
Water
8.85g 
5ml 
to 1 litre
Dilution fluid 
NaCl 
Tween 80 
Water
pH adjusted to 7.6
Acetate buffer
Sodium acetate 
Glacial acetic acid 
Water
pH adjusted to 5.0
29. 5g 
1 0ml 
to 1 litre
0.58g 
0. 2ml 
200ml
Substrate stock
3-amino-9-ehtylcarbazole (Sigma) 160mg 
Dimethyl-formamide (Sigma D4254) 24ml 
(store in dark at room temperature)
Substrate working solution 
Substrate stock 
Acetate buffer 
Hydrogen peroxide 30% 
(prepared just before use)
0. 3ml 
5. 0ml 
5]jl1
TMB solution for ELISA tests:
Solution A:
Tetramethyl benzidine (Aldrich) 0.1 g 
Ethanol 100ml
Solution B (Phosphate/citrate buffer pH 5):
Citric acid 20.4g
Na2PC>4 29.2g
Water to 2 litres
Add 250]il (0.075%) of hydrogen peroxide per litre
TMB working solution:
Add 1 part "A" to 9 parts of "B".
TMB stop solution:
2M H2SO4
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Results of serum-virus neutralization tests:
Sow 303 (inoculum 137/4)
Antibodies to:
137/4 Baker A C24V_____ 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 20 <10 <10 <10 <10 <10
28 60 <10 <10 <10 <10 <10
42 480 <10 <10 30 30 <10
56 960 <10 <10 30 80 <10
112 640 <10 <10 40 60 <10
Piglets
FI <10 <10 <10 <10 <10 <10
F2 120 <10 <10 40 40 <10
F3 2560 <10 <10 <10 40 <10
F4 <10 <10 <10 <10 <10 <10
F5 60 <10 <10 <10 20 <10
F6 240 <10 <10 <10 20 <10
Sow 304 (inoculum 137/4)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 60 <10 <10 <10 15 <10
28 120 10 <10 15 40 16
42 1920 60 20 60 120 <10
56 1920 15 30 160 80 <10
112 2560 20 40 120 320 <10
Piglets
FI 640 <10 <10 30 20 <10
F2 5120 15 20 320 480 <10
F3 5120 <10 <10 15 240 <10
F4 1280 <10 <10 30 60 <10
F5 <10 <10 <10 <10 <10 <10
F6 5120 <10 <10 120 80 <10
F7 <10 <10 <10 <10 <10 <10
FB 1920 <10 <10 60 60 <10
F9 960 <10 <10 <10 15 <10
FI 0 160 . *10 <10 <10 15 <10
F11 5120 15 <10 320 2560 <10
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Sow 111 (inoculum 137/4)
Antibodies to:
__________ 137/4 Baker A C24V 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 20 <10 <10 <10 <10 <10
28 40 <10 <10 <10 <10 12
42 240 15 <10 30 10 <10
56 480 15 <10 40 20 <10
112 160 10 10 120 80 16
FI
Piglets
<10 <10 <10 <10 <10 <10
F2 <10 <10 <10 <10 <10 <10
F3 <10 <10 <10 <10 <10 32
F4 <10 <10 <10 <10 <10 <10
F5 40 <10 <10 <10 <10 48
F6 <10 <10 <10 <10 <10 <10
F7 <10 <10 <10 <10 <10 <10
FB <10 <10 <10 <10 <10 <10
F9 <10 <10 <10 <10 <10 <10
FI 0 480 <10 <10 140 10 <10
F11 5120 <10 20 640 1280 <10
DAYS
0
Sow 302 
<10
(inoculum 137/4) 
<10 <10
i
<10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 <10 <10 <10 <10 <10 <10
28 20 <10 <10 <10 <10 <10
42 240 <10 <10 <10 <10 <10
56 480 <10 <10 <10 60 <10
112 640 <10 10 40 20 <10
Piglets
FI 20480 <10 10 960 240 <10
F2 100 <10 <10 60 <10 <10
F3 5740 80 <10 1280 480 24
F4 12200 <10 30 480 80 12
F5 120 <10 10 30 30 <10
F6 5120 <10 <10 640 40 <10
F7 <10 <10 60 <10 <10 <10
FB <10 <10 <10 <10 <10 <10
F9 960 <10 <10 120 15 96
FI 0 3000 <10 <10 1280 480 <10
F11 17200 <10 <10 2560 240 <10
FI 2 ND ND ND ND ND ND
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Sow 163 (inoculum 87/6)
Antibodies to:
________ 137/4 Baker A C24V 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 10 15 <10 15 <10 <10
21 15 20 <10 60 <10 <10
28 20 20 <10 240 15 <10
42 80 120 <10 640 30 <10
56 240 80 <10 960 40 <10
78 160 160 <10 320 40 <10
Piglets
FI 40 <10 <10 1280 20 <10
F2 <10 <10 <10 160 <10 <10
F3 <10 <10 <10 1280 <10 <10
F4 40 <10 <10 5120 40 <10
F5 <10 <10 <10 5120 <10 <10
F6 10 <10 <10 640 15 <10
F7 <10 <10 <10 <10 <10 <10
FB <10 <10 <10 <10 <10 <10
F9 <10 
164 (inoculum
<10
87/6)
320 320 <10 <10
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 10 <10 <10
14 <10 <10 <10 160 <10 <10
21 <10 <10 <10 15 <10
28 10 <10 <10 960 30 <10
42 20 <10 <10 960 80 <10
56 40 <10 10 640 60 <10
74 60 <10 10 640 60 <10
FI
Piglets
<10 <10 <10 <10 <10 <10
F2 <10 510 <10 <10 <10 <10
F3 <10 <10 <10 <10 <10 <10
F4 <10 <10 <10 <10 <10 <10
F5 <10 <10 <10 <10 <10 <10
F6 <10 <10 <10 <10 <10 <10
F7 <10 <10 <10 <10 <10 <10
F8 <10 <10 <10 <10 <10 <10
F9 <10 <10 <10 <10 <10 <10
F10 <10 <10 <10 <10 <10 <10
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Sow 305 (inoculum 87/6)
Antibodies to:
137/4 Baker A C24V 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 <10 20 <10 80 30 <10
28 <10 10 10 320 40 <10
42 10 10 10 640 80 <10
56 40 15 15 960 480 <10
75 80 30 10 1280 240 <10
Piglets
FI <10 <10 <10 <10 <10 <10
F2 40 <10 <10 15360 <10 <10
F3 <10 <10 <10 320 30 <10
F4 <10 <10 <10 <10 <10 <10
F5 <10 <10 <10 <10 <10 <10
F6 10 <10 <10 7680 30 <10
F7 15 30 <10 960 40 <10
FB 60 <10 10 5120 80 <10
F9 <10 <10 <10 640 15 <10
FI 0 60 <10 <10 20480 60 <10
F11 20 <10 <10 960 15 <10
FI 2
Sow 307
<10 <10 
(inoculum 87/6 )
<10 640 80 <10
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 10 <10 <10
21 <10 30 <10 80 <10 24
28 <10 80 <10 960 <10 <10
42 15 30 15 960 80 <10
56 60 60 20 1280 60 16
66 40 20 15 240 40 12
Piglets
FI <10 <10 <10 <10 <10 <10
F2 <10 <10 <10 <10 <10 <10
F3 <10 <10 <10 <10 <10 <10
F4 <10 <10 <10 <10 <10 <10
F5 <10 <10 <10 <10 <10 <10
F6 <10 <10 <10 <10 <10 <10
F7 <10 <10 <10 <10 <10 <10
FB <10 <10 <10 <10 <10 <10
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Ewe 1482 (inoculum 137/4)
Antibodies to:
137/4 Baker A C24V 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 320 30 <10 <10 15 12
21 960 15 15 30 20 <10
28 2560 10 15 120 80 <10
42 1920 40 20 240 120 24
56 2560 20 80 480 240 32
112 10240 80 160 960 960 128
Lambs
FI <10 <10 <10 <10 <10 <10
F2 510 <10 <10 <10 <10 <10
709 (inoculum 137/4)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 <10 <10 <10 <10 <10 <10
21 240 <10 15 15 10 <10
28 960 <10 60 30 40 <10
42 1920 15 120 120 20 32
56 3840 40 320 120 120 32
142 3840 160 480 80 320 64
FI <10
Lambs
<10 <10 <10 <10 <10
F2 ND ND ND ND ND ND
Ewe 330 (inoculum 137/4)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 <10 <10 <10
14 120 15 <10 <10 <10 <10
21 320 30 <10 <10 <10 <10
28 960 30 160 20 <10 12
42 5120 30 640 160 320 <10
56 3840 60 640 480 640 <10
82 3840 60 640 160 240 <10
Lambs
FI ND ND ND ND ND ND
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Ewe 329 (inoculum 137/4)
137/4 Baker
Antibodies 
A C24V
to:
87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 20 <10 <10 <10 <10 <10
14 160 10 15 <10 15 <10
21 480 15 80 15 40 <10
28 960 30 120 80 60 48
42 2560 40 120 120 160 96
56 2560 120 160 160 120 96
142 2560 240 240 240 80 128
Ewe 361 (inoculum 87/6)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 30 <10 <10
14 15 10 15 640 15 <10
21 20 40 20 1920 30 <10
28 80 30 80 1280 60 24
42 240 240 240 1920 240 48
56 320 240 320 960 120 24
103 640 120 640 2560 160 16
Lambs
FI <10 <10 <10 <10 <10 <10
Ewe 357 (inoculum 87/6)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 120 <10 <10
14 <10 <10 480 15 <10
21 20 60 960 40 12
28 80 1280 80 5120 60 32
42 320 1280 240 3840 240 64
56 240 320 120 1280 160 64
101 1280 640 960 7680 480 512
Lambs
FI <10 <10 <10 <10 <10 <10
F2 <10 <10 <10 <10 <10 <10
357
Ewe 779 (inoculum 87/6)
Antibodies 
137/4 Baker A
to : 
C24V 87/6 Moredun Alfort
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 <10 <10 <10
10 <10 <10 <10 60 <10 <10
14 20 <10 10 240 15 <10
21 40 15 40 1280 10 <10
28 120 320 160 7680 80 12
42 320 320 120 7680 120 32
56 960 1280 240 3840 160 96
101 1280 960 240 7680 1280 128
Lambs
FI <10 <10 <10 <10 <10 <10
Ewe 813 (inoculum 87/6)
DAYS
0 <10 <10 <10 <10 <10 <10
5 <10 <10 <10 60 <10 <10
10 <10 <10 <10 120 <10 <10
14 30 <10 <10 640 <10 <10
21 60 10 <10 960 <10 <10
28 160 30 15 1280 20 24
42 640 320 160 1280 160 128
56 960 640 240 5120 320 96
97 1280 640 160 20480 480 192
Lambs
FI <10 <10 <10 <10 <10
F2 <10 <10 <10 <10 <10
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Parameters used for morphemetrie evaluation of piglets and 
lambs (upper and lower 95% confidence limits for normal 
animals at birth; Wrathall, 1972; Richardson and others, 
1976; Richardson, 1977):
Piglets (at 111-116 days):
Body weight: 782-1788g 
C-R length: 25.1-34.5cm
Bone length:
Tibia 34.9-46.4mm 
Femur 35.7-47.6mm 
Ulna 34.5-47.2mm 
Radius 25.7-35.Omm 
Humerus 36.2-47.0mm
Lambs (at 140 days):
Body weight : 3190-2750g 
C-R length : 37.5-44.4cm
Bone length:
Tibia 93-107cm
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Sex, weight, crown-rump length, brain and cerebellum
measurements of piglets.
GROUP I
Weight 
(grams)
sow 307 Sex
PI F 720.00
P2 M 960.00
P3 M 1,400.00
P4 M 1,510.00
P5 F 1,350.00
P6 F 1,340.00
P7 F 1,130.00
P8 M 1,290.00
sow 305
PI F 640.00
P2 M 1,040.00
P3 M 1,030.00
P4 F 1,120.00
P5 F 1 ,040.00
P6 F 710.00
P7 F 1,060.00
P8 M 870.00
P9 F 1,200.00
P10 F 1,040.00
P11 F NA
PI 2 M 510.00
sow 163
PI M 1,060.00
P2 F 1 ,050.00
P3 M 1,270.00
P4 M 1,000.00
P5 F 790.00
P6 M 1,070.00
P7 M 1,110.00
P8 M 1,180.00
P9 F 1,030.00
sow 164
PI F 1,100.00
P2 F 1,210.00
P3 M 1,200.00
P4 F 990.00
P5 M 1,060.00
P6 M 1,260.00
P7 M 830.00
PB M 1,200.00
P9 M 930.00
P10 F 1,220.00
C/R Brain Cerebellum
length Weight Weight
(cm) (grams) (grams)
25.00 26.72 2.60
28.00 26.76 2.80
31 .50 27.82 3.12
31 .00 35.42 3.50
29.50 28.72 2.86
31 .00 30.60 3.22
29.00 30.12 2.96
30.00 28.04 3.14
25.00 26.06 2.24
28.00 29.20 2.92
27.50 25.64 2.82
29.00 26.26 2.64
28.00 27.62 2.40
27.00 23.66 2.50
28.00 30.06 3.00
27.00 30.34 3.00
30.00 28.22 2.72
29.00 31 .76 2.54
29.00 24.96 2.50
23.00 22.28 2.26
30.00 28.84 2.84
30.00 29.88 2.98
31 .00 32.98 3.70
28.00 25.46 2.78
27.00 24.02 2.48
29.00 29.28 3.30
30.00 28.86 3.74
30.00 28.54 3.48
29.00 27.34 2.88
28.00 30.50 3.40
30.50 26.42 2.94
30.00 30.02 3.28
28.00 27.78 3.10
28.50 31.36 3.04
31 .00 28.96 2.96
27.00 30.02 3.16
29.00 28.26 3.34
27.00 26.18 2.96
29.50 29.12 3.24
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Sex, weight, crown-rump length, brain and cerebellum
measurements of piglets.
GROUP II Weight C/R Brain Cerebellum
(grams) length Weight Weight
(cm) (grams) (grams)
sow 303 Sex
PI M 1,480.00 30.00 35.26 3.76
P2 M 1,410.00 31 .50 NA* NA
P3 M 1,530.00 32.00 35.00 3.58
P4 F 1,280.00 29.50 31 .06 3.28
P5 M 1,070.00 28.50 31.86 3.04
P6 M 1,510.00 31 .00 NA NA
sow 302
PI M 1,200.00 30.00 23.44 2.58
P2 M 1,000.00 28.00 26.26 2.64
P3 NR** NR NR 19.54 2.22
P4 F 920.00 30.00 21 .58 2.46
P5 NR NR NR 21 .98 2.44
P6 NR NR NR 23.84 2.50
P7 NR NR NR 23.02 2.18
P8 M 1,100.00 30.00 23.78 2.32
P9 M 750.00 27.00 24.00 2.24
PI 0 M 1,100.00 29.00 23.40 2 . 38
P11 F 750.00 25.00 23.52 2 . 38
PI 2 ( + ) NR NR NR NR NR
sow 304
PI M 940.00 27.50 26.48 2.72
P2 M 1,140.00 29.00 27.56 2.64
P3 NR NR NR 27.60 2.66
P4 F 840.00 27.00 26.42 2 . 50
P5 M 1,130.00 29.00 29.30 2.98
P6 M 1,200.00 29.00 27.14 2.60
P7 M 1,230.00 29.00 30.22 3 . 28
P8 F 1,160.00 30.00 25.84 2.52
P9 F 970.00 28.00 29.28 2.86
P10 F 980.00 28.50 27.30 2.64
P11 M 1,080.00 28.50 22.72 2.58
sow 111
PI ( + ) F 1,150.00 29.00 NA NA
P2 F 770.00 26.00 28.32 2.32
P3 F 1,030.00 27.00 25.30 2.22
P4 M 1,050.00 27.00 25.74 2.40
P5 M 880.00 25.50 26.82 2.56
P6 F 720.00 24.00 25.76 1 .88
P7 F 920.00 25.00 24.36 2.20
P8 F 1 ,100.00 29.00 27.50 2.58
P9 F 760.00 25.00 26.64 2.12
P10 M 1,010.00 27.00 23.80 2.20
P11 F 1 .010.00 27.00 25.12 2.38
(*) = not available 
(**) = not registered
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Estimation of fatal age of piglets by bona measurement.
GROUP I
sow307
T ib ia * Age** Femur Age Ulna Age Radius Age Humerus Age Average age o f 
p ig le t  l i t t e r
PI 31.0 96 33.0 100 32.0 99 24.0 98 34.0 101 99 111
P2 36.0 105 38.0 107 36.0 105 26.0 103 40.0 111 106
P3 41.0 115 41.0 113 40.0 113 29.0 110 42.0 115 114
P4 41.0 115 41.0 113 41.0 115 30.0 113 41.0 114 114
P5 41.0 115 41.0 113 40.0 113 30.0 113 42.0 115 114
P6 42.0 116 42.0 115 42.0 117 21.0 114 43.0 116 115
P7 38.0 110 38.0 107 38.0 110 28.0 108 39.0 110 113
P8 41.0 115 41.0 113 39.0 111 29.0 110 41.0 114 113
sow 305 
PI 33.0 100 32.0 98 31.0 96 26.0 103 33.0 100 100 105
P2 36.0 105 36.0 105 35.0 104 25.0 100 37.0 105 104
P3 38.0 110 37.0 106 38.0 110 28.0 108 40.0 111 109
P4 38.0 110 38.0 107 36.0 105 27.0 105 38.0 107 107
P5 33.0 100 33.0 100 36.0 105 26.0 103 37.0 105 103
P6 34.0 102 36.0 105 34.0 103 27.0 105 35.0 104 104
P7 37.0 107 37.0 106 36.0 105 26.0 103 38.0 107 106
P8 33.0 100 35.0 103 38.0 110 28.0 108 37.0 105 106
P9 36.0 105 36.0 105 36.0 105 27.0 105 39.0 110 106
P10 38.0 110 38.0 107 37.0 107 27.0 105 40.0 111 108
P11 38.0 110 38.0 107 36.0 105 28.0 108 38.0 107 107
PI 2 30.0 95 30.0 94 31.0 96 24.0 98 33.0 100 97
sow 163 
PI 39.0 111 38.0 107 37.0 107 27.0 105 39.0 110 108
106
P2 36.0 105 37.0 106 36.0 105 28.0 108 39.0 110 107
P3 39.0 111 39.0 110 37.0 107 27.0 105 41.0 114 110
P4 34.0 102 36.0 105 35.0 104 25.0 100 37.0 105 103
P5 33.0 100 30.0 90 30.0 95 24.0 98 33.0 100 97
P6 39.0 111 36.0 105 37.0 107 27.0 105 40.0 111 108
P7 36.0 105 36.0 105 36.0 105 26.0 103 38.0 107 105
P8 39.0 111 40.0 111 39.0 111 29.0 110 41.0 114 112
P9 36.0 105 34.0 101 36.0 105 27.0 105 37.0 105
104
sow 164 
PI 39.0 111 39.0 110 39.0 111 30.0 113 42.0 115 112
110
P2 41.0 115 33.0 100 40.0 113 29.0 110 42.0
115 111
P3 38.0 110 39.0 110 39.0 111 29.0 110 42.0 115
111
P4 41.0 115 40.0 111 38.0 110 28.0 108 40.0
111 111
P5 41.0 115 40.0 111 36.0 105 28.0 108 40.0
111 110
P6 42.0 116 43.0 116 41.0 115 30.0 113 42.0
115 115
P7 36.0 105 36.0 105 36.0 105 26.0 103 35.0
102 104
P8 40.0 113 42.0 115 40.0 113 28.0 108 41.0
114 112
P9 35.0 104 37.0 106 35.0 104 24.0 98 36.0 105
103
P10 41.0 115 42.0 115 38.0 110 26.0 103 40.0 111
111
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Estimation of fetal age of piglets by bone measurement.
GROUP II__________________________________________________________________________________________________________________________
Tibia* Age** Femur Age Ulna Age Radius Age Humerus Age Average age of
piglet litter
sow 303 
PI 44.0 119 44.0 119 42.0 117 30.0 113 45.0 120 117
P2 43.0 117 44.0 119 42.0 117 30.0 113 41.0 - 119 117
P3 42.0 116 42.0 115 41.0 115 31.0 110 43.0 116 115
P4 39.0 ill 41.0 113 40.0 113 30.0 113 43.0 116 113
PS 39.0 ill 39.0 no 40.0 113 30.0 113 42.0 115 113
P6 41.0 115 41.0 113 41.0 115 32.0 117 42.0 115 115
sow 302 
PI 35.0 104 36.0 105 37.0 107 27.0 105 39.0 no 106
P2 35.0 104 35.0 103 36.0 105 26.0 103 37.0 105 104
P3 36.0 105 36.0 105 37.0 107 27.0 105 38.0 107 105
P4 32.0 99 32.0 98 34.0 103 26.0 103 35.0 104 102
PS 34.0 102 33.0 100 34.0 103 25.0 100 35.0 104 102
PS 32.0 99 31.0 95 33.0 100 25.0 100 36.0 105 100
P7 31.0 96 31.0 95 32.0 99 23.0 95 33.0 100 97
PS 38.0 110 36.0 105 37.0 107 27.0 105 39.0 110 107
P9 33.0 100 32.0 98 35.0 104 25.0 100 35.0 104 101
P10 36.0 105 35.0 103 36.0 105 27.0 105 37.0 105 105
P11 33.0 100 33.0 100 34.0 103 25.0 100 33.0 100 100
P12(+) 21.0 79 21.0 79 25.0 86 16.0 78 21.0 77 80
sow 304
PI 35.0 104 36.0 105 35.0 104 27.0 105 39.0 no 106
P2 38.0 110 38.0 107 37.0 107 28.0 108 39.0 110 108
P3 37.0 107 36.0 105 39.0 111 29.0 no 40.0 111 no
P4 35.0 104 35.0 103 34.0 103 25.0 100 36.0 105 109
P5 40.0 113 40.0 111 38.0 110 28.0 108 41.0 114 111
P6 39.0 111 39.0 110 38.0 110 28.0 108 40.0 111 110
P7 40.0 113 41.0 113 40.0 113 30.0 113 41.0 114 113
P8 40.0 113 39.0 110 38.0 no 29.0 110 40.0 111 111
P9 37.0 107 37.0 106 38.0 110 28.0 108 40.0 111 108
P10 37.0 107 36.0 105 37.0 107 27.0 105 38.0 107 107
P ll 38.0 110 38.0 ’ 107 38.0 110 28.0 108 38.0 107 108
sow 111
P1(+) 33.0 100 32.0 98 34.0 103 26.0 103 35.0 102 101
P2 35.0 104 35.0 102 34.0 103 26.0 103 38.0 107 104
P3 36.0 105 36.0 105 36.0 105 28.0 108 37.0 105 105
P4 37.0 107 39.0 110 36.0 105 27.0 105 38.0 107 107
P5 34.0 102 34.0 101 33.0 100 25.0 100 36.0 105 102
P6 32.0 99 34.0 101 31.0 96 23.0 95 33.0 100 100
P7 34.0 102 35.0 102 32.0 99 25.0 100 35.0 102 101
P8 . 39.0 111 39.0 110 39.0 111 29.0 110 42.0 115 111
P9 36.0 105 37.0 106 34.0 103 24.0 98 37.0 105 103
P10 39.0 111 39.0 110 36.0 105 28.0 108 41.0 114 no
P ll 39.0 111 39.0 110 38.0 110 28.0 108 39.0 110 110
(+) * mummified fetuses
(*) « all length measurements In millimeters
(**) » measured in days
Morphometrical evaluation of infected lambs.
GROUP I
Sex Weight*
C/R 
length 9
Brain Cerebellum 
Weight Weight
Tibial
length^
Estimated 
fetal age**
no. Lamb no.
813 LI M 2,250.00 40.80 49.82 5.58 78 131
L2 F 2,590.00 39.00 45.72 5.06 74 127
779 LI M 3,050.00 44.00 52.18 5.58 88 141
357 LI M 3,020.00 42.00 45.06 4.80 79 127
L2 F 2,510.00 40.00 44.02 4.32 82 135
361 LI M 4,150.00 47.50 48.66 5.10 91 144
GROUP II
Ewe no. Lamb no.
329 LI F 2,670.00 42.00 42.72 3.54 78 131
L2 M 2,840.00 42.00 42.92 3.00 87 140
330 LI F 320.00 23.00 9.25 0.89 30 83
1482 LI M 2,490.00 39.00 53.82 6.18 71 124
L2 F 2,300.00 38.00 37.52 4.46 72 ' 125
709 LI F 1,060.00 33.00 29.54 2.28 88 137
L2 M 2,730.00 41.50 19.00 3.70 84 141
* = in grams
** = in days 
A- = in millimetres 
@ = in centimetres
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Results of F/T experiments.
SNTs :
GROUP I
SNT SNT
sow 307 BEFORE AFTER
PI <2 <2
P2 <2 2
P3 <2 2
P4 <2 <2
P5 <2 3
P6 <2 2
P7 <2 <2
P8 <2 <2
sow 305
PI <2 2
P2 25600 25600
P3 8000 6000
P4 48 196
P5 64 256
P6 24000 24000
P7 6000 12000
P8 6000 8000
P9 3000 6000
PI 0 96000 64000
P11 8000 8000
P12 3000 2000
sow 163
PI 16000 12000
P2 256 256
P3 <2 <2
P4 128000 96000
P5 6000 4000
P6 12000 8000
P7 16 24
PB <2 NA
P9 4000 12000
sow 164
PI 2 4
P2 <2 <2
P3 <2 <2
P4 <2 <2
P5 <2 <2
P6 <2 <2
P7 <2 <2
PB <2 <2
P9 <2 <2
PI 0 <2 2
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SNTs :
GROUP II
SNT SNT
BEFORE AFTER
sow 303
PI 8 NA
P2 480 240
P3 1600 1200
P4 NA NA
P5 256 256
P6 256 256
sow 302
PI 64000 64000
P2 256 256
P3 256 NA
P4 96000 64000
P5 3000 1000
P6 24000 16000
P7 <2 <2
P8 <2 <2
P9 1200 12800
PI 0 19200 51200
P11 48000 96000
Pi 2( + ) NA NA
sow 304
PI 4800 3200
P2 19200 38400
P3 19200 6400
P4 800 1600
P5 <2 <2
P6 6400 9600
P7 2 3
P8 3200 25600
P9 800 9600
P10 600 600
Pll 48000 48000
sow 111
PI ( + ) NA NA
P2 <2 <2
P3 <2 96
P4 <2 <2
P5 12 240
P6 <2 <2
P7 <2 <2
PB <2 <2
P9 <2 <2
P10 960 1500
P11 24000 32000
(+)= mummified fetus
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GROUP I Polyclonal ELISA
BEFORE AFTER VARIATION
sow 307 F/T F/T
PI 0.050 0.047 0.063
P2 0.038 0.062 0.630
P3 0.079 0.153 0.940
P4 0.128 0.164 0.028
P5 0.133 0.141 0.060
P6 0.135 0.150 0.110
P7 0.208 0.1 55 0.340
P8 0.150 0.122 0.230
sow 305
PI 0.071 0.102 0.440
P2 0.109 0.467 3.280
P3 0.074 0.087 0.170
P4 NA 0.143 NA
P5 NA 0.198 NA
P6 0.110 0.248 1.250
P7 0.063 0.073 0.158
P8 0.049 0.060 0.224
P9 0.039 0.115 1 .948
Pi 0 0.099 0.296 1 .989
P11 0.066 0.084 0.272
PI 2 NA NA
sow 163
Pi 0.150 0.153 0.020
P2 0.130 0.144 0.107
P3 0.166 0.191 0.150
P4 0.145 0.344 1 .372
P5 0.133 0.217 0.631
P6 0.080 0.040 1.000
P7 0.090 0.105 0.167
P8 0.053 0.051 0.039
P9 NA 0.093 NA
sow 164
PI 0.072 0.059 0.220
P2 0.105 0.098 0.071
P3 0.081 0.068 0.191
P4 0.080 0.046 0.739
P5 0.062 0.075 0.209
P6 0.066 0.075 0.136
P7 0.056 0.049 0.142
PB 0.049 0.052 0.061
P9 0.058 0.064 0.103
PI 0 0.064 0.053 0.207
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GROUP II Polyclonal ELISA
BEFORE AFTER
sow 303 F/T F/T
PI 0.054 0.056
P2 0.075 0.125
P3 0.089 0.082
P4 0.057 0.116
P5 0.141 0.088
P6 0.090 0.077
sow 302
PI 0.074 0.146
P2 0.045 0.056
P3 0.094 0.278
P4 0.121 0.255
P5 0.086 0.092
P6 0.112 0.413
P7 0.040 0.041
PB 0.049 0.053
P9 0.075 0.147
PI 0 0.132 0.342
P11 0.096 0.274
PI 2( + ) NA NA
sow 304
PI 0.127 0.141
P2 0.143 0.393
P3 0.074 0.152
P4 0.084 0.132
P5 0.127 0.096
P6 0.096 0.202
P7 0.082 0.109
P8 0.083 0.185
P9 0.072 0.105
P10 0.091 0.095
Pll 0.135 0.369
sow 111
PI ( + ) NA Ni
P2 0.096 0.087
P3 0.050 0.048
P4 0.064 0.063
P5 0.072 0.113
P6 0.076 0.057
P7 0.058 0.055
P8 0.064 0.059
P9 0.045 0.047
PI 0 0.085 0.168
Pi 1 0.148 0.324
+)= mummified fetus
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F/T e x p e r i m e n t s .
GROUP
GROUP
LAMBS
SNT SNT
POLYCLONAL
ELISA
BEFORE AFTER BEFORE AFTER
357L1 <2 48 NA 0.315
357L2 <2 12 NA 0.182
779L1 <2 4 NA 0.163
813L1 <2 8 NA 0.146
813L2 <2 4 NA 0.199
361 LI <2 32 NA 0.203
1482L1 <2 4 NA 0.187
1482L2 <2 <2 NA 0.266
709L1 NA NA NA NA
709L2 NA NA NA 0.189
329L1 64000 96000 0 . 509 0.503
329L2 96000 96000 0.603 0 .577
330L1 NA NA NA NA
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f /t  e x p e r i m e n t s
ELISA 
Rabbit anti-porcine 
IgG only
BEFORE AFTER
P6 0.919 2.094
P7 0.134 0.472
P8 0.117 0.539
P9 0.653 1 .454
PI 0 0.994 1 .054
SOW 164
Pi 0.079 0 .137
P2 0.065 0 .124
P3 0.072 0 .117
P4 0.061 0 .,094
P5 0.076 0 . 140
P6 0.066 0.,151
P7 0.096 0..110
P8 0.064 0 . 096
P9 0.050 0 .091
PI 0 0.061 0 .088
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UNINOCULATED PIGLETS AND LAMBS
ELISA with rabbit anti­swine IgG only
or
ELISA with rabbit anti sheep IgG only
12 F/T 15 F/T
SOW PD4 BEFORE AFTER VARIATION BEFORE AFTER
PI 0.459 0.463 0.008 0.390 0.367
P2 0.375 0.353 -0.060 0.250 0.492
P3 0.332 0.350 0.050 0.286 0.257
P4 0.329 0.340 0.030 0.259 0.270
P5 0.314 0.313 -0.003 0.244 0.234
P6 0.306 0.308 0.006 0.223 0.233
P7 0.301 0.300 0.003 0.195 0.217
P8 0.293 0.298 0.017 0.220 0.288
P9 0.356 0.373 0.050 0.320 0.316
PI 0 0.346 0.349 0.008 0.297 0.289
P11 0.303 0.297 -0.020 0.228 0.225
EWE 2661
LI 0.556 0.566 0.020 0.110 0.121
L2 0.478 0.486 0.010 0.083 0.141
L3 0.402 0.406 0.009 0.089 0.062
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